
<html lang="en"     class="pb-page"  data-request-id="b125fe8d-f4ff-4ab4-93e3-63b0d615d27f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01430;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity" /></meta><meta name="dc.Creator" content="BinQing  Wei" /></meta><meta name="dc.Creator" content="Janet  Gunzner-Toste" /></meta><meta name="dc.Creator" content="Hui  Yao" /></meta><meta name="dc.Creator" content="Tao  Wang" /></meta><meta name="dc.Creator" content="Jing  Wang" /></meta><meta name="dc.Creator" content="Zijin  Xu" /></meta><meta name="dc.Creator" content="Jinhua  Chen" /></meta><meta name="dc.Creator" content="John  Wai" /></meta><meta name="dc.Creator" content="Jim  Nonomiya" /></meta><meta name="dc.Creator" content="Siao Ping  Tsai" /></meta><meta name="dc.Creator" content="Josefa  Chuh" /></meta><meta name="dc.Creator" content="Katherine R.  Kozak" /></meta><meta name="dc.Creator" content="Yichin  Liu" /></meta><meta name="dc.Creator" content="Shang-Fan  Yu" /></meta><meta name="dc.Creator" content="Jeff  Lau" /></meta><meta name="dc.Creator" content="Guangmin  Li" /></meta><meta name="dc.Creator" content="Gail D.  Phillips" /></meta><meta name="dc.Creator" content="Doug  Leipold" /></meta><meta name="dc.Creator" content="Amrita  Kamath" /></meta><meta name="dc.Creator" content="Dian  Su" /></meta><meta name="dc.Creator" content="Keyang  Xu" /></meta><meta name="dc.Creator" content="Charles  Eigenbrot" /></meta><meta name="dc.Creator" content="Stefan  Steinbacher" /></meta><meta name="dc.Creator" content="Rachana  Ohri" /></meta><meta name="dc.Creator" content="Helga  Raab" /></meta><meta name="dc.Creator" content="Leanna R.  Staben" /></meta><meta name="dc.Creator" content="Guiling  Zhao" /></meta><meta name="dc.Creator" content="John A.  Flygare" /></meta><meta name="dc.Creator" content="Thomas H.  Pillow" /></meta><meta name="dc.Creator" content="Vishal  Verma" /></meta><meta name="dc.Creator" content="Luke A.  Masterson" /></meta><meta name="dc.Creator" content="Philip W.  Howard" /></meta><meta name="dc.Creator" content="Brian  Safina" /></meta><meta name="dc.Description" content="Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements ..." /></meta><meta name="Description" content="Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 21, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01430" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01430" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01430" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01430" /></link>
        
    
    

<title>Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01430" /></meta><meta property="og:title" content="Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0020.jpeg" /></meta><meta property="og:description" content="Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements in ADC therapeutic index are desired. Peptide-based ADC linkers that are cleaved by lysosomal proteases have shown sufficient stability in serum and effective payload-release in targeted cells. If the linker can be preferentially hydrolyzed by tumor-specific proteases, safety margin may improve. However, the use of peptide-based linkers limits our ability to modulate protease specificity. Here we report the structure-guided discovery of novel, nonpeptidic ADC linkers. We show that a cyclobutane-1,1-dicarboxamide-containing linker is hydrolyzed predominantly by cathepsin B while the valine–citrulline dipeptide linker is not. ADCs bearing the nonpeptidic linker are as efficacious and stable in vivo as those with the dipeptide linker. Our results strongly support the application of the peptidomimetic linker and present new opportunities for improving the selectivity of ADCs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01430"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01430">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01430&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01430&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01430&amp;href=/doi/10.1021/acs.jmedchem.7b01430" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 989-1000</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01409" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01466" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=BinQing++Wei">BinQing Wei</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3654-3459" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner-Toste">Janet Gunzner-Toste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Yao">Hui Yao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Wang">Tao Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Wang">Jing Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zijin++Xu">Zijin Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinhua++Chen">Jinhua Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Wai">John Wai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Nonomiya">Jim Nonomiya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Siao+Ping++Tsai">Siao Ping Tsai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josefa++Chuh">Josefa Chuh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+R.++Kozak">Katherine R. Kozak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yichin++Liu">Yichin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shang-Fan++Yu">Shang-Fan Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Lau">Jeff Lau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangmin++Li">Guangmin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gail+D.++Phillips">Gail D. Phillips</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Doug++Leipold">Doug Leipold</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amrita++Kamath">Amrita Kamath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dian++Su">Dian Su</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keyang++Xu">Keyang Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Eigenbrot">Charles Eigenbrot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Steinbacher">Stefan Steinbacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachana++Ohri">Rachana Ohri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helga++Raab">Helga Raab</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leanna+R.++Staben">Leanna R. Staben</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guiling++Zhao">Guiling Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Flygare">John A. Flygare</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+H.++Pillow">Thomas H. Pillow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7300-1002" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vishal++Verma">Vishal Verma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luke+A.++Masterson">Luke A. Masterson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+W.++Howard">Philip W. Howard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Safina">Brian Safina</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Spirogen, QMB Innovation Centre, 42 New Road, London E1 2AX, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Proteros Biostructures GmbH, Bunsenstrasse 7a, D-82152 Martinsried, Germany</span></div><div class="corresp-info"><strong>*</strong>B.W.: phone, (650) 467-8283; fax, (650) 225-2061; e-mail, <a href="/cdn-cgi/l/email-protection#2473414d0a664d4a754d4a436443414a410a474b49"><span class="__cf_email__" data-cfemail="97c0f2feb9d5fef9c6fef9f0d7f0f2f9f2b9f4f8fa">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>B.S.: e-mail, <a href="/cdn-cgi/l/email-protection#693a080f000708472b1b000807290e0c070c470a0604"><span class="__cf_email__" data-cfemail="a8fbc9cec1c6c986eadac1c9c6e8cfcdc6cd86cbc7c5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01430&amp;href=/doi/10.1021%2Facs.jmedchem.7b01430" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 989–1000</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 11, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 September 2017</li><li><span class="item_label"><b>Published</b> online</span>21 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01430" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01430</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D989%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBinQing%2BWei%252C%2BJanet%2BGunzner-Toste%252C%2BHui%2BYao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D3%26contentID%3Dacs.jmedchem.7b01430%26title%3DDiscovery%2Bof%2BPeptidomimetic%2BAntibody%25E2%2580%2593Drug%2BConjugate%2BLinkers%2Bwith%2BEnhanced%2BProtease%2BSpecificity%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1000%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01430"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5534</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01430" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;BinQing&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner-Toste&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zijin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Jinhua&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Wai&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Nonomiya&quot;},{&quot;first_name&quot;:&quot;Siao&quot;,&quot;last_name&quot;:&quot;Ping Tsai&quot;},{&quot;first_name&quot;:&quot;Josefa&quot;,&quot;last_name&quot;:&quot;Chuh&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;R. Kozak&quot;},{&quot;first_name&quot;:&quot;Yichin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shang-Fan&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Lau&quot;},{&quot;first_name&quot;:&quot;Guangmin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Gail&quot;,&quot;last_name&quot;:&quot;D. Phillips&quot;},{&quot;first_name&quot;:&quot;Doug&quot;,&quot;last_name&quot;:&quot;Leipold&quot;},{&quot;first_name&quot;:&quot;Amrita&quot;,&quot;last_name&quot;:&quot;Kamath&quot;},{&quot;first_name&quot;:&quot;Dian&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Keyang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Eigenbrot&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Steinbacher&quot;},{&quot;first_name&quot;:&quot;Rachana&quot;,&quot;last_name&quot;:&quot;Ohri&quot;},{&quot;first_name&quot;:&quot;Helga&quot;,&quot;last_name&quot;:&quot;Raab&quot;},{&quot;first_name&quot;:&quot;Leanna&quot;,&quot;last_name&quot;:&quot;R. Staben&quot;},{&quot;first_name&quot;:&quot;Guiling&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Flygare&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;H. Pillow&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;Verma&quot;},{&quot;first_name&quot;:&quot;Luke&quot;,&quot;last_name&quot;:&quot;A. Masterson&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;W. Howard&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Safina&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;989-1000&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01430&quot;},&quot;abstract&quot;:&quot;Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements in ADC therapeutic index are desired. Peptide-based ADC linkers that are cleaved by lysosomal proteases have shown sufficient stability in serum and effective payload-release in targeted cells. If the linker can be preferentially hydrolyzed by tumor-specific proteases, safety margin may improve. However, the use of peptide-based linkers limits our ability to modulate protease specificity. Here we report the structure-guided discovery of novel, nonpeptidic ADC linkers. We show that a cyclobutane-1,1-dicarboxamide-containing linker is hydrolyzed predominantly by cathepsin B while the valine–citrulline dipeptide linker is not. ADCs bearing the nonpeptidic linker are as efficacious and stable in vivo as those with the dipeptide linker. Our results strongly support the application of the peptidomimetic linker and present&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01430&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01430" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01430&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01430" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01430&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01430" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01430&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01430&amp;href=/doi/10.1021/acs.jmedchem.7b01430" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01430" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01430" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01430%26sid%3Dliteratum%253Aachs%26pmid%3D29227683%26genre%3Darticle%26aulast%3DWei%26date%3D2018%26atitle%3DDiscovery%2Bof%2BPeptidomimetic%2BAntibody%25E2%2580%2593Drug%2BConjugate%2BLinkers%2Bwith%2BEnhanced%2BProtease%2BSpecificity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D989%26epage%3D1000%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (6)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=291891" title="Crystal cleavage">Crystal cleavage</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements in ADC therapeutic index are desired. Peptide-based ADC linkers that are cleaved by lysosomal proteases have shown sufficient stability in serum and effective payload-release in targeted cells. If the linker can be preferentially hydrolyzed by tumor-specific proteases, safety margin may improve. However, the use of peptide-based linkers limits our ability to modulate protease specificity. Here we report the structure-guided discovery of novel, nonpeptidic ADC linkers. We show that a cyclobutane-1,1-dicarboxamide-containing linker is hydrolyzed predominantly by cathepsin B while the valine–citrulline dipeptide linker is not. ADCs bearing the nonpeptidic linker are as efficacious and stable in vivo as those with the dipeptide linker. Our results strongly support the application of the peptidomimetic linker and present new opportunities for improving the selectivity of ADCs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The use of antibody–drug conjugates has emerged as a powerful approach to deliver cytotoxic drugs to tumor cells. There are a number of clinical trials ongoing involving this class of therapeutics.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, the therapeutic window of existing clinical-stage ADC’s is relatively narrow.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Factors likely contributing to this phenomenon include linker instability that results in premature release of the attached cytotoxic payload during systemic circulation<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> and the release of payload in noncancerous tissues due to nonspecific uptake (pinocytosis) and/or low level of antigen-expression on normal cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Accordingly, current approaches to the design of new ADCs seek to improve on at least one of these parameters in order to achieve enhanced clinical performance.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">The use of protease-cleavable peptide linkers, in particular a valine–citrulline dipeptide linker (Val-Cit),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> has proved to be an effective strategy for ADC construction owing much to the clinical success of brentuximab vedotin.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Peptidic linkers have been shown to be stable in circulation and able to effectively release attached payloads inside target cells<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and, when conjugated to noninternalizing antibodies, outside target cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> They are the subject of active investigations.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> It is generally believed that lysosomal cathepsin B is one of the proteases mainly responsible for the cleavage of the Val-Cit ADC linker inside target cells. Other proteases, including both close homologs of cathepsin B (e.g., cathepsin X) and enzymes that are distantly related/unrelated (e.g., cathepsins L and D), may also be involved.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Importantly, the precise extent to which the activation of Val-Cit ADC linker depends on cathepsin B enzyme activity has not been reported.</div><div class="NLM_p">Cathepsin B (EC 3.4.22.1) is a member of the papain family of cysteine proteases.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It can function as an exopeptidase (i.e., carboxydipeptidase) at acidic pH as well as an endopeptidase at neutral pH, owing to a structural feature called the occluding loop.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Cathepsin B is normally associated with lysosomes involved in autophagy and immune response, but numerous studies have shown that its overexpression is correlated with invasive and metastatic phenotypes in cancers.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> A major mechanism that cathepsin B contributes to cancer progression is its involvement in degradation of the extracellular matrix.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A recent report suggested that the exopeptidase and endopeptidase activities of cathepsin B both contribute to the proteolysis of extracellular matrix and tumor cell invasion.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, it is conceivable that, compared to the Val-Cit linker, an ADC linker whose hydrolysis is more dependent on cathepsin B may help target the release of the attached cytotoxic payloads more specifically to tumor cells.</div><div class="NLM_p last">In an effort to further enhance the tumor-specific release of ADC payload via protease-dependent cleavage, we sought to identify nonpeptidic protease-substrates that could serve as effective linkers for ADC. To the best of our knowledge, the exploration of such peptidomimetic ADC linkers has not been previously reported. We anticipated that, due to a reduction in the number of hydrolyzable amide bonds, the new linker moieties would offer greater opportunities to modulate the recognition by tumor-specific/elevated proteases relative to the legacy peptide linkers. In this initial report, we describe the identification of several peptidomimetic linkers with enhanced specificity toward cathepsin B that efficiently release various attached payloads following intracellular ADC-mediated delivery.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To facilitate rapid in vitro biochemical testing of our new linker designs, we devised a simplified molecular construct to assess the ability of various linker-payloads to undergo protease-mediated cleavage (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, compound <b>1</b>). Using this system, hydrolysis of the aniline-derived amide bond present in <b>1</b> can be readily detected through a norfloxacin payload released by subsequent immolation of the liberated <i>p</i>-aminobenzylcarbonyl moiety. We anticipated that these simple molecules could be used to model the ability of peptidomimetic linkers to undergo similar protease-effected cleavage following ADC-mediated intracellular delivery. We expect the model to be valid regardless of whether the linker-payload is attached to an antibody or to just a cysteine, since the exact sequence of events between linker cleavage and antibody degradation is not known.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Simplified Molecular Construct for Measuring the Cleavage of ADC Linker Moieties by Protease<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reduction of ADC to the simplified construct is illustrated using the dipeptide linker Val-Cit (compound <b>1</b>).</p></p></figure><div class="NLM_p">To validate our approach of using this simplified molecular construct, we applied it to some representative dipeptide linkers and measured their cleavage kinetic parameters using a constant concentration of cathepsin B enzyme. Michaelis–Menten steady-state <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> data for the linkers were compared as the P1 and P2 side chains with different charge, polarity, and shape were explored (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). A hydrogen bond donor-rich citrulline side chain at the P1 position afforded a ∼9-fold higher <i>V</i><sub>max</sub> value than an alanine side chain (<b>1</b> vs <b>2</b>). A positively charged arginine side chain at this position further improved substrate binding affinity (>10-fold reduction of <i>K</i><sub>m</sub>) compared to the citrulline, making <b>3</b> the most preferred substrate in the biochemical assay. Despite its positive charge, β-(4-piperidinyl)alanine (<b>4</b>) caused a ∼10-fold decrease in binding affinity than <b>3</b>, suggesting that this bulky side chain may fit less well in the active site. At the P2 position, bulky aromatic side chains gained affinity (lower <i>K</i><sub>m</sub>) at the cost of <i>V</i><sub>max</sub>, resulting in no improvement in the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio (<b>1</b> vs <b>5</b> or <b>6</b>). These observed trends are consistent with previous reports of the substrate preference profile of human cathepsin B determined using combinatorial peptide libraries<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> and support the use of this approach. Additionally it is important to note that despite having a <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> value 3-fold lower than the Val-Cit linker, the valine–alanine linker (Val-Ala) has been successfully used in ADCs currently in clinical trials.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, we reasoned that a proteolytic efficiency level similar to that of the Val-Ala linker would be sufficient for an effective ADC.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> Properties for the Cleavage of Representative Dipeptide Linkers by Cathepsin B Measured Using the Simplified Constructs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The concentration of human cathepsin B enzyme was kept constant at 2 nM.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> values were obtained by fitting the cleavage assay data (duplicate, <i>n</i> = 1) using Michaelis–Menten equation. All values are rounded to two significant digits (95% confidence intervals given in parentheses).</p></div></div><div></div></div><div class="NLM_p">To guide the design of new, nonpeptidic linkers cleavable by cathepsin B, we identified the structure of the enzyme bound to a dipeptidyl nitrile inhibitor (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This structure was particularly informative of the substrate recognition by the enzyme because the inhibitor has a peptide scaffold while its nitrile moiety formed a thioimidate ester with the catalytic cysteine residue (Cys29), mimicking the acyl enzyme intermediate of substrate hydrolysis (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The amide backbone of the molecule extends along the active site, forming hydrogen bonds with Gly74 and Gly198 residues known to be critical for substrate binding (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> At the position corresponding to the P1 residue of peptide substrate is a glycine moiety. Its Cα carbon atom is within 5 Å of the carboxylate group of Glu122 residue, which has been proposed to confer a preference for cationic side chains at P1 position.<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15, 23)</a> At the position corresponding to the P2 residue is a phenylalanine-like moiety, fitting snugly in a hydrophobic pocket presumably occupied by those lipophilic side chains favored at this position (e.g., valine and phenylalanine). We hypothesized that these backbone and side chain interactions together hold the scissile amide bond in the correct position for nucleophilic attack by Cys29. This led us to investigate two ways to design nonpeptidic substrates: (1) to replace the amide bond between the P1 and P2 residues and (2) to replace the P2 residue.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based design of cathepsin B-cleavable, nonpeptidic ADC linkers. (A, B) PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a> shows that a network of hydrogen bonds are involved in proper positioning of a substrate for nucleophilic attack by the thiol of Cys29 residue. Modeling based on the structure led to three series of new linkers: the F-olefin, the triazole, and the cBu series. The inhibitor (carbon atoms colored in green) forms a thioimidate adduct with the protein, mimicking the acyl enzyme intermediate of substrate hydrolysis. Orange dotted lines show selected hydrogen bonds mentioned in the text. The moieties corresponding to the P1 and P2 side chains of a peptide substrate are labeled in blue in the chemical sketch. The scissile amide bond is in red. (C, D) Model of the tetrahedral intermediate of hydrolysis for a cBu linker with a <i>p</i>-aminobenzyl alcohol leaving group (<b>15</b>, carbon atoms in cyan). Orange dotted lines show selected hydrogen bonds mentioned in the text. The 1,1-dicarboxamide moiety is predicted to form the same hydrogen bonds with the protein as the PDB compound, while the cyclobutyl group is expected to occupy the S2 site. The norfloxacin moiety is too far from the active site to participate in the amide bond hydrolysis, so it is omitted in the figure for clarity. (E, F) X-ray crystal structure of human cathepsin B in complex with <b>28</b>, a covalent inhibitor analogous to the cBu-Cit linker, refined at 1.6 Å resolution. The Polder omit electron density map contoured at 2.8σ is shown as blue mesh. Orange dotted lines show select hydrogen bonds mentioned in the text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We first sought to replace the amide moiety between the P1 and P2 residues while maintaining the interaction of those side chains with the protein. Guided by modeling based on the crystal structure (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">Supporting Information Figure S1A and Figure S1B</a>), we identified two chemical series that showed significant activities as substrate: fluoro olefins (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and 1,2,3-triazoles (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). With a citrulline side chain at the P1 position, the valine–fluoroolefin–citrulline linker (<b>7</b>) showed a 6-fold lower <i>V</i><sub>max</sub> value and a 7-fold higher <i>K</i><sub>m</sub> value than the Val-Cit peptide linker (<b>1)</b>, amounting to a nearly 40-fold reduction in the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio. Changing the P1 side chain from citrulline to alanine decreased the catalytic efficiency by approximately 6-fold (<b>7</b> vs <b>8</b>), which is consistent with the trend observed from the corresponding peptide linkers (<b>1</b> vs <b>2</b>). In the triazole series, the valine–triazole–citrulline linker (<b>9</b>) showed a 210-fold loss in catalytic efficiency relative to the Val-Cit linker. Replacing the citrulline side chain with an arginine (<b>10</b>) or a lysine (<b>11</b>) side chain at the P1 position improved the cleavage efficiency of the triazole linker by 18- to 29-fold, though the substrates were still significantly less active than the corresponding peptide linkers (<b>10</b> vs <b>3</b>). Unlike the peptide linkers, incorporation of an aromatic P2 side chain reduced the cleavage efficiency (<b>11</b> vs <b>12</b>, and <b>9</b> vs <b>13</b>). On the basis of modeling, we had anticipated that for both these series, some of the hydrogen bonds between the linker’s peptide backbone and the protein could be lost (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">Supporting Information Figure S1A and S1B</a>). The reduction in proteolytic efficiency of those new molecules relative to the peptides suggested to us that those hydrogen bond interactions are critical.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> Properties for the Cleavage of Fluoroolefin Linkers by Cathepsin B Measured Using the Simplified Constructs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The concentration of human cathepsin B enzyme was kept constant at 2 nM.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> values were obtained by fitting the cleavage assay data (duplicate, <i>n</i> = 1) using Michaelis–Menten equation. All values are rounded to two significant digits (95% confidence intervals given in parentheses).</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> Properties for the Cleavage of Triazole Linkers by Cathepsin B Measured Using the Simplified Constructs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0012.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0013.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">The concentration of human cathepsin B enzyme was kept constant at 2 nM.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last"><i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> values were obtained by fitting the cleavage assay data (duplicate, <i>n</i> = 1) using Michaelis–Menten equation. All values are rounded to two significant digits (95% confidence intervals given in parentheses).</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Not determined because the cleavage activity was too low to be measured under the assay condition.</p></div></div><div></div></div><div class="NLM_p">Next we sought to replace the P2 amino acid of peptide linker while keeping its hydrogen bond interactions with the residues Gly74 and Gly198 of the protease. Using a computational, shape-similarity search, we identified the cyclobutane-1,1-dicarboxamide series (“cBu”, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C, and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D). The cyclobutyl group was predicted to be optimal in size to fill the hydrophobic S2 pocket, while the 1,1-dicarboxamide moiety was expected to form all three hydrogen bonds to the protein like the peptide linker. Furthermore, the bound conformation of cyclobutane-1,1-dicarboxamide predicted by modeling was found to be energetically favored. We tested those predictions by making a series of compounds, varying the moieties on either side of the cyclobutyl ring as well as the ring itself (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). As the ring size ranged from 3 to 6 atoms, the <i>V</i><sub>max</sub> and <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio both peaked when the size reached 4 (compounds <b>14</b>–<b>17</b>). The linker bearing a <i>gem</i>-dimethylglycine (<b>18</b>) showed an activity too low to be determined under our assay conditions. At the P1 position, compared to a citrulline side chain (<b>15</b>), an arginine side chain increased the cleavage efficiency of the linker by about 8-fold (<b>19</b>), while a lysine or dimethyllysine side chain only improved the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio by up to about 3-fold (<b>20</b>, <b>21</b>). Acetylation of the lysine side chain reduced the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio by about 2-fold (<b>22</b>). More significantly, removal of all hydrogen bond donors at this position rendered the cleavage activity too low to be determined (<b>23</b>). In addition to the P1 and P2 positions, we also explored substitutions on the cBu linker that correspond to the P3 side chain of the peptide linker. Modeling suggested that an aryl/heteroaryl ring with appropriate chirality may contribute to tighter binding affinity by stacking with the backbone amide of Gly74 and interacting with Try75 residue. Indeed, compared to an isopropyl group (<b>24</b>), a 3-thiophenyl (<b>25</b>) or phenyl (<b>27</b>) moiety increased the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio by 5- to 10-fold. That improvement was more due to tighter substrate-binding than better <i>V</i><sub>max</sub>. Given that both Val-Cit and Val-Ala dipeptides were shown to be effective linkers in vivo, it was not clear to us that a P3 substitution was necessary, so we did not try to optimize the P3 moiety further.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> Properties for the Cleavage of Cycloalkyl-1,1-dicarboxamide Linkers by Cathepsin B Measured Using the Simplified Constructs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0014.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0015.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">The concentration of human cathepsin B enzyme was kept constant at 2 nM.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last"><i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> values were obtained by fitting the cleavage assay data (duplicate, <i>n</i> = 1) using Michaelis–Menten equation. All values are rounded to two significant digits (95% confidence intervals given in parentheses).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Not determined because the cleavage activity was too low to be measured under the assay conditions.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last"><b>25</b> and <b>26</b> are a pair of diastereomers with unknown stereochemistry.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last"><b>28</b> is a single diastereomer with unknown stereochemistry at one of the chiral centers. It was used in the crystallography study as a mimic of the cBu-Cit linker.</p></div></div><div></div></div><div class="NLM_p">To verify our computational model of the cBu linker, we obtained a crystal structure of human cathepsin B in complex with an analog of the cBu-Cit compound (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, <b>28</b>). Because <b>15</b> would be hydrolyzed by the enzyme, we replaced the scissile amide bond with an electrophilic cyano group to trap the hydrolysis product. The resulting 1.6 Å-resolution crystallographic structure showed <b>28</b> forming a thioimidate ester with the catalytic residue Cys29 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E), like the PDB structure that guided the modeling (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Gratifyingly, some of the predicted interactions were observed: the dicarboxamide moiety is well-positioned to form three hydrogen bonds with residues Gly74 and Gly198, and the cyclobutyl ring indeed occupies the S2 pocket. The electron density was sufficient to determine the coordinates of the citrulline side chain only up to the C<sub>β</sub> atom. We speculated that in the absence of a substrate leaving group, the rest of the side chain could be rather mobile. Also, there was not enough electron density to define the position of the terminal methyl or the chirality of <b>28</b>. Overall, the crystallographic structure as well as the data (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) confirmed our computational model for the cBu linker.</div><div class="NLM_p">Among the new peptidomimetic linkers we identified, <i>V</i><sub>max</sub> values for the cBu series were found to be similar to those for the peptide linkers while the fluoroolefin and the triazole series exhibited lower <i>V</i><sub>max</sub> values (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In terms of <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio, the cBu linker was about 15-fold lower than the corresponding peptide linker (<b>15</b> vs <b>1</b>, <b>19</b> vs <b>3</b>). We wondered whether/how this difference would affect the payload release and efficacy of ADC.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> properties across all series. Data from <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are plotted. Chemical series are color-coded: peptides from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> are in red, fluoroolefins from <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> in magenta, 1,2,3-triazoles from <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> in orange, and cycloalkyl-1,1-dicarboxamides from <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> in green. For reference, compounds Val-Cit (<b>1</b>), Val-Ala (<b>2</b>), Val-Arg (<b>3</b>), cBu-Cit (<b>15</b>), and cBu-Arg (<b>19</b>) are labeled, and three different levels of <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio are shown by black lines. Compounds on the same line share the same <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using those new, nonpeptidic linkers, we prepared ADCs conjugated to different payloads (<a class="ref internalNav" href="#tbl5" aria-label="Tables 5">Tables 5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). We adopted a cysteine-engineering strategy that allows for the straightforward conjugation of payloads to yield homogeneous antibody–drug conjugates.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The drug/antibody ratios (DAR) for all the conjugates were between 1.8 and 2 as determined by LC/MS analysis of the lysyl endopeptidase digest of the ADCs. Here we report the data from ADCs conjugated at position 118 (EU numbering) on the antibody heavy chain. The results are representative of our findings using ADCs conjugated at different sites<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (data not shown). <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A shows a representative data set obtained with ADCs carrying monomethyl auristatin E<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (MMAE) payload. In the Her2-overexpressing SK-BR-3 cells, anti-Her2 ADCs using either Val-Cit (<b>29</b>) or cBu-Cit (<b>31</b>) linkers were equally active in inhibiting cell proliferation. As expected, a nontarget control antibody (anti-CD22) conjugated with MMAE using the cBu-Cit linker had little activity in SK-BR-3 cells. Similarly, the anti-Her2 ADCs showed very small effects against MCF7 cells which express only low levels of the Her2 antigen (data not shown). Collectively, the data indicated that the two ADCs were equally active in inhibiting the proliferation of the cancer cells and their activities were antigen-specific. However, this equivalence in activity does not necessarily mean that the rates of payload release inside target cells are similar for the two linkers. This is because, for example, full release of free MMAE molecules may not be required for the activity.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of ADCs bearing different linkers in their antiproliferation potencies and intracellular concentrations of the released payload in SK-BR-3 cancer cell line. MMAE drug was conjugated to anti-Her2 and anti-CD22 (control) monoclonal antibodies via the Val-Cit and cBu-Cit linker, respectively (mAb-<b>29</b>, mAb-<b>31</b>). (A) Cell viability after 5 days of ADC treatment. Each sample was in quadruplicate. (B) Intracellular concentrations of the released MMAE in SK-BR-3 cells measured at 23 h after the treatment with the ADCs. For comparison, ADCs bearing Val-(<i>R</i>)-Cit or cBu-(<i>R</i>)-Cit linker were also included (mAb-<b>30</b>, mAb-<b>32</b>). Each sample was in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structures of the Linker-MMAE Molecules Used To Prepare the ADCs Tested in Biological Studies<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0016.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0017.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table a</sup><p class="last">All ADCs were conjugated via the maleimide group to an engineered cysteine at position 118 (EU numbering) on the two heavy chains of the respective antibodies.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Structures of the Linker-PBD Molecules Used To Prepare the ADCs Tested in Biological Studies<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0018.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0019.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>Table a</sup><p class="last">All ADCs were conjugated via the maleimide group to an engineered cysteine at position 118 (EU numbering) on the two heavy chains of the respective antibodies.</p></div></div><div></div></div><div class="NLM_p">Given the differences in <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> values observed for the Val-Cit and cBu-Cit model constructs (<b>1</b> vs <b>15</b>), we wondered whether the two ADCs (<b>29</b> vs <b>31</b>) may differ in their ability to release free MMAE in targeted cells. We measured the concentrations of MMAE inside SK-BR-3 cells after ADC treatment. A duration of 23 h was found to be optimal for the assay as it was long enough to allow ADCs to be substantially endocytosed and extensive cell killings or lysis had not started yet. We tested ADC concentrations ranging from 0.08 to 10 μg/mL and found that the Her2-mediated endocytosis appeared to saturate at about the 2 μg/mL level. Surprisingly, no statistically significant difference in the amounts of released MMAE was found between an ADC containing the cBu-Val linker (<b>31</b>) or one bearing the Val-Cit peptide linker (<b>29</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). This was observed at all ADC concentrations tested regardless of whether the target-mediated endocytosis reached saturation or not. To test whether enzymatic or nonenzymatic process underlie the release of MMAE, two ADCs containing the respective (<i>R</i>)-citrulline linkers (<b>30</b>, <b>32</b>) were included for comparison. Switching from the (<i>S</i>)- to the (<i>R</i>)-citrulline is expected to render those linkers resistant to proteases. Indeed, both <b>30</b> and <b>32</b> afforded negligible release of MMAE at all concentration levels examined. This confirms that the observed release resulted from protease hydrolysis instead of nonenzymatic process. The apparent discrepancy between these observations in the cells and the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> data of the corresponding model compounds (<b>1</b> vs <b>15</b>) can be explained by the fact that the cathepsin B assay does not fully capture how the ADC linkers are degraded in cell lysosome. For example, intracellular concentrations of the substrates (i.e., ADC) and/or the proteases may be substantially different (higher) than those in the enzymatic assay. In addition, other proteases besides cathepsin B may contribute to intracellular payload release. To further probe this latter possibility, we conducted additional experiments using the MMAE conjugates.</div><div class="NLM_p">Using a panel of commercially available protease inhibitors with varying degrees of specificity, we assessed the impact of these reagents on the MMAE payload release from several ADCs bearing peptide or nonpeptidic linkers (<b>29</b>, <b>31</b>, <b>33, 34</b>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). We tested CA-074_Me<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (cathepsin B inhibitor), CAA0225<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (cathepsin L inhibitor), BML_244<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (cathepsin K inhibitor), pepstatin<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (inhibitor of aspartyl proteases such as cathepsin D), and leupeptin<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (inhibitor of cysteine, serine, and threonine proteases). The inhibitors were applied at a concentration of 50 μM in order to saturate the enzymes. Interestingly, release of MMAE from the Val-Cit-containing ADC (<b>29</b>) appeared resistant to all but the broad-spectrum protease inhibitor leupeptin, which reduced the intracellular MMAE level by 50%. For example, only a 15% decrease in the MMAE level was observed upon the treatment with either the aspartyl proteases inhibitor (not statistically significant) or the potent cathepsin B inhibitor. In contrast, for the three ADCs bearing the peptidomimetic linkers, the release of MMAE was over 90% blocked by leupeptin. More importantly, the payload release of those ADCs was more sensitive to the inhibition of cathepsin B than that of the Val-Cit-containing ADC. For the cBu-Cit-containing ADC (<b>31</b>), the MMAE release was over 75% suppressed. while for the triazole (<b>34</b>) and the fluoroolefin-containing ADCs (<b>33</b>), the reductions were 60% and 32%, respectively. The additional decrease of MMAE level upon the treatment with leupeptin compared to that with the cathepsin B inhibitor suggests that some other enzyme(s) may contribute to the cleavage of these nonpeptidic linkers as well. We also observed a 26% decrease in payload release by the triazole-containing ADC after the treatment with the cathepsin L-specific inhibitor. It is important to note that this comparison relies on the published specificity data of those inhibitors. Nevertheless, the observed differences strongly suggest that the new peptidomimetic linkers, especially cBu-Cit linker, have an enhanced protease specificity toward cathepsin B compared to the Val-Cit peptide linker.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of protease inhibitors on the release of MMAE payload by ADCs bearing different linkers. SK-BR-3 cells were treated overnight with 1 μg/mL of anti-Her2 ADC carrying one of the four linker-MMAEs (<b>29</b>, <b>31</b>, <b>33</b>, or <b>34</b>) and 50 μM protease inhibitor. Cell lysates were then prepared and analyzed by LC–MS/MS. Intracellular MMAE levels were quantified by total ion chromatogram (TIC), and for each linker-MMAE, all inhibitor-treated samples were normalized to the respective DMSO-treated control (100% TIC). Each sample was in triplicate except for the DMSO treated controls (<i>n</i> = 4, in black).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next compared CD22-targeting ADCs bearing the cBu-Cit (<b>31</b>) or Val-Cit linker (<b>29</b>) in their efficacy and stability in mouse xenograft tumor models. In a CD22-expressing lymphoma model (WSU-DLCL2), the two ADCs displayed equivalent, target-dependent activity when administered at two different doses (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). No body weight loss was observed from either conjugate at up to 8 mg/kg dose level, suggesting they were both well-tolerated (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). We also tested the same ADCs in another CD22-expressing lymphoma model (Bjab-luc) and again observed equivalent efficacies for the two conjugates (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). To see if this observation was only applicable to tubulin-targeting payloads, we also tested a DNA-damaging payload, pyrrolobenzodiazepine dimer<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (PBD) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In a Napi2b-expressing ovarian cancer model (OVCAR3X2.1), Napi2b-targeting ADCs containing either the Val-Cit or cBu-Cit linker were both efficacious in inhibiting tumor growth when dosed at the 3 mg/kg level (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). Interestingly, the cBu-Cit linked ADC appeared somewhat more potent and afforded tumor regression in this model. The efficacy comparison suggested that in the tumor cells the proteolytic capacity of cathepsin B was sufficient for effective release of payload from the cBu-Cit linker. Contributions by other proteases that can digest the Val-Cit but not the cBu-Cit linker are not required for the efficacy. Besides the efficacy, we also monitored the pharmacokinetic profiles of the two ADCs in the same mouse xenograft study. For example, for the 1 mg/kg dose groups in the above Bjab-luc lymphoma study (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, groups 2 and 4), no significant difference was observed in either the half-life of the antibody (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A) or the stability of the conjugate (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) between the two ADCs bearing different linkers. This equivalence in both antibody half-life and conjugate stability between the Val-Cit and the cBu-Cit linkers was also demonstrated in mouse tumor studies using ADCs carrying the PBD payload (data not shown).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of ADC efficacies in mouse xenograft tumor models. (A, B) In vivo efficacy of the anti-CD22 ADCs carrying MMAE payload was assessed in mice bearing WSU-DLCL2 (A) or Bjab-luc (B) human lymphoma xenografts. (C) In vivo efficacy of the anti-Napi2b ADCs carrying PBD dimer payload was evaluated in mice bearing OVCAR3X2.1 human ovarian xenografts. In each study, animals received on day 0 a single intravenous injection of antibody–drug conjugates through the tail vein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the in vivo stability of ADCs in mice bearing Bjab-luc human lymphoma xenograft. Blood samples were taken from the mice in groups 2 and 4 of the efficacy study shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, at 1, 7, and 14 days postdosing. (A) Total antibody concentrations. (B) Conjugated antibody concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure-based design led to the discovery of three series of nonpeptidic ADC linkers, including the cBu series which exhibited a level of proteolysis efficiency approaching that of the peptide linkers. A crystal structure of an analogous covalent inhibitor bound to cathepsin B confirmed the modeling predictions regarding how a cBu-Cit linker is recognized by the protease active site for cleavage. A comparison of the cBu-Cit linker with the Val-Cit linker in cancer cell lines found that they exhibited equally potent antiproliferation effects and displayed similar rates of intracellular payload release. Using selected protease inhibitors, we showed that the cleavage of the cBu-Cit linker predominantly depends on cathepsin B. In contrast, the degradation of the Val-Cit peptide linker was resistant to the inhibition of cathepsin B. Furthermore, ADCs containing the cBu-Cit linker were equally efficacious and stable in multiple mouse tumor models compared to the conjugates bearing the Val-Cit linker. This equivalence in in vivo efficacy and stability was consistently observed with ADCs delivering MMAE drug (a tubulin polymerization blocker) as well as ADCs carrying PBD dimer payload (a DNA-alkylator). Our data support the application of the new peptidomimetic linkers in the construction of ADC therapeutics and demonstrate the feasibility and opportunity to tailor the linker moiety toward cleavage by tumor-specific/enhanced proteases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cathepsin B Cleavage Assay</h3><div class="NLM_p last">Cathepsin B-catalyzed linker cleavage activity was assessed by an LC/MS MRM-based quantitation method. Briefly, varying concentrations of experimental linker (1.5-fold serial dilution from 100 μM maximum down to 1.16 μM minimum) were incubated with 2 nM human liver cathepsin B (EMD Millipore, no. 219364), 25 nM norfloxacin-<i>d</i><sub>5</sub> internal standard (CDN Isotopes, no. D-7196), 10 mM MES, pH 6.0, and 1 mM DTT. The reaction was incubated for 1 h at 37 °C, followed by quenching with the addition of an equal volume of 2% formic acid in water. Free norfloxacin liberated by cathepsin B and norfloxacin-<i>d</i><sub>5</sub> internal standard were quantitated by an LC/MS MRM method on a Sciex 5500 QTRAP mass spectrometer (Sciex, Framingham, MA) equipped with a Waters Acquity H-class uHPLC. Norfloxacin and norfloxacin-<i>d</i><sub>5</sub> were purified and desalted using a Water BEH-C18 column, using a gradient of water/acetonitrile with 0.1% formic acid. Measured norfloxacin MRM AUC was normalized against norfloxacin-<i>d</i><sub>5</sub> AUC, then plotted against linker concentration using GraphPad Prism (GraphPad Software, La Jolla, CA). The resulting data were fitted for <i>K</i><sub>m</sub> and <i>V</i><sub>max</sub> values using Michaelis–Menten equation. Each experiment was done in duplicate for each linker concentration. MRM parameters for norfloxacin: <i>Q</i><sub>1</sub> = 320, <i>Q</i><sub>3</sub> = 233.1, collision energy = 30. MRM parameters for norfloxacin-<i>d</i><sub>5</sub>: <i>Q</i><sub>1</sub> = 325, <i>Q</i><sub>3</sub> = 238.1, collision energy = 30.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Computational Modeling and Crystallography</h3><div class="NLM_p last">Available human cathepsin B structures in Protein Data Bank were analyzed, and a structure bound covalently to a dipeptidyl nitrile inhibitor (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a>) was selected to guide the design of nonpeptidic, cathepsin B-cleavable linkers. Specific interactions between the inhibitor and cathepsin B observed from the crystallographic structure inspired us to pursue two design strategies: (1) to replace the amide bond between the P1 and P2 moieties while maintaining the positions/interactions of their side chains; (2) to replace the P2 moiety while keeping the network of hydrogen bond interaction with residues Gly74 and Gly198 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). In both cases, a “Link Multiple Fragments” search was performed in MOE (Chemical Computing Group, version 2012) using the default library to identify chemical structures that could connect the two fragments on either side of the moiety being replaced. By use of MOE, the hits were filtered by pharmacophores defined by the observed interactions, energy-minimized in the absence of the protein in order to identify highly strained conformations, and then visually inspected in the enzyme active site. For a selected subset of candidate structures, the tetrahedral intermediate of linker hydrolysis with a <i>p</i>-aminobenzyl alcohol leaving group was built in MOE based on the reported catalytic mechanism of cathepsin B (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">Supporting Information Figure S1A and S1B</a>).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The X-ray crystallographic structure of <b>28</b> (crystallized and determined by Proteros Biostructures, Germany) was refined at 1.6 Å resolution to <i>R</i><sub>free</sub> = 17.6% in space group <i>P</i>21. The data were twinned (twin fraction = 48.5%, twin operator: −H, −K, H + L). The coordinates were deposited under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AY2">6AY2</a> in Protein Data Bank.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of Chemicals</h3><div class="NLM_p last">Synthesis and characterization of compounds <b>1</b>–<b>36</b> are provided in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">Supporting Information</a>. For all biologically evaluated compounds, the purity was determined by HPLC to be >95%.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Conjugation Process and Characterization by Mass Spectrometry</h3><div class="NLM_p last">Construction and production of the THIOMAB antibodies used were done as reported previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Briefly, an alanine-to-cysteine mutation was made at 118 (EU numbering) position of the heavy chain of the antibody to produce the corresponding THIOMAB antibody. The THIOMAB antibodies were conjugated to different linker drugs as described previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Briefly, the antibody was reduced in the presence of 50-fold molar excess DTT (Calbiochem) overnight. The reducing agent and the cysteine and glutathione blocks were purified away using HiTrap SP-HP column (GE Healthcare). The antibody was reoxidized in the presence of 15-fold molar excess dhAA (MP Biomedical) for 2.5 h. The formation of interchain disulfide bonds was monitored by LC/MS. Linker drug in range of 3-fold to 10-fold molar excess over protein was incubated with the activated THIOMAB antibodies for 3 or 16 h. The antibody drug conjugate was purified on HiTrap SP-HP column (GE Healthcare) to remove excess linker drug. The number of conjugated linker drug molecules per THIOMAB antibody was quantified by LC/MS analysis. Purity was also assessed by size exclusion chromatography. LC/MS analysis was performed on a 6530 Accurate-Mass quadrupole time-of-flight (Q-TOF) LC/MS (Agilent Technologies). Samples were chromatographed on a PRLP-S, 1000 Å, 8 μm (50 mm × 2.1 mm, Agilent Technologies), heated to 80 °C. A linear gradient from 30 to 60% B in 4.3 min (solvent A, 0.05% TFA in water; solvent B, 0.04% TFA in acetonitrile) was used, and the eluent was directly ionized using the electrospray source. Data were collected and deconvoluted using the Agilent Mass Hunter qualitative analysis software. Before LC/MS analysis, antibody–drug conjugate was treated with 15 mM DTT for 30 min at pH 8.0 and 37 °C to separate the HC and LC portion for ease of analysis. Chromatographic conditions were chosen to achieve baseline resolution of LC, HC, and HC + 1 drug in different peaks. The drug to antibody ratio (DAR) was calculated using the integrated peak area of the UV chromatogram at 280 nm and orthogonally from the abundance of the ions present in LC/MS deconvoluted results. The peaks were identified using LC/MS. All ADCs in this study employed THIOMAB antibodies, and the DAR values were determined to be between 1.8 and 2.0.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Characterization of ADC Activity in Cell Viability Assay</h3><div class="NLM_p last">Cells were plated in black-walled 96-well plates (4000 cells/100 μL for SK-BR-3 and MCF7 cells) and allowed to adhere overnight at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub>. Medium (Ham’s F-12, high glucose DMEM [50:50] supplemented with 10% heat-inactivated fetal bovine serum and 2 mmol/L <span class="smallcaps smallerCapital">l</span>-glutamine) (all from Invitrogen Corp.) was then removed and replaced by 100 μL of fresh culture medium containing various concentrations of each conjugate (conjugate stock [in 20 mM histidine acetate, pH 5.5, 240 mM sucrose, 0.02% Tween 20] diluted in medium). Cell Titer-Glo (Promega Corp.) was added to the wells at 5 days after drug administration, and the luminescent signal was measured using EnVision multilabel plate reader (PerkinElmer).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Quantitation of ADC Payload Release in Cell Lines and the Effect of Protease Inhibitor Treatment</h3><div class="NLM_p">Her2-expressing SKBR3 cells were seeded at 2.0 × 10<sup>5</sup> cells/mL in 50 μL of DMEM culture medium supplemented with 10% fetal bovine serum and 2 mM glutamine (Genentech Media Prep), in 96-well Costar plates and incubated at 37 °C overnight in a CO<sub>2</sub> incubator. The next day, antibody–drug conjugates (ADC) with Val-Cit or cBu-Cit linkers diluted with the culture medium at 2× final concentrations ranging from 0.16 μg/mL to 20 μg/mL were added to the plates and incubated with cells for 2 or 23 h. After incubation, close to 100 μL of medium was removed from each well and transferred to a new deep-well plate, then mixed with 300 μL of 100% acetonitrile per sample. Immediately after the removal of the medium, cell lysate samples were prepared with 200 μL of 75% acetonitrile to disrupt the cells and precipitate the protein. All lysed samples were centrifuged at 4000<i>g</i> for 15 min at 4 °C. After centrifugation the 150 μL supernant from cell lysate plate was transferred to a new plate, and 300 μL from media plate supernatants into fresh 96-well plate, both plates were placed in the Turbo Vap concentration workstation to facilitate evaporation for 20 and 40 min, respectively (N<sub>2</sub> gas flow rate 60 ft<sup>3</sup>/h, heater temperature 50 °C) using TurboVap 96 (Biotage, Charlotte, NC). Pellets were reconstituted in 120 μL of water (Optima LC/MS, Fisher Chemical) and centrifuged at 4000<i>g</i> for 15 min at 4 °C. The samples were then reconstituted with H<sub>2</sub>O. After centrifugation, 100 μL of each supernatant was transferred to a new 96-well plate. All samples were than analyzed using electrospray LC–MS/MS.</div><div class="NLM_p">For LC–MS/MS analysis protocol, an amount of 10 μL of the acidified samples was injected onto a Phenomenex Kinetex 50 mm × 2.1 mm i.d. XB-C18 reversed phase column coupled to an Sciex 6500 QTRAP mass spectrometer system at a flow rate of 0.8 mL/min with the following gradient: 5% B (100% acetonitrile + 0.1% formic acid) at 0–0.5 min; 70% B at 1 min; 95% B at 1.1 min. The mass spectrometer turbo spray ion drive source temperature was 400 °C and the ion spray voltage 3500 V. The source parameters curtain gas, ion source gas 1, and ion source gas 2 were set at 35, 50, and 50 psi, respectively. Multiple reaction monitoring (MRM) transitions <i>m</i>/<i>z</i> 718.4 → 134.2 (CE 43 V, CXP 8 V), 718.4 → 506.3 (CE 31 V, CXP 14 V), and 718.4 → 686.3 (CE 39 V, CXP 18 V) were used with dwell time 100 ms and declustering potential 46 V. And for internal control loperamide MRM <i>m</i>/<i>z</i> 477.15 → 266.2 (CE 35 V, CXP 14 V, declustering potential 116 V, dwell time 100 ms). Data were analyzed using MultiQuant software, and graphs were generated using Microsoft Excel and GraphPad Prism 6.</div><div class="NLM_p">For the protease inhibitor treatment experiment, SKBR3 cells were seeded at 80 000 cells/well onto the Costar plate as described above. ADC at 1 μg/mL was added onto the plate in the presence of 50 μM inhibitor. All ADC-inhibitor combinations were incubated with cells overnight. Cell lysates were collected, prepared, and then analyzed using electrospray LC–MS/MS as described above.</div><div class="NLM_p last">Inhibitors CA-074_Me (catalog no. 205531), CAA0225 (catalog no. 2019502), and pepstatin (catalog no. 516481) were purchased from EMD Millipore Corp. (Billerica, MA). BML_244 (catalog no. ab141723) was purchased from Abcam (Cambridge, MA), and leupeptin (catalog no. 78435) was from Fisher Scientific Co. (Pittsburgh, PA). The purities of the inhibitors were all above 95% by HPLC according to the vendors.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Efficacy Study in Mouse Xenograft Models</h3><div class="NLM_p">All animal studies were carried out in compliance with National Institutes of Health guidelines for the care and use of laboratory animals and were approved by the Institutional Animal Care and Use Committee at Genentech, Inc.</div><div class="NLM_p">The efficacy of anti-CD22 drug conjugates was evaluated in a mouse xenograft model of CD22-expressing WSU-DLCL2 or Bjab-luc human non-Hodgkin lymphoma. The WSU-DLCL2 cell line was obtained from DSMZ (German Collection of Microorganisms and Cell Cultures; Braunschweig, Germany). The Bjab-luc cell line was obtained from Genentech cell line repository and was authenticated by short tandem repeat (STR) profiling using the Promega PowerPlex 16 system to determine cell line ancestry.</div><div class="NLM_p last">To set up the WSU-DLCL2 or Bjab-luc xenograft model, tumor cells (20 million cells in 0.2 mL of Hanks’ balanced salt solution; Hyclone) were inoculated subcutaneously into the flanks of female C.B-17 SCID mice (Charles Rivers Laboratories). The efficacy of anti-NaPi2b drug conjugates was investigated in a mouse xenograft model of NaPi2b-expressing OVCAR3X2.1 human ovarian cancer. The OVCAR3 cell line was obtained from ATCC (American Type Culture Collection; Manassas, VA) and a sub-line OVCAR3X2.1 was generated at Genentech for optimal growth in mice. To set up the OVCAR3X2.1 xenograft model, tumor cells (10 million cells in 0.2 mL Hanks’ balanced salt solution; Hyclone) were inoculated in the thoracic mammary fat pad region of female C.B-17 SCID-beige mice (Charles Rivers Laboratories). When the xenograft tumors reached the desired volume (day 0), animals were divided into groups of 8 mice with similar mean tumor size and received a single intravenous injection of antibody–drug conjugates through the tail vein. The results were plotted as mean tumor volume ± SEM of each group over time. Blood samples were collected via retro-orbital bleeds and used to derive plasma for PK analyses.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Sparse PK and in Vivo ADC Stability</h3><div class="NLM_p last">Sparse pharmacokinetic sampling (collections at study days 1, 7, and 14 postdose) was collected from efficacy study (12-3033A) to preliminarily assess exposure and stability differences of these conjugates. The total antibody (TAB) is a measurement of the antibody, and irrespective of the drug load, while the conjugated antibody (Conj. Ab) is measurement of the antibody and stability of the linker. Both analytes were measured by ELISA as described previously.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> For total antibody ELISA, Nunc MaxiSorp 384-well plates (Nalge Nunc International, Rochester, NY) were coated with 0.33 μg/mL 6D3 anti-idiotypic antibody (Genentech, South San Francisco, CA) diluted in coat buffer (0.05 M carbonate/bicarbonate buffer, pH 9.6) and incubated overnight at 4 °C. The plates were washed 3 times with wash buffer (0.5% Tween-20 in PBS buffer, pH 7.4) and treated with block buffer (PBS/0.5% BSA/15 ppm Proclin, pH 7.4) for 1–2 h. The plates were again washed 3 times with wash buffer, and then samples diluted in sample diluent (PBS/0.5% BSA/0.05% Tween 20/5 mM EDTA/0.25% CHAPS/0.35 M NaCl/15 ppm Proclin, pH 7.4) were added to the wells and incubated overnight at 4 °C. The next day, the plates were brought to room temperature and then washed 6 times with wash buffer. A detection antibody, sheep anti-human IgG conjugated to horseradish peroxidase (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), diluted to 120 ng/mL in assay buffer (PBS/0.5% BSA/15 ppm Proclin/0.05% Tween 20, pH 7.4), was added to the wells and incubated on a shaker for 1 h at 4 °C. The plates were washed 6 times with wash buffer and developed using TMB peroxidase substrate (Moss Inc., Pasadena, MD) for 15 min followed by 1 M phosphoric acid to stop the reaction. Absorbance was measured at 450 nm against a reference wavelength of 620 nm. The assay range was 0.164–40 ng/mL with a minimum dilution of 1:100 (LOD = 16.4 ng/mL).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01430">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01430" class="ext-link">10.1021/acs.jmedchem.7b01430</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figure S1 showing models of the tetrahedral intermediate of hydrolysis for <b>7</b> and <b>9</b>; Figure S2 showing the body weight data for the efficacy study in the CD22-expressing lymphoma model WSU-DLCL2; Table S1 listing the crystallographic data statistics; synthesis and characterization of compounds <b>1</b>–<b>36</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound chain A of PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">SMILES strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_006.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf">jm7b01430_si_001.pdf (1.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_002.pdb">jm7b01430_si_002.pdb (7.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_003.pdb">jm7b01430_si_003.pdb (8.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_004.pdb">jm7b01430_si_004.pdb (6.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_005.pdb">jm7b01430_si_005.pdb (179.04 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_006.csv">jm7b01430_si_006.csv (4.85 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray crystallographic structure of <b>28</b> bound to human cathepsin B was deposited in the PDB under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AY2">6AY2</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01430" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">BinQing Wei</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3654-3459" title="Orcid link">http://orcid.org/0000-0002-3654-3459</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f2a5979bdcb09b9ca39b9c95b295979c97dc919d9f"><span class="__cf_email__" data-cfemail="702715195e32191e21191e173017151e155e131f1d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Safina</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link">http://orcid.org/0000-0001-8134-9949</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#326153545b5c531c70405b535c7255575c571c515d5f"><span class="__cf_email__" data-cfemail="10437176797e713e526279717e5077757e753e737f7d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner-Toste</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Yao</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Wang</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Wang</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zijin Xu</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinhua Chen</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Wai</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Nonomiya</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siao Ping Tsai</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josefa Chuh</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine R. Kozak</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yichin Liu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shang-Fan Yu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Lau</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangmin Li</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gail D. Phillips</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Doug Leipold</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amrita Kamath</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dian Su</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keyang Xu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Eigenbrot</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Steinbacher</span> - <span class="hlFld-Affiliation affiliation">Proteros
Biostructures GmbH, Bunsenstrasse 7a, D-82152 Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachana Ohri</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helga Raab</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanna R. Staben</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiling Zhao</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Flygare</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas H. Pillow</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7300-1002" title="Orcid link">http://orcid.org/0000-0001-7300-1002</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal Verma</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luke A. Masterson</span> - <span class="hlFld-Affiliation affiliation">Spirogen,
QMB
Innovation Centre, 42 New Road, London E1 2AX, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip W. Howard</span> - <span class="hlFld-Affiliation affiliation">Spirogen,
QMB
Innovation Centre, 42 New Road, London E1 2AX, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are employees of Genentech Inc., Wuxi AppTec, or Proteros Biostructures GmbH.<br /></br></div></li></ul></div><div class="ack" id="ACK-d42e1851-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jack Sadowsky and Martine Darwish for helping with the preparation and analysis of some materials used in the study, Susan Spencer and Genee Lee for coordinating the studies, and Peter S. Dragovich and Daniel F. Ortwine for reviewing the manuscript. Special thanks are extended to James Kiefer for twin refinement of the cathepsin B structure in complex with <b>28</b>.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP December 21, 2017, Luke A. Masterson and Philip W. Howard were added to the author list. The revised version was reposted January 11, 2018.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">antibody–drug conjugate</p></td></tr><tr><td class="NLM_term">Val-Cit</td><td class="NLM_def"><p class="first last">valine–citrulline</p></td></tr><tr><td class="NLM_term">Val-Ala</td><td class="NLM_def"><p class="first last">valine–alanine</p></td></tr><tr><td class="NLM_term">cBu</td><td class="NLM_def"><p class="first last">cyclobutane-1,1-dicarboxamide</p></td></tr><tr><td class="NLM_term">MMAE</td><td class="NLM_def"><p class="first last">monomethyl auristatin</p></td></tr><tr><td class="NLM_term">PBD</td><td class="NLM_def"><p class="first last">pyrrolobenzodiazepine dimer</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Junutula, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span> </span><span class="NLM_article-title">Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">972</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=972-973&issue=11&author=J.+R.+Junutulaauthor=H.-P.+Gerber&title=Next-Generation+Antibody-Drug+Conjugates+%28ADCs%29+for+Cancer+Therapy&doi=10.1021%2Facsmedchemlett.6b00421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00421%26sid%3Dliteratum%253Aachs%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26aulast%3DGerber%26aufirst%3DH.-P.%26atitle%3DNext-Generation%2520Antibody-Drug%2520Conjugates%2520%2528ADCs%2529%2520for%2520Cancer%2520Therapy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D11%26spage%3D972%26epage%3D973%26doi%3D10.1021%2Facsmedchemlett.6b00421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Saber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, J. K.</span><span> </span><span class="NLM_article-title">An FDA Oncology Analysis of Antibody-Drug Conjugates</span> <span class="citation_source-journal">Regul. Toxicol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1016/j.yrtph.2015.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1016%2Fj.yrtph.2015.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=25661711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2rsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=444-452&issue=3&author=H.+Saberauthor=J.+K.+Leighton&title=An+FDA+Oncology+Analysis+of+Antibody-Drug+Conjugates&doi=10.1016%2Fj.yrtph.2015.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An FDA oncology analysis of antibody-drug conjugates</span></div><div class="casAuthors">Saber, Haleh; Leighton, John K.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) are complex mols. composed of monoclonal antibodies conjugated to potent cytotoxic agents through chem. linkers.  Because of this complexity, sponsors have used different approaches for the design of nonclin. studies to support the safety evaluation of ADCs and first-in-human (FIH) dose selection.  We analyzed this data with the goal of describing the relationship between nonclin. study results and Phase 1 study outcomes.  We summarized the following data from investigational new drug applications (INDs) for ADCs: plasma stability, animal study designs and toxicities, and algorithms used for FIH dose selection.  Our review found that selecting a FIH dose that is 1/6th the highest non-severely toxic dose (HNSTD) in cynomolgus monkeys or 1/10th the STD10 in rodents scaled according to body surface area (BSA) generally resulted in the acceptable balance of safety and efficient dose-escalation in a Phase 1 trial.  Other approaches may also be acceptable, e.g. 1/10th the HNSTD in monkeys using BSA or 1/10th the NOAEL in monkeys or rodents using body wt. for scaling.  While the animal data for the vc-MMAE platform yielded variable range of HNSTDs in cynomolgus monkeys, MTDs were in a narrow range in patients, suggesting that for ADCs sharing the same small mol. drug, linker and drug:antibody ratio, prior clin. data can inform the design of a Phase 1 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNKxNbn4b6rVg90H21EOLACvtfcHk0lhL-iDF3m11bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2rsrY%253D&md5=513d5d669e869260ceb67a4419f5b208</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2015.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2015.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DSaber%26aufirst%3DH.%26aulast%3DLeighton%26aufirst%3DJ.%2BK.%26atitle%3DAn%2520FDA%2520Oncology%2520Analysis%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2015%26volume%3D71%26issue%3D3%26spage%3D444%26epage%3D452%26doi%3D10.1016%2Fj.yrtph.2015.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Donaghy, H.</span><span> </span><span class="NLM_article-title">Effects of Antibody, Drug and Linker on the Preclinical and Clinical Toxicities of Antibody-Drug Conjugates</span> <span class="citation_source-journal">MAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1080/19420862.2016.1156829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1080%2F19420862.2016.1156829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=27045800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFant7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=659-671&issue=4&author=H.+Donaghy&title=Effects+of+Antibody%2C+Drug+and+Linker+on+the+Preclinical+and+Clinical+Toxicities+of+Antibody-Drug+Conjugates&doi=10.1080%2F19420862.2016.1156829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates</span></div><div class="casAuthors">Donaghy, Heather</div><div class="citationInfo"><span class="NLM_cas:title">mAbs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">659-671</span>CODEN:
                <span class="NLM_cas:coden">MABSCP</span>;
        ISSN:<span class="NLM_cas:issn">1942-0870</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) represent a new class of cancer therapeutics.  Their design involves a tumor-specific antibody, a linker and a cytotoxic payload.  They were designed to allow specific targeting of highly potent cytotoxic agents to tumor cells while sparing normal cells.  Frequent toxicities that may be driven by any of the components of an ADC have been reported.  There are currently more than 50 ADCs in active clin. development, and a further ∼20 that have been discontinued.  For this review, the reported toxicities of ADCs were analyzed, and the mechanisms for their effects are explored in detail.  Methods to reduce toxicities, including dosing strategies and drug design, are discussed.  The toxicities reported for active and discontinued drugs are important to drive the rational design and improve the therapeutic index of ADCs of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb4UbDQ7svIrVg90H21EOLACvtfcHk0lg-05BX3raBsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFant7k%253D&md5=b2ba3e43e8362d8a3f7c368a5af5f94e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F19420862.2016.1156829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F19420862.2016.1156829%26sid%3Dliteratum%253Aachs%26aulast%3DDonaghy%26aufirst%3DH.%26atitle%3DEffects%2520of%2520Antibody%252C%2520Drug%2520and%2520Linker%2520on%2520the%2520Preclinical%2520and%2520Clinical%2520Toxicities%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DMAbs%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D659%26epage%3D671%26doi%3D10.1080%2F19420862.2016.1156829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Shen, B.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenrick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons-Reponte, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudys, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hass, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solis, W. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawli, L. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandlen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junutula, J. R.</span><span> </span><span class="NLM_article-title">Conjugation Site Modulates the in Vivo Stability and Therapeutic Activity of Antibody-Drug Conjugates</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1038/nbt.2108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.2108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=22267010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=184-189&issue=2&author=B.-Q.+Shenauthor=K.+Xuauthor=L.+Liuauthor=H.+Raabauthor=S.+Bhaktaauthor=M.+Kenrickauthor=K.+L.+Parsons-Reponteauthor=J.+Tienauthor=S.-F.+Yuauthor=E.+Maiauthor=D.+Liauthor=J.+Tibbittsauthor=J.+Baudysauthor=O.+M.+Saadauthor=S.+J.+Scalesauthor=P.+J.+McDonaldauthor=P.+E.+Hassauthor=C.+Eigenbrotauthor=T.+Nguyenauthor=W.+a+Solisauthor=R.+N.+Fujiauthor=K.+M.+Flagellaauthor=D.+Patelauthor=S.+D.+Spencerauthor=L.+a+Khawliauthor=A.+Ebensauthor=W.+L.+Wongauthor=R.+Vandlenauthor=S.+Kaurauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=J.+R.+Junutula&title=Conjugation+Site+Modulates+the+in+Vivo+Stability+and+Therapeutic+Activity+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnbt.2108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span></div><div class="casAuthors">Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saad, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Nguyen, Trung; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawli, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates.  To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge.  The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione.  In contrast, a partially accessible site with a pos. charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction.  The site with partial solvent-accessibility and neutral charge displayed both properties.  In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected pos. by succinimide ring hydrolysis and neg. by maleimide exchange with thiol-reactive constituents in plasma.  Thus, the chem. and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkINkMwQTMFrVg90H21EOLACvtfcHk0lgCjCuFf63xXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D&md5=c647fc5bdfe93dfdabb15ca40934837f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2108%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DB.-Q.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DParsons-Reponte%26aufirst%3DK.%2BL.%26aulast%3DTien%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DMai%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DTibbitts%26aufirst%3DJ.%26aulast%3DBaudys%26aufirst%3DJ.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DMcDonald%26aufirst%3DP.%2BJ.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSolis%26aufirst%3DW.%2Ba%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DK.%2BM.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DKhawli%26aufirst%3DL.%2Ba%26aulast%3DEbens%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26atitle%3DConjugation%2520Site%2520Modulates%2520the%2520in%2520Vivo%2520Stability%2520and%2520Therapeutic%2520Activity%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26issue%3D2%26spage%3D184%26epage%3D189%26doi%3D10.1038%2Fnbt.2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dorywalska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton-Witt, J. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasa-Moreno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farias, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galindo Casas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaria, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foletti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajpal, A.</span><span> </span><span class="NLM_article-title">Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span><span class="refDoi"> DOI: 10.1021/bc5005747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc5005747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=650-659&author=M.+Dorywalskaauthor=P.+Stropauthor=J.+a.+Melton-Wittauthor=A.+Hasa-Morenoauthor=S.+E.+Fariasauthor=M.+Galindo+Casasauthor=K.+Delariaauthor=V.+Luiauthor=K.+Poulsenauthor=C.+Looauthor=S.+Krimmauthor=G.+Boltonauthor=L.+Moineauthor=R.+Dushinauthor=T.-T.+Tranauthor=S.-H.+Liuauthor=M.+Rickertauthor=D.+Folettiauthor=D.+L.+Sheltonauthor=J.+Ponsauthor=A.+Rajpal&title=Effect+of+Attachment+Site+on+Stability+of+Cleavable+Antibody+Drug+Conjugates&doi=10.1021%2Fbc5005747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates</span></div><div class="casAuthors">Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Galindo Casas, Meritxell; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Loo, Carole; Krimm, Stellanie; Bolton, Gary; Moine, Ludivine; Dushin, Russell; Tran, Thomas-Toan; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The systemic stability of the antibody-drug linker is crucial for delivery of an intact antibody-drug conjugate (ADC) to target-expressing tumors.  Linkers stable in circulation but readily processed in the target cell are necessary for both safety and potency of the delivered conjugate.  Here, we report a range of stabilities for an auristatin-based payload site-specifically attached through a cleavable valine-citrulline-p-aminobenzylcarbamate (VC-PABC) linker across various sites on an antibody.  We demonstrate that the conjugation site plays an important role in detg. VC-PABC linker stability in mouse plasma, and that the stability of the linker pos. correlates with ADC cytotoxic potency both in vitro and in vivo.  Furthermore, we show that the VC-PABC cleavage in mouse plasma is not mediated by Cathepsin B, the protease thought to be primarily responsible for linker processing in the lysosomal degrdn. pathway.  Although the VC-PABC cleavage is not detected in primate plasma in vitro, linker stabilization in the mouse is an essential prerequisite for designing successful efficacy and safety studies in rodents during preclin. stages of ADC programs.  The divergence of linker metab. in mouse plasma and its intracellular cleavage offers an opportunity for linker optimization in the circulation without compromising its efficient payload release in the target cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof2xwnbbtSz7Vg90H21EOLACvtfcHk0lgTh7bIs8Mzew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsb4%253D&md5=c6ea72edbc33b0ad4aa743bc21707401</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fbc5005747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc5005747%26sid%3Dliteratum%253Aachs%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DMelton-Witt%26aufirst%3DJ.%2Ba.%26aulast%3DHasa-Moreno%26aufirst%3DA.%26aulast%3DFarias%26aufirst%3DS.%2BE.%26aulast%3DGalindo%2BCasas%26aufirst%3DM.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DPoulsen%26aufirst%3DK.%26aulast%3DLoo%26aufirst%3DC.%26aulast%3DKrimm%26aufirst%3DS.%26aulast%3DBolton%26aufirst%3DG.%26aulast%3DMoine%26aufirst%3DL.%26aulast%3DDushin%26aufirst%3DR.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DFoletti%26aufirst%3DD.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DEffect%2520of%2520Attachment%2520Site%2520on%2520Stability%2520of%2520Cleavable%2520Antibody%2520Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D650%26epage%3D659%26doi%3D10.1021%2Fbc5005747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cohen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vugts, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, G. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter-van Walsum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, G. A. M. S.</span><span> </span><span class="NLM_article-title">Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5700</span><span class="NLM_x">–</span> <span class="NLM_lpage">5710</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1158%2F0008-5472.CAN-14-1141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5700-5710&issue=20&author=R.+Cohenauthor=D.+J.+Vugtsauthor=G.+W.+M.+Visserauthor=M.+Stigter-van+Walsumauthor=M.+Bolijnauthor=M.+Spigaauthor=P.+Lazzariauthor=S.+Shankarauthor=M.+Saniauthor=M.+Zandaauthor=G.+A.+M.+S.+van+Dongen&title=Development+of+Novel+ADCs%3A+Conjugation+of+Tubulysin+Analogues+to+Trastuzumab+Monitored+by+Dual+Radiolabeling&doi=10.1158%2F0008-5472.CAN-14-1141"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1141%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DVugts%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DG.%2BW.%2BM.%26aulast%3DStigter-van%2BWalsum%26aufirst%3DM.%26aulast%3DBolijn%26aufirst%3DM.%26aulast%3DSpiga%26aufirst%3DM.%26aulast%3DLazzari%26aufirst%3DP.%26aulast%3DShankar%26aufirst%3DS.%26aulast%3DSani%26aufirst%3DM.%26aulast%3DZanda%26aufirst%3DM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%2BM.%2BS.%26atitle%3DDevelopment%2520of%2520Novel%2520ADCs%253A%2520Conjugation%2520of%2520Tubulysin%2520Analogues%2520to%2520Trastuzumab%2520Monitored%2520by%2520Dual%2520Radiolabeling%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D20%26spage%3D5700%26epage%3D5710%26doi%3D10.1158%2F0008-5472.CAN-14-1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Beck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaia, N.</span><span> </span><span class="NLM_article-title">Strategies and Challenges for the next Generation of Therapeutic Antibodies</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1038/nri2747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnri2747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=20414207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltV2ksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=345-352&issue=5&author=A.+Beckauthor=T.+Wurchauthor=C.+Baillyauthor=N.+Corvaia&title=Strategies+and+Challenges+for+the+next+Generation+of+Therapeutic+Antibodies&doi=10.1038%2Fnri2747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and challenges for the next generation of therapeutic antibodies</span></div><div class="casAuthors">Beck, Alain; Wurch, Thierry; Bailly, Christian; Corvaia, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-352</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies and related products are the fastest growing class of therapeutic agents.  By analyzing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, the authors can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market.  Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic.  Here, the authors discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with addnl. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZTNUjT-_v7Vg90H21EOLACvtfcHk0lgf2EbBlnotVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltV2ksb8%253D&md5=f8b6ffa33310f5ab2a5dfb92872b71a0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri2747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2747%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DWurch%26aufirst%3DT.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DCorvaia%26aufirst%3DN.%26atitle%3DStrategies%2520and%2520Challenges%2520for%2520the%2520next%2520Generation%2520of%2520Therapeutic%2520Antibodies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26issue%3D5%26spage%3D345%26epage%3D352%26doi%3D10.1038%2Fnri2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasch, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific in Vitro Anticancer Activity</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span><span class="refDoi"> DOI: 10.1021/bc025536j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc025536j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=855-869&issue=4&author=G.+M.+Dubowchikauthor=R.+A.+Firestoneauthor=L.+Padillaauthor=D.+Willnerauthor=S.+J.+Hofsteadauthor=K.+Mosureauthor=J.+O.+Knipeauthor=S.+J.+Laschauthor=P.+A.+Trail&title=Cathepsin+B-Labile+Dipeptide+Linkers+for+Lysosomal+Release+of+Doxorubicin+from+Internalizing+Immunoconjugates%3A+Model+Studies+of+Enzymatic+Drug+Release+and+Antigen-Specific+in+Vitro+Anticancer+Activity&doi=10.1021%2Fbc025536j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity</span></div><div class="casAuthors">Dubowchik, Gene M.; Firestone, Raymond A.; Padilla, Linda; Willner, David; Hofstead, Sandra J.; Mosure, Kathleen; Knipe, Jay O.; Lasch, Shirley J.; Trail, Pamela A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-869</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The anticancer drug doxorubicin (DOX) was linked to chimeric BR96, an internalizing monoclonal antibody that binds to a Lewisy-related, tumor-assocd. antigen, through 2 lysosomally cleavable dipeptides, Phe-Lys and Val-Cit, giving immunoconjugates (I and II).  A self-immolative p-aminobenzyloxycarbonyl (PABC) spacer between the dipeptides and the DOX was required for rapid and quant. generation of free drug. DOX release from the model substrate Z-Phe-Lys-PABC-DOX was 30-fold faster than from Z-Val-Cit-PABC-DOX with the cysteine protease cathepsin B alone, but rates were identical in a rat liver lysosomal prepn. suggesting the participation of more than one enzyme.  Conjugates I and II showed rapid and near quant. drug release with cathepsin B and in a lysosomal prepn., while demonstrating excellent stability in human plasma.  Against tumor cell lines with varying levels of BR96 expression, both conjugates showed potent, antigen-specific cytotoxic activity, suggesting that they will be effective in delivering DOX selectively to antigen-expressing carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolCImqg5WKbVg90H21EOLACvtfcHk0liLJbCwknsXOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFentr8%253D&md5=09fb70d94d8997033b109fa3b5e79621</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbc025536j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc025536j%26sid%3Dliteratum%253Aachs%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26aulast%3DFirestone%26aufirst%3DR.%2BA.%26aulast%3DPadilla%26aufirst%3DL.%26aulast%3DWillner%26aufirst%3DD.%26aulast%3DHofstead%26aufirst%3DS.%2BJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DLasch%26aufirst%3DS.%2BJ.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DCathepsin%2520B-Labile%2520Dipeptide%2520Linkers%2520for%2520Lysosomal%2520Release%2520of%2520Doxorubicin%2520from%2520Internalizing%2520Immunoconjugates%253A%2520Model%2520Studies%2520of%2520Enzymatic%2520Drug%2520Release%2520and%2520Antigen-Specific%2520in%2520Vitro%2520Anticancer%2520Activity%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D4%26spage%3D855%26epage%3D869%26doi%3D10.1021%2Fbc025536j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Senter, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, E. L.</span><span> </span><span class="NLM_article-title">The Discovery and Development of Brentuximab Vedotin for Use in Relapsed Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1038/nbt.2289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.2289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=22781692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=631-637&issue=7&author=P.+D.+Senterauthor=E.+L.+Sievers&title=The+Discovery+and+Development+of+Brentuximab+Vedotin+for+Use+in+Relapsed+Hodgkin+Lymphoma+and+Systemic+Anaplastic+Large+Cell+Lymphoma&doi=10.1038%2Fnbt.2289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma</span></div><div class="casAuthors">Senter, Peter D.; Sievers, Eric L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-637</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Progress was made recently in developing antibody-drug conjugates (ADCs) that can selectively deliver cancer drugs to tumor cells.  In principle, the idea is simple: by attaching drugs to tumor-seeking antibodies, target cells will be killed and nontarget cells will be spared.  In practice, many parameters needed to be addressed to develop safe and effective ADCs, including the expression profiles of tumor vs. normal tissues, the potency of the drug, the linker attaching the drug and placement of the drug on the antibody, and the pharmacokinetic and stability profiles of the resulting ADC.  All these issues had been taken into account in developing brentuximab vedotin (Adcetris), an ADC that recently received accelerated approval by the US Food and Drug Administration for the treatment of relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).  Research is under way to extend the applications of brentuximab vedotin and to advance the field by developing other ADCs with new linker and conjugation strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyPib6JxGsSrVg90H21EOLACvtfcHk0liLJbCwknsXOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFCqtbw%253D&md5=6940eb8178e8c8c150a7b21361e23234</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2289%26sid%3Dliteratum%253Aachs%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DSievers%26aufirst%3DE.%2BL.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520Brentuximab%2520Vedotin%2520for%2520Use%2520in%2520Relapsed%2520Hodgkin%2520Lymphoma%2520and%2520Systemic%2520Anaplastic%2520Large%2520Cell%2520Lymphoma%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26issue%3D7%26spage%3D631%26epage%3D637%26doi%3D10.1038%2Fnbt.2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span> </span><span class="NLM_article-title">Current ADC Linker Chemistry</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3526</span><span class="NLM_x">–</span> <span class="NLM_lpage">3540</span><span class="refDoi"> DOI: 10.1007/s11095-015-1657-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1007%2Fs11095-015-1657-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=25759187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Omu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=3526-3540&author=N.+Jainauthor=S.+W.+Smithauthor=S.+Ghoneauthor=B.+Tomczuk&title=Current+ADC+Linker+Chemistry&doi=10.1007%2Fs11095-015-1657-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current ADC Linker Chemistry</span></div><div class="casAuthors">Jain, Nareshkumar; Smith, Sean W.; Ghone, Sanjeevani; Tomczuk, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3526-3540</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The list of ADCs in the clinic continues to grow, bolstered by the success of first two marketed ADCs: ADCETRIS and Kadcyla.  Currently, there are 40 ADCs in various phases of clin. development.  However, only 34 of these have published their structures.  Of the 34 disclosed structures, 24 of them use a linkage to the thiol of cysteines on the monoclonal antibody.  The remaining 10 candidates utilize chem. to surface lysines of the antibody.  Due to the inherent heterogeneity of conjugation to the multiple lysines or cysteines found in mAbs, significant research efforts are now being directed toward the prodn. of discrete, homogeneous ADC products, via site-specific conjugation.  These site-specific conjugations may involve genetic engineering of the mAb to introduce discrete, available cysteines or non-natural amino acids with an orthogonally-reactive functional group handle such as an aldehyde, ketone, azido, or alkynyl tag.  These site-specific approaches not only increase the homogeneity of ADCs but also enable novel bio-orthogonal chemistries that utilize reactive moieties other than thiol or amine.  This broadens the diversity of linkers that can be utilized which will lead to better linker design in future generations of ADCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDSDdeJOKlG7Vg90H21EOLACvtfcHk0lgXBXTyBA_k_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Omu70%253D&md5=efbfe1c9469f4bf93f6a19ebc966ea1d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11095-015-1657-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-015-1657-7%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DS.%2BW.%26aulast%3DGhone%26aufirst%3DS.%26aulast%3DTomczuk%26aufirst%3DB.%26atitle%3DCurrent%2520ADC%2520Linker%2520Chemistry%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D3526%26epage%3D3540%26doi%3D10.1007%2Fs11095-015-1657-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dal Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzamalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gébleux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattarella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, D.</span><span> </span><span class="NLM_article-title">Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1826</span><span class="NLM_x">–</span> <span class="NLM_lpage">1833</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyhs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1826-1833&issue=7&author=A.+Dal+Corsoauthor=S.+Cazzamalliauthor=R.+G%C3%A9bleuxauthor=M.+Mattarellaauthor=D.+Neri&title=Protease-Cleavable+Linkers+Modulate+the+Anticancer+Activity+of+Noninternalizing+Antibody-Drug+Conjugates&doi=10.1021%2Facs.bioconjchem.7b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates</span></div><div class="casAuthors">Dal Corso, Alberto; Cazzamalli, Samuele; Gebleux, Remy; Mattarella, Martin; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1826-1833</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) represent an attractive class of biopharmaceutical agents, with the potential to selectively deliver potent cytotoxic agents to tumors.  It is generally assumed that ADC products should preferably bind and internalize into cancer cells in order to liberate their toxic payload, but a growing body of evidence indicates that also ADCs based on noninternalizing antibodies may be potently active.  In this Communication, we investigated dipeptide-based linkers (frequently used for internalizing ADC products) in the context of the noninternalizing F16 antibody, specific to a splice isoform of tenascin-C.  Using monomethyl auristatin E (MMAE) as potent cytotoxic drug, we obsd. that a single amino acid substitution of the Val-Cit dipeptide linker can substantially modulate the in vivo stability of the corresponding ADC products, as well as the anticancer activity in mice bearing the human epidermoid A431 carcinoma.  In these settings, the linker based on the Val-Ala dipeptide exhibited better performances, compared to Val-Cit, Val-Lys, and Val-Arg analogs.  Mass spectrometric anal. revealed that the four linkers displayed not only different stability in vivo but also differences in cleavage sites.  Moreover, the absence of anticancer activity for a F16-MMAE conjugate featuring a noncleavable linker indicated that drug release modalities, based on proteolytic degrdn. of the Ig moiety, cannot be exploited with noninternalizing antibodies.  ADC products based on the noninternalizing F16 antibody may be useful for the treatment of several human malignancies, as the cognate antigen is abundantly expressed in the extracellular matrix of several tumors, while being virtually undetectable in most normal adult tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOwK4KEoAgLVg90H21EOLACvtfcHk0liNtSPIIO6M0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyhs7fK&md5=7ebb8cd3dc791ce2b5d29a1a2153a72c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00304%26sid%3Dliteratum%253Aachs%26aulast%3DDal%2BCorso%26aufirst%3DA.%26aulast%3DCazzamalli%26aufirst%3DS.%26aulast%3DG%25C3%25A9bleux%26aufirst%3DR.%26aulast%3DMattarella%26aufirst%3DM.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DProtease-Cleavable%2520Linkers%2520Modulate%2520the%2520Anticancer%2520Activity%2520of%2520Noninternalizing%2520Antibody-Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26issue%3D7%26spage%3D1826%26epage%3D1833%26doi%3D10.1021%2Facs.bioconjchem.7b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setiady, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovtun, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishkin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccia, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costoplus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaletskaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdison, W. C.</span><span> </span><span class="NLM_article-title">A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1158%2F1535-7163.MCT-16-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=27197308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVeqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1311-1320&issue=6&author=R.+Singhauthor=Y.+Y.+Setiadyauthor=J.+Ponteauthor=Y.+V.+Kovtunauthor=K.+C.+Laiauthor=E.+E.+Hongauthor=N.+Fishkinauthor=L.+Dongauthor=G.+E.+Jonesauthor=J.+A.+Cocciaauthor=L.+Lanieriauthor=K.+Vealeauthor=J.+A.+Costoplusauthor=A.+Skaletskayaauthor=R.+Gabrielauthor=P.+Salomonauthor=R.+Wuauthor=Q.+Qiuauthor=H.+K.+Ericksonauthor=J.+M.+Lambertauthor=R.+V.+Chariauthor=W.+C.+Widdison&title=A+New+Triglycyl+Peptide+Linker+for+Antibody-Drug+Conjugates+%28ADCs%29+with+Improved+Targeted+Killing+of+Cancer+Cells&doi=10.1158%2F1535-7163.MCT-16-0021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells</span></div><div class="casAuthors">Singh, Rajeeva; Setiady, Yulius Y.; Ponte, Jose; Kovtun, Yelena V.; Lai, Katharine C.; Hong, E. Erica; Fishkin, Nathan; Dong, Ling; Jones, Gregory E.; Coccia, Jennifer A.; Lanieri, Leanne; Veale, Karen; Costoplus, Juliet A.; Skaletskaya, Anna; Gabriel, Rabih; Salomon, Paulin; Wu, Rui; Qiu, Qifeng; Erickson, Hans K.; Lambert, John M.; Chari, Ravi V. J.; Widdison, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A triglycyl peptide linker (CX) was designed for use in antibody-drug conjugates (ADC), aiming to provide efficient release and lysosomal efflux of cytotoxic catabolites within targeted cancer cells.  ADCs comprising anti-epithelial cell adhesion mol. (anti-EpCAM) and anti-EGFR antibodies with maytansinoid payloads were prepd. using CX or a noncleavable SMCC linker (CX and SMCC ADCs).  The in vitro cytotoxic activities of CX and SMCC ADCs were similar for several cancer cell lines; however, the CX ADC was more active (5-100-fold lower IC50) than the SMCC ADC in other cell lines, including a multidrug-resistant line.  Both CX and SMCC ADCs showed comparable MTDs and pharmacokinetics in CD-1 mice.  In Calu-3 tumor xenografts, antitumor efficacy was obsd. with the anti-EpCAM CX ADC at a 5-fold lower dose than the corresponding SMCC ADC in vivo.  Similarly, the anti-EGFR CX ADC showed improved antitumor activity over the resp. SMCC conjugate in HSC-2 and H1975 tumor models; however, both exhibited similar activity against FaDu xenografts.  Mechanistically, in contrast with the charged lysine-linked catabolite of SMCC ADC, a significant fraction of the carboxylic acid catabolite of CX ADC could be uncharged in the acidic lysosomes, and thus diffuse out readily into the cytosol.  Upon release from tumor cells, CX catabolites are charged at extracellular pH and do not penetrate and kill neighboring cells, similar to the SMCC catabolite.  Overall, these data suggest that CX represents a promising linker option for the development of ADCs with improved therapeutic properties.  Mol Cancer Ther; 15(6); 1311-20. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf-TVhCpDSJbVg90H21EOLACvtfcHk0liNtSPIIO6M0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVeqs7c%253D&md5=854059079d1e44942fef682889e96220</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0021%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DSetiady%26aufirst%3DY.%2BY.%26aulast%3DPonte%26aufirst%3DJ.%26aulast%3DKovtun%26aufirst%3DY.%2BV.%26aulast%3DLai%26aufirst%3DK.%2BC.%26aulast%3DHong%26aufirst%3DE.%2BE.%26aulast%3DFishkin%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DG.%2BE.%26aulast%3DCoccia%26aufirst%3DJ.%2BA.%26aulast%3DLanieri%26aufirst%3DL.%26aulast%3DVeale%26aufirst%3DK.%26aulast%3DCostoplus%26aufirst%3DJ.%2BA.%26aulast%3DSkaletskaya%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DR.%26aulast%3DSalomon%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DErickson%26aufirst%3DH.%2BK.%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DWiddison%26aufirst%3DW.%2BC.%26atitle%3DA%2520New%2520Triglycyl%2520Peptide%2520Linker%2520for%2520Antibody-Drug%2520Conjugates%2520%2528ADCs%2529%2520with%2520Improved%2520Targeted%2520Killing%2520of%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26issue%3D6%26spage%3D1311%26epage%3D1320%26doi%3D10.1158%2F1535-7163.MCT-16-0021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Puthenveetil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teske, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosselet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumey, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, E. I.</span><span> </span><span class="NLM_article-title">Multivalent Peptidic Linker Enables Identification of Preferred Sites of Conjugation for a Potent Thialanstatin Antibody Drug Conjugate</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0178452</span><span class="refDoi"> DOI: 10.1371/journal.pone.0178452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1371%2Fjournal.pone.0178452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0178452&issue=5&author=S.+Puthenveetilauthor=H.+Heauthor=F.+Loganzoauthor=S.+Mustoauthor=J.+Teskeauthor=M.+Greenauthor=X.+Tanauthor=C.+Hosseletauthor=J.+Lucasauthor=L.+N.+Tumeyauthor=P.+Sapraauthor=C.+Subramanyamauthor=C.+J.+O%E2%80%99Donnellauthor=E.+I.+Graziani&title=Multivalent+Peptidic+Linker+Enables+Identification+of+Preferred+Sites+of+Conjugation+for+a+Potent+Thialanstatin+Antibody+Drug+Conjugate&doi=10.1371%2Fjournal.pone.0178452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0178452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0178452%26sid%3Dliteratum%253Aachs%26aulast%3DPuthenveetil%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLoganzo%26aufirst%3DF.%26aulast%3DMusto%26aufirst%3DS.%26aulast%3DTeske%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DHosselet%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DTumey%26aufirst%3DL.%2BN.%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DGraziani%26aufirst%3DE.%2BI.%26atitle%3DMultivalent%2520Peptidic%2520Linker%2520Enables%2520Identification%2520of%2520Preferred%2520Sites%2520of%2520Conjugation%2520for%2520a%2520Potent%2520Thialanstatin%2520Antibody%2520Drug%2520Conjugate%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3De0178452%26doi%3D10.1371%2Fjournal.pone.0178452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R.</span><span> </span><span class="NLM_article-title">Twenty Years of the MEROPS Database of Proteolytic Enzymes, Their Substrates and Inhibitors</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">D1</span><span class="NLM_x">) </span> <span class="NLM_fpage">D343</span><span class="NLM_x">–</span> <span class="NLM_lpage">D350</span><span class="refDoi"> DOI: 10.1093/nar/gkv1118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1093%2Fnar%2Fgkv1118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=26527717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=D343-D350&issue=D1&author=N.+D.+Rawlingsauthor=A.+J.+Barrettauthor=R.+Finn&title=Twenty+Years+of+the+MEROPS+Database+of+Proteolytic+Enzymes%2C+Their+Substrates+and+Inhibitors&doi=10.1093%2Fnar%2Fgkv1118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors</span></div><div class="casAuthors">Rawlings, Neil D.; Barrett, Alan J.; Finn, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D343-D350</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The MEROPS database (http://merops.sanger.ac.uk) is an integrated source of information about peptidases, their substrates and inhibitors, which are of great relevance to biol., medicine and biotechnol.  The hierarchical classification of the database is as follows: homologous sets of sequences are grouped into a protein species; protein species are grouped into a family; families are grouped into clans.  There is a type example for each protein species (known as a 'holotype'), family and clan, and each protein species, family and clan has its own unique identifier.  Pages to show the involvement of peptidases and peptidase inhibitors in biol. pathways have been created.  Each page shows the peptidases and peptidase inhibitors involved in the pathway, along with the known substrate cleavages and peptidase-inhibitor interactions, and a link to the KEGG database of biol. pathways.  Links have also been established with the IUPHAR Guide to Pharmacol.  A new service has been set up to allow the submission of identified substrate cleavages so that conservation of the cleavage site can be assessed.  This should help establish whether or not a cleavage site is physiol. relevant on the basis that such a cleavage site is likely to be conserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ImObN0bWOrVg90H21EOLACvtfcHk0lhIrzI_KFIoTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gu7rF&md5=9ede9e4742347becdc30067a7ac5a192</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv1118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv1118%26sid%3Dliteratum%253Aachs%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DFinn%26aufirst%3DR.%26atitle%3DTwenty%2520Years%2520of%2520the%2520MEROPS%2520Database%2520of%2520Proteolytic%2520Enzymes%252C%2520Their%2520Substrates%2520and%2520Inhibitors%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26issue%3DD1%26spage%3DD343%26epage%3DD350%26doi%3D10.1093%2Fnar%2Fgkv1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Musil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towatari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">The Refined 2.15 A X-Ray Crystal Structure of Human Liver Cathepsin B: The Structural Basis for Its Specificity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2321-2330&issue=9&author=D.+Musilauthor=D.+Zucicauthor=D.+Turkauthor=R.+a+Enghauthor=I.+Mayrauthor=R.+Huberauthor=T.+Popovicauthor=V.+Turkauthor=T.+Towatariauthor=N.+Katunuma&title=The+Refined+2.15+A+X-Ray+Crystal+Structure+of+Human+Liver+Cathepsin+B%3A+The+Structural+Basis+for+Its+Specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DZucic%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DEngh%26aufirst%3DR.%2Ba%26aulast%3DMayr%26aufirst%3DI.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DPopovic%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTowatari%26aufirst%3DT.%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DThe%2520Refined%25202.15%2520A%2520X-Ray%2520Crystal%2520Structure%2520of%2520Human%2520Liver%2520Cathepsin%2520B%253A%2520The%2520Structural%2520Basis%2520for%2520Its%2520Specificity%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26issue%3D9%26spage%3D2321%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Illy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purisima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mort, J. S.</span><span> </span><span class="NLM_article-title">Role of the Occluding Loop in Cathepsin B Activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span><span class="refDoi"> DOI: 10.1074/jbc.272.2.1197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1074%2Fjbc.272.2.1197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=1197-1202&issue=2&author=C.+Illyauthor=O.+Quraishiauthor=J.+Wangauthor=E.+Purisimaauthor=T.+Vernetauthor=J.+S.+Mort&title=Role+of+the+Occluding+Loop+in+Cathepsin+B+Activity&doi=10.1074%2Fjbc.272.2.1197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.2.1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.2.1197%26sid%3Dliteratum%253Aachs%26aulast%3DIlly%26aufirst%3DC.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPurisima%26aufirst%3DE.%26aulast%3DVernet%26aufirst%3DT.%26aulast%3DMort%26aufirst%3DJ.%2BS.%26atitle%3DRole%2520of%2520the%2520Occluding%2520Loop%2520in%2520Cathepsin%2520B%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D2%26spage%3D1197%26epage%3D1202%26doi%3D10.1074%2Fjbc.272.2.1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mohamed, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, B. F.</span><span> </span><span class="NLM_article-title">Cysteine Cathepsins: Multifunctional Enzymes in Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1038/nrc1949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnrc1949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=16990854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=764-775&issue=10&author=M.+M.+Mohamedauthor=B.+F.+Sloane&title=Cysteine+Cathepsins%3A+Multifunctional+Enzymes+in+Cancer&doi=10.1038%2Fnrc1949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: multifunctional enzymes in cancer</span></div><div class="casAuthors">Mohamed, Mona Mostafa; Sloane, Bonnie F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">764-775</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cysteine cathepsins are highly upregulated in a wide variety of cancers by mechanisms ranging from gene amplification to post-transcriptional modification.  Their localization within intracellular lysosomes often changes during neoplastic progression, resulting in secretion of both inactive and active forms and assocn. with binding partners on the tumor cell surface.  Secreted, cell-surface and intracellular cysteine cathepsins function in proteolytic pathways that increase neoplastic progression.  Direct proof for causal roles in tumor growth, migration, invasion, angiogenesis and metastasis has been shown by downregulating or ablating the expression of individual cysteine cathepsins in tumor cells and in transgenic mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDlqycZnS3qbVg90H21EOLACvtfcHk0lihDgSTYoZx1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7Y%253D&md5=360e206cd24a46a71c0d223c6bbd5875</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc1949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1949%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DM.%2BM.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26atitle%3DCysteine%2520Cathepsins%253A%2520Multifunctional%2520Enzymes%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D10%26spage%3D764%26epage%3D775%26doi%3D10.1038%2Fnrc1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gondi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Cathepsin B as a Cancer Target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1517/14728222.2013.740461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1517%2F14728222.2013.740461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=23293836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislOnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=281-291&issue=3&author=C.+S.+Gondiauthor=J.+S.+Rao&title=Cathepsin+B+as+a+Cancer+Target&doi=10.1517%2F14728222.2013.740461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B as a cancer target</span></div><div class="casAuthors">Gondi, Christopher S.; Rao, Jasti S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Cathepsin B is of significant importance to cancer therapy as it is involved in various pathologies and oncogenic processes in humans.  Numerous studies have shown that abnormal regulation of cathepsin B overexpression is correlated with invasive and metastatic phenotypes in cancers.  Cathepsin B is normally assocd. with the lysosomes involved in autophagy and immune response, but its aberrant expression has been shown to lead to cancers.Areas covered: This review highlights the oncogenic role of cathepsin B, discusses the regulation of cathepsin B in light of oncogenesis, discusses the role of cathepsin B as a signaling mol., and highlights the therapeutic potential of targeting cathepsin B.Expert opinion: Targeting cathepsin B alone does not appear to abolish tumor growth, and this is probably because cathepsin B appears to have diverse functions and influence numerous pathways.  It is not clear whether global suppression of cathepsin B activity or expression would produce unintended effects or cause the activation or suppression of unwanted pathways.  A localized approach for targeting the expression of cathepsin B would be more relevant.  Moreover, a combination of targeting cathepsin B with other relevant oncogenic mols. has significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtcRD5I_kMbVg90H21EOLACvtfcHk0lgtweXcCaQUfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislOnur8%253D&md5=502239d3736e79eecd38c6e08b72127e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.740461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.740461%26sid%3Dliteratum%253Aachs%26aulast%3DGondi%26aufirst%3DC.%2BS.%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DCathepsin%2520B%2520as%2520a%2520Cancer%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D281%26epage%3D291%26doi%3D10.1517%2F14728222.2013.740461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Roshy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moin, K.</span><span> </span><span class="NLM_article-title">Pericellular Cathepsin B and Malignant Progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1023/A:1023007717757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1023%2FA%3A1023007717757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=12785001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=271-286&author=S.+Roshyauthor=B.+F.+Sloaneauthor=K.+Moin&title=Pericellular+Cathepsin+B+and+Malignant+Progression&doi=10.1023%2FA%3A1023007717757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pericellular cathepsin B and malignant progression</span></div><div class="casAuthors">Roshy, Stefanie; Sloane, Bonnie F.; Moin, Kamiar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">271-286</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Cathepsin B is a lysosomal cysteine protease in normal cells and tissues.  In malignant tumors and premalignant lesions, the expression of cathepsin B is highly upregulated and the enzyme is secreted and becomes assocd. with the cell surface.  Increases in expression are mediated at many levels ranging from gene amplification to increased stability of mRNA and protein.  Cathepsin B is synthesized as a pre-proenzyme and the primary pathways for its normal trafficking to the lysosome utilize mannose 6-phosphate receptors (MPRs).  Inactive procathepsin B is processed to active single and double chain forms of cathepsin B in the late endosomes and lysosomes, resp.  Tumor cells secrete procathepsin B and both active forms of cathepsin B. Secretion of procathepsin B occurs principally as a result of increased expression, whereas secretion of active cathepsin B seems to involve active processes that can be induced by a variety of mechanisms.  Once secreted procathepsin B binds to the tumor cell surface via p11, the light chain of the annexin II hetero-tetramer.  This binding seems to facilitate conversion of procathepsin B to its active forms.  Cathepsin B and the annexin II hetero-tetramer colocalize in caveolae (lipid raft) fractions isolated from tumor cells.  Serine proteases and matrix metalloproteinases also have been found to assoc. with caveolae and some with the annexin II hetero-tetramer.  Our working hypothesis is that pericellular cathepsin B through its proximity to other proteases in caveolae participates in, perhaps even initiates, a proteolytic cascade on the tumor cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMshEulUWsx7Vg90H21EOLACvtfcHk0lhgg2Bd_apV4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CjtLs%253D&md5=90c4716a4c1f7fa190ebaf6a0704abf0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023007717757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023007717757%26sid%3Dliteratum%253Aachs%26aulast%3DRoshy%26aufirst%3DS.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26aulast%3DMoin%26aufirst%3DK.%26atitle%3DPericellular%2520Cathepsin%2520B%2520and%2520Malignant%2520Progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D271%26epage%3D286%26doi%3D10.1023%2FA%3A1023007717757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mitrović, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirković, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosič, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span> </span><span class="NLM_article-title">Inhibition of Endopeptidase and Exopeptidase Activity of Cathepsin B Impairs Extracellular Matrix Degradation and Tumour Invasion</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1515/hsz-2015-0236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2Fhsz-2015-0236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=164-174&issue=2&author=A.+Mitrovi%C4%87author=B.+Mirkovi%C4%87author=I.+Sosi%C4%8Dauthor=S.+Gobecauthor=J.+Kos&title=Inhibition+of+Endopeptidase+and+Exopeptidase+Activity+of+Cathepsin+B+Impairs+Extracellular+Matrix+Degradation+and+Tumour+Invasion&doi=10.1515%2Fhsz-2015-0236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0236%26sid%3Dliteratum%253Aachs%26aulast%3DMitrovi%25C4%2587%26aufirst%3DA.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Endopeptidase%2520and%2520Exopeptidase%2520Activity%2520of%2520Cathepsin%2520B%2520Impairs%2520Extracellular%2520Matrix%2520Degradation%2520and%2520Tumour%2520Invasion%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26issue%3D2%26spage%3D164%26epage%3D174%26doi%3D10.1515%2Fhsz-2015-0236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cezari, M. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Cathepsin B Carboxydipeptidase Specificity Analysis Using Internally Quenched Fluorescent Peptides</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.1042/bj20020840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1042%2Fbj20020840" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2002&pages=365-369&issue=1&author=M.+H.+S.+Cezariauthor=L.+Puzerauthor=M.+A.+Julianoauthor=A.+K.+Carmonaauthor=L.+Juliano&title=Cathepsin+B+Carboxydipeptidase+Specificity+Analysis+Using+Internally+Quenched+Fluorescent+Peptides&doi=10.1042%2Fbj20020840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1042%2Fbj20020840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020840%26sid%3Dliteratum%253Aachs%26aulast%3DCezari%26aufirst%3DM.%2BH.%2BS.%26aulast%3DPuzer%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DCarmona%26aufirst%3DA.%2BK.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DCathepsin%2520B%2520Carboxydipeptidase%2520Specificity%2520Analysis%2520Using%2520Internally%2520Quenched%2520Fluorescent%2520Peptides%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D368%26issue%3D1%26spage%3D365%26epage%3D369%26doi%3D10.1042%2Fbj20020840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Choe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbaum, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span> </span><span class="NLM_article-title">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">12824</span><span class="NLM_x">–</span> <span class="NLM_lpage">12832</span><span class="refDoi"> DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&issue=18&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+Profiling+of+Cysteine+Proteases+Using+a+Combinatorial+Peptide+Library+Identifies+Functionally+Unique+Specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0li1YMmdqQv8Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520Profiling%2520of%2520Cysteine%2520Proteases%2520Using%2520a%2520Combinatorial%2520Peptide%2520Library%2520Identifies%2520Functionally%2520Unique%2520Specificities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D18%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuire, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duzer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppa, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigg, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughty, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knap, A. K.</span><span> </span><span class="NLM_article-title">Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4524</span><span class="NLM_x">–</span> <span class="NLM_lpage">4534</span><span class="refDoi"> DOI: 10.1021/jm010206q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010206q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1eltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4524-4534&issue=26&author=P.+D.+Greenspanauthor=K.+L.+Clarkauthor=R.+A.+Tommasiauthor=S.+D.+Cowenauthor=L.+W.+McQuireauthor=D.+L.+Farleyauthor=J.+H.+Van+Duzerauthor=R.+L.+Goldbergauthor=H.+Zhouauthor=Z.+Duauthor=J.+J.+Fittauthor=D.+E.+Coppaauthor=Z.+Fangauthor=W.+Macchiaauthor=L.+Zhuauthor=M.+P.+Capparelliauthor=R.+Goldsteinauthor=A.+M.+Wiggauthor=J.+R.+Doughtyauthor=R.+S.+Bohacekauthor=A.+K.+Knap&title=Identification+of+Dipeptidyl+Nitriles+as+Potent+and+Selective+Inhibitors+of+Cathepsin+B+through+Structure-Based+Drug+Design&doi=10.1021%2Fjm010206q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design</span></div><div class="casAuthors">Greenspan, Paul D.; Clark, Kirk L.; Tommasi, Ruben A.; Cowen, Scott D.; McQuire, Leslie W.; Farley, David L.; van Duzer, John H.; Goldberg, Ronald L.; Zhou, Huanghai; Du, Zhengming; Fitt, John J.; Coppa, David E.; Fang, Zheng; Macchia, William; Zhu, Lijuan; Capparelli, Michael P.; Goldstein, Robert; Wigg, Andrew M.; Doughty, John R.; Bohacek, Regine S.; Knap, Ania K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4524-4534</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin B is a member of the papain superfamily of cysteine proteases and has been implicated in the pathol. of numerous diseases, including arthritis and cancer.  As part of an effort to identify potent, reversible inhibitors of this protease, we examd. a series of dipeptidyl nitriles, starting with the previously reported Cbz-Phe-NH-CH2CN (19, IC50 = 62 μM).  High-resoln. x-ray crystallog. data and mol. modeling were used to optimize the P1, P2, and P3 substituents of this template.  Cathepsin B is unique in its class in that it contains a carboxylate recognition site in the S2' pocket of the active site.  Inhibitor potency and selectivity were enhanced by tethering a carboxylate functionality from the carbon α to the nitrile to interact with this region of the enzyme.  This resulted in the identification of a compd., a 7 nM inhibitor of cathepsin B, with excellent selectivity over other cysteine cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUT8o-gafaJbVg90H21EOLACvtfcHk0licJltrCIKSrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1eltrs%253D&md5=14a409ddc82d1ee0d43609d85c5fc647</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm010206q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010206q%26sid%3Dliteratum%253Aachs%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DClark%26aufirst%3DK.%2BL.%26aulast%3DTommasi%26aufirst%3DR.%2BA.%26aulast%3DCowen%26aufirst%3DS.%2BD.%26aulast%3DMcQuire%26aufirst%3DL.%2BW.%26aulast%3DFarley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DGoldberg%26aufirst%3DR.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DFitt%26aufirst%3DJ.%2BJ.%26aulast%3DCoppa%26aufirst%3DD.%2BE.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DMacchia%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCapparelli%26aufirst%3DM.%2BP.%26aulast%3DGoldstein%26aufirst%3DR.%26aulast%3DWigg%26aufirst%3DA.%2BM.%26aulast%3DDoughty%26aufirst%3DJ.%2BR.%26aulast%3DBohacek%26aufirst%3DR.%2BS.%26aulast%3DKnap%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520Dipeptidyl%2520Nitriles%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Cathepsin%2520B%2520through%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D26%26spage%3D4524%26epage%3D4534%26doi%3D10.1021%2Fjm010206q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Junutula, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, D. D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duenas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDorman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venook, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Wong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandlen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, W.</span><span> </span><span class="NLM_article-title">Site-Specific Conjugation of a Cytotoxic Drug to an Antibody Improves the Therapeutic Index</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1038/nbt.1480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.1480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=18641636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Wmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=925-932&issue=8&author=J.+R.+Junutulaauthor=H.+Raabauthor=S.+Clarkauthor=S.+Bhaktaauthor=D.+D.+D.+Leipoldauthor=S.+Weirauthor=Y.+Chenauthor=M.+Simpsonauthor=S.+P.+Tsaiauthor=M.+S.+Dennisauthor=Y.+Luauthor=Y.+G.+Mengauthor=C.+Ngauthor=J.+Yangauthor=C.+C.+Leeauthor=E.+Duenasauthor=J.+Gorrellauthor=V.+Kattaauthor=A.+Kimauthor=K.+McDormanauthor=K.+Flagellaauthor=R.+Venookauthor=S.+Rossauthor=S.+D.+Spencerauthor=W.+Lee+Wongauthor=H.+B.+Lowmanauthor=R.+Vandlenauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=W.+Mallet&title=Site-Specific+Conjugation+of+a+Cytotoxic+Drug+to+an+Antibody+Improves+the+Therapeutic+Index&doi=10.1038%2Fnbt.1480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index</span></div><div class="casAuthors">Junutula, Jagath R.; Raab, Helga; Clark, Suzanna; Bhakta, Sunil; Leipold, Douglas D.; Weir, Sylvia; Chen, Yvonne; Simpson, Michelle; Tsai, Siao Ping; Dennis, Mark S.; Lu, Yanmei; Meng, Y. Gloria; Ng, Carl; Yang, Jihong; Lee, Chien C.; Duenas, Eileen; Gorrell, Jeffrey; Katta, Viswanatham; Kim, Amy; McDorman, Kevin; Flagella, Kelly; Venook, Rayna; Ross, Sarajane; Spencer, Susan D.; Wong, Wai Lee; Lowman, Henry B.; Vandlen, Richard; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Mallet, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">925-932</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antibody-drug conjugates enhance the antitumor effects of antibodies and reduce adverse systemic effects of potent cytotoxic drugs.  However, conventional drug conjugation strategies yield heterogeneous conjugates with relatively narrow therapeutic index (max. tolerated dose/curative dose).  Using leads from the authors' previously described phage display-based method to predict suitable conjugation sites, the authors engineered cysteine substitutions at positions on light and heavy chains that provide reactive thiol groups and do not perturb Ig folding and assembly, or alter antigen binding.  When conjugated to monomethyl auristatin E, an antibody against the ovarian cancer antigen MUC16 is as efficacious as a conventional conjugate in mouse xenograft models.  Moreover, it is tolerated at higher doses in rats and cynomolgus monkeys than the same conjugate prepd. by conventional approaches.  The favorable in vivo properties of the near-homogeneous compn. of this conjugate suggest that this strategy offers a general approach to retaining the antitumor efficacy of antibody-drug conjugates, while minimizing their systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4HIiPBABzRLVg90H21EOLACvtfcHk0licJltrCIKSrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Wmu7s%253D&md5=d55f59594fb6349d0337dfed2783e83c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1480%26sid%3Dliteratum%253Aachs%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DLeipold%26aufirst%3DD.%2BD.%2BD.%26aulast%3DWeir%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DS.%2BP.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DY.%2BG.%26aulast%3DNg%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DDuenas%26aufirst%3DE.%26aulast%3DGorrell%26aufirst%3DJ.%26aulast%3DKatta%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DMcDorman%26aufirst%3DK.%26aulast%3DFlagella%26aufirst%3DK.%26aulast%3DVenook%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DLee%2BWong%26aufirst%3DW.%26aulast%3DLowman%26aufirst%3DH.%2BB.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DMallet%26aufirst%3DW.%26atitle%3DSite-Specific%2520Conjugation%2520of%2520a%2520Cytotoxic%2520Drug%2520to%2520an%2520Antibody%2520Improves%2520the%2520Therapeutic%2520Index%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26issue%3D8%26spage%3D925%26epage%3D932%26doi%3D10.1038%2Fnbt.1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vollmar, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourie-O’Donohue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, H. K.</span><span> </span><span class="NLM_article-title">Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2548</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGks7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=2538-2548&issue=10&author=B.+S.+Vollmarauthor=B.+Weiauthor=R.+Ohriauthor=J.+Zhouauthor=J.+Heauthor=S.-F.+Yuauthor=D.+Leipoldauthor=E.+Cosinoauthor=S.+Yeeauthor=A.+Fourie-O%E2%80%99Donohueauthor=G.+Liauthor=G.+L.+Phillipsauthor=K.+R.+Kozakauthor=A.+Kamathauthor=K.+Xuauthor=G.+Leeauthor=G.+A.+Lazarauthor=H.+K.+Erickson&title=Attachment+Site+Cysteine+Thiol+pKa+Is+a+Key+Driver+for+Site-Dependent+Stability+of+THIOMAB+Antibody-Drug+Conjugates&doi=10.1021%2Facs.bioconjchem.7b00365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates</span></div><div class="casAuthors">Vollmar, Breanna S.; Wei, Binqing; Ohri, Rachana; Zhou, Jianhui; He, Jintang; Yu, Shang-Fan; Leipold, Douglas; Cosino, Ely; Yee, Sharon; Fourie-O'Donohue, Aimee; Li, Guangmin; Phillips, Gail L.; Kozak, Katherine R.; Kamath, Amrita; Xu, Keyang; Lee, Genee; Lazar, Greg A.; Erickson, Hans K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2548</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incorporation of cysteines into antibodies by mutagenesis allows for the direct conjugation of small mols. to specific sites on the antibody via disulfide bonds.  The stability of the disulfide bond linkage between the small mol. and the antibody is highly dependent on the location of the engineered cysteine in either the heavy chain (HC) or the light chain (LC) of the antibody.  Here, we explore the basis for this site-dependent stability.  We evaluated the in vivo efficacy and pharmacokinetics of five different cysteine mutants of trastuzumab conjugated to a pyrrolobenzodiazepine (PBD) via disulfide bonds.  A significant correlation was obsd. between disulfide stability and efficacy for the conjugates.  We hypothesized that the obsd. site-dependent stability of the disulfide-linked conjugates could be due to differences in the attachment site cysteine thiol pKa.  We measured the cysteine thiol pKa using isothermal titrn. calorimetry (ITC) and found that the variants with the highest thiol pKa (LC K149C and HC A140C) were found to yield the conjugates with the greatest in vivo stability.  Guided by homol. modeling, we identified several mutations adjacent to LC K149C that reduced the cysteine thiol pKa and, thus, decreased the in vivo stability of the disulfide-linked PBD conjugated to LC K149C.  We also present results suggesting that the high thiol pKa of LC K149C is responsible for the sustained circulation stability of LC K149C TDCs utilizing a maleimide-based linker.  Taken together, our results provide evidence that the site-dependent stability of cys-engineered antibody-drug conjugates may be explained by interactions between the engineered cysteine and the local protein environment that serves to modulate the side-chain thiol pKa.  The influence of cysteine thiol pKa on stability and efficacy offers a new parameter for the optimization of ADCs that utilize cysteine engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfrN62jixCbVg90H21EOLACvtfcHk0lgXoPe8mGCrnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGks7vL&md5=ba1805c493f468d4ffbb198dbf8b3d02</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00365%26sid%3Dliteratum%253Aachs%26aulast%3DVollmar%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DOhri%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DLeipold%26aufirst%3DD.%26aulast%3DCosino%26aufirst%3DE.%26aulast%3DYee%26aufirst%3DS.%26aulast%3DFourie-O%25E2%2580%2599Donohue%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DG.%2BL.%26aulast%3DKozak%26aufirst%3DK.%2BR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLazar%26aufirst%3DG.%2BA.%26aulast%3DErickson%26aufirst%3DH.%2BK.%26atitle%3DAttachment%2520Site%2520Cysteine%2520Thiol%2520pKa%2520Is%2520a%2520Key%2520Driver%2520for%2520Site-Dependent%2520Stability%2520of%2520THIOMAB%2520Antibody-Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26issue%3D10%26spage%3D2538%26epage%3D2548%26doi%3D10.1021%2Facs.bioconjchem.7b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Doronina, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toki, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgov, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, B. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerveny, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chace, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBlanc, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegall, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Development of Potent Monoclonal Antibody Auristatin Conjugates for Cancer Therapy</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span><span class="refDoi"> DOI: 10.1038/nbt832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=12778055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=778-784&issue=7&author=S.+O.+Doroninaauthor=B.+E.+Tokiauthor=M.+Y.+Torgovauthor=B.+a+Mendelsohnauthor=C.+G.+Cervenyauthor=D.+F.+Chaceauthor=R.+L.+DeBlancauthor=R.+P.+Gearingauthor=T.+D.+Boveeauthor=C.+B.+Siegallauthor=J.+a+Franciscoauthor=A.+F.+Wahlauthor=D.+L.+Meyerauthor=P.+D.+Senter&title=Development+of+Potent+Monoclonal+Antibody+Auristatin+Conjugates+for+Cancer+Therapy&doi=10.1038%2Fnbt832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span></div><div class="casAuthors">Doronina, Svetlana O.; Toki, Brian E.; Torgov, Michael Y.; Mendelsohn, Brian A.; Cerveny, Charles G.; Chace, Dana F.; DeBlanc, Ron L.; Gearing, R. Patrick; Bovee, Tim D.; Siegall, Clay B.; Francisco, Joseph A.; Wahl, Alan F.; Meyer, Damon L.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">778-784</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs auristatin E (AE) and monomethylauristatin E (MMAE), linked to the chimeric mAbs cBR96 (specific to Lewis Y on carcinomas) and cAC10 (specific to CD30 on hematol. malignancies).  The linkers used for conjugate formation included an acid-labile hydrazone and protease-sensitive dipeptides, leading to uniformly substituted conjugates that efficiently released active drug in the lysosomes of antigen-pos. (Ag+) tumor cells.  The peptide-linked mAb-valine-citrulline-MMAE and mAb-phenylalanine-lysine-MMAE conjugates were much more stable in buffers and plasma than the conjugates of mAb and the hydrazone of 5-benzoylvaleric acid-AE ester (AEVB).  As a result, the mAb-Val-Cit-MMAE conjugates exhibited greater in vitro specificity and lower in vivo toxicity than corresponding hydrazone conjugates.  In vivo studies demonstrated that the peptide-linked conjugates induced regressions and cures of established tumor xenografts with therapeutic indexes as high as 60-fold.  These conjugates illustrate the importance of linker technol., drug potency and conjugation methodol. in developing safe and efficacious mAb-drug conjugates for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro97SFKtdQ7rVg90H21EOLACvtfcHk0lg6qtL1QetNrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D&md5=d77716ec93de5ac7473c18a597339086</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnbt832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt832%26sid%3Dliteratum%253Aachs%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DToki%26aufirst%3DB.%2BE.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DMendelsohn%26aufirst%3DB.%2Ba%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DDeBlanc%26aufirst%3DR.%2BL.%26aulast%3DGearing%26aufirst%3DR.%2BP.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DSiegall%26aufirst%3DC.%2BB.%26aulast%3DFrancisco%26aufirst%3DJ.%2Ba%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDevelopment%2520of%2520Potent%2520Monoclonal%2520Antibody%2520Auristatin%2520Conjugates%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D7%26spage%3D778%26epage%3D784%26doi%3D10.1038%2Fnbt832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Montaser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalmanach, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, L.</span><span> </span><span class="NLM_article-title">CA-074, but Not Its Methyl Ester CA-074Me, Is a Selective Inhibitor of Cathepsin B within Living Cells</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x"> (</span><span class="NLM_issue">7–8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span><span class="refDoi"> DOI: 10.1515/BC.2002.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2FBC.2002.147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=1305-1308&issue=7%E2%80%938&author=M.+Montaserauthor=G.+Lalmanachauthor=L.+Mach&title=CA-074%2C+but+Not+Its+Methyl+Ester+CA-074Me%2C+Is+a+Selective+Inhibitor+of+Cathepsin+B+within+Living+Cells&doi=10.1515%2FBC.2002.147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1515%2FBC.2002.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2002.147%26sid%3Dliteratum%253Aachs%26aulast%3DMontaser%26aufirst%3DM.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DMach%26aufirst%3DL.%26atitle%3DCA-074%252C%2520but%2520Not%2520Its%2520Methyl%2520Ester%2520CA-074Me%252C%2520Is%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520B%2520within%2520Living%2520Cells%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26issue%3D7%25E2%2580%25938%26spage%3D1305%26epage%3D1308%26doi%3D10.1515%2FBC.2002.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minematsu-Ikeguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kominami, E.</span><span> </span><span class="NLM_article-title">Characterization of CAA0225, a Novel Inhibitor Specific for Cathepsin L, as a Probe for Autophagic Proteolysis</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1248/bpb.32.475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1248%2Fbpb.32.475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=19252298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-479&issue=3&author=K.+Takahashiauthor=T.+Uenoauthor=I.+Tanidaauthor=N.+Minematsu-Ikeguchiauthor=M.+Murataauthor=E.+Kominami&title=Characterization+of+CAA0225%2C+a+Novel+Inhibitor+Specific+for+Cathepsin+L%2C+as+a+Probe+for+Autophagic+Proteolysis&doi=10.1248%2Fbpb.32.475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis</span></div><div class="casAuthors">Takahashi, Katsuyuki; Ueno, Takashi; Tanida, Isei; Minematsu-Ikeguchi, Naoko; Murata, Mitsuo; Kominami, Eiki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-479</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">We screened a series of new epoxysuccinyl peptides for the development of a lysosomal cathepsin L-specific inhibitor.  Among the compds. tested, (2S,3S)-oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide} (compd. CAA0225) was the most potent inhibitor of cathepsin L.  CAA0225 inhibited rat liver cathepsin L with IC50 values of 1.9 nm, but not rat liver cathepsin B (IC50, >1000 - 5000 nm).  To assess the contribution of cathepsin L to lysosomal proteolysis, we evaluated autophagy, which is the process of lysosomal self-degrdn. of cell constituents.  In HeLa and Huh-7 cells cultured under nutrient-deprived conditions CAA0225 significantly inhibited degrdn. of long-lived proteins; however, the magnitude of inhibition was comparable to that in the presence of CA-074-OMe, which is a cathepsin B-specific inhibitor.  Thus the contributions of cathepsin L and cathepsin B to autophagic protein degrdn. of cytoplasmic proteins are nearly equal.  During autophagy, microtubule-assocd. protein IA/IB light chain 3-II (LC3-II) and γ-aminobutyric acid (A) receptor-assocd. protein (GABARAP)-II, which are specific markers of autophagosomal membranes that engulf cytoplasmic components, also undergo degrdn. upon fusion of autophagosomes with lysosomes.  CAA0225 effectively inhibited degrdn. of LC3-II and GABARAP, whereas CA-074-OMe had only a marginal effect on their levels.  Therefore we conclude that cathepsin L does not play a general role in the degrdn. of proteins in the lumen of autophagosomes, but rather is involved specifically in the degrdn. of autophagosomal membrane markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4bMti3zSNRrVg90H21EOLACvtfcHk0liFQNBONJtQHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVarurg%253D&md5=3ca4f7ed503320e9a8c160d626cb7aa7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1248%2Fbpb.32.475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.32.475%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DTanida%26aufirst%3DI.%26aulast%3DMinematsu-Ikeguchi%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DKominami%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520CAA0225%252C%2520a%2520Novel%2520Inhibitor%2520Specific%2520for%2520Cathepsin%2520L%252C%2520as%2520a%2520Probe%2520for%2520Autophagic%2520Proteolysis%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D32%26issue%3D3%26spage%3D475%26epage%3D479%26doi%3D10.1248%2Fbpb.32.475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Pharmacological Inhibitors to Identify Roles of Cathepsin K in Cell-Based Studies: A Comparison of Available Tools</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span><span class="refDoi"> DOI: 10.1515/BC.2009.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2FBC.2009.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2009&pages=941-948&issue=9&author=S.+Desmaraisauthor=F.+Mass%C3%A9author=M.+D.+Percival&title=Pharmacological+Inhibitors+to+Identify+Roles+of+Cathepsin+K+in+Cell-Based+Studies%3A+A+Comparison+of+Available+Tools&doi=10.1515%2FBC.2009.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1515%2FBC.2009.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2009.092%26sid%3Dliteratum%253Aachs%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DPharmacological%2520Inhibitors%2520to%2520Identify%2520Roles%2520of%2520Cathepsin%2520K%2520in%2520Cell-Based%2520Studies%253A%2520A%2520Comparison%2520of%2520Available%2520Tools%26jtitle%3DBiol.%2520Chem.%26date%3D2009%26volume%3D390%26issue%3D9%26spage%3D941%26epage%3D948%26doi%3D10.1515%2FBC.2009.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Marciniszyn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartsuck, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Mode of Inhibition of Acid Proteases by Pepstatin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7088</span><span class="NLM_x">–</span> <span class="NLM_lpage">7094</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1976&pages=7088-7094&issue=22&author=J.+Marciniszynauthor=J.+A.+Hartsuckauthor=J.+Tang&title=Mode+of+Inhibition+of+Acid+Proteases+by+Pepstatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarciniszyn%26aufirst%3DJ.%26aulast%3DHartsuck%26aufirst%3DJ.%2BA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DMode%2520of%2520Inhibition%2520of%2520Acid%2520Proteases%2520by%2520Pepstatin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1976%26volume%3D251%26issue%3D22%26spage%3D7088%26epage%3D7094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Libby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, a L.</span><span> </span><span class="NLM_article-title">Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased Muscles</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x"> (</span><span class="NLM_issue">4328</span><span class="NLM_x">) </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1126/science.622552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1126%2Fscience.622552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=622552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADyaE1cXpvFOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=1978&pages=534-536&issue=4328&author=P.+Libbyauthor=a+L.+Goldberg&title=Leupeptin%2C+a+Protease+Inhibitor%2C+Decreases+Protein+Degradation+in+Normal+and+Diseased+Muscles&doi=10.1126%2Fscience.622552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles</span></div><div class="casAuthors">Libby, Peter; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">4328</span>),
    <span class="NLM_cas:pages">534-6</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The protease inhibitor leupeptin decreased protein degrdn. in rat skeletal and cardiac muscle incubated in vitro, whereas protein synthesis remained unaltered.  Leupeptin also lowered protein breakdown in denervated rat muscles and affected muscles from mice with hereditary muscular dystrophy.  Leupeptin may thus be useful in retarding tissue atrophy.  Since homogenates of leupeptin-treated muscles had decreased cathepsin B  [9047-22-7] activity, this lysosomal protease may play a role in protein turnover in normal and diseased muscles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu3olGcFFW_LVg90H21EOLACvtfcHk0liZgPCG-BWGDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXpvFOhsw%253D%253D&md5=83994895cf8685a1844e8efc6e17f640</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.622552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.622552%26sid%3Dliteratum%253Aachs%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGoldberg%26aufirst%3Da%2BL.%26atitle%3DLeupeptin%252C%2520a%2520Protease%2520Inhibitor%252C%2520Decreases%2520Protein%2520Degradation%2520in%2520Normal%2520and%2520Diseased%2520Muscles%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1978%26volume%3D199%26issue%3D4328%26spage%3D534%26epage%3D536%26doi%3D10.1126%2Fscience.622552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gregson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, D. E.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of a Novel Pyrrolobenzodiazepine DNA-Interactive Agent with Highly Efficient Cross-Linking Ability and Potent Cytotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1021/jm001064n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001064n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=737-748&issue=5&author=S.+J.+Gregsonauthor=P.+W.+Howardauthor=J.+A.+Hartleyauthor=N.+A.+Brooksauthor=L.+J.+Adamsauthor=T.+C.+Jenkinsauthor=L.+R.+Kellandauthor=D.+E.+Thurston&title=Design%2C+Synthesis%2C+and+Evaluation+of+a+Novel+Pyrrolobenzodiazepine+DNA-Interactive+Agent+with+Highly+Efficient+Cross-Linking+Ability+and+Potent+Cytotoxicity&doi=10.1021%2Fjm001064n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm001064n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001064n%26sid%3Dliteratum%253Aachs%26aulast%3DGregson%26aufirst%3DS.%2BJ.%26aulast%3DHoward%26aufirst%3DP.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DAdams%26aufirst%3DL.%2BJ.%26aulast%3DJenkins%26aufirst%3DT.%2BC.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DThurston%26aufirst%3DD.%2BE.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520a%2520Novel%2520Pyrrolobenzodiazepine%2520DNA-Interactive%2520Agent%2520with%2520Highly%2520Efficient%2520Cross-Linking%2520Ability%2520and%2520Potent%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D5%26spage%3D737%26epage%3D748%26doi%3D10.1021%2Fjm001064n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dere, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco-Triguero, M.</span><span> </span><span class="NLM_article-title">Bioanalytical Assay Strategies for the Development of Antibody–drug Conjugate Biotherapeutics</span> <span class="citation_source-journal">Bioanalysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.4155/bio.12.299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.4155%2Fbio.12.299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=23330562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=201-226&issue=2&author=S.+Kaurauthor=K.+Xuauthor=O.+M.+Saadauthor=R.+C.+Dereauthor=M.+Carrasco-Triguero&title=Bioanalytical+Assay+Strategies+for+the+Development+of+Antibody%E2%80%93drug+Conjugate+Biotherapeutics&doi=10.4155%2Fbio.12.299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics</span></div><div class="casAuthors">Kaur, Surinder; Xu, Keyang; Saad, Ola M.; Dere, Randall C.; Carrasco-Triguero, Montserrat</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-226</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) are monoclonal antibodies with covalently bound cytotoxic drugs.  They are designed to target tumor antigens selectively and offer the hope of cancer treatment without the debilitating side-effects of conventional therapies.  The concept of ADCs is not new; however, development of these therapeutics is challenging and only recently are promising clin. data emerging.  These challenges include ADC bioanal., such as quantifying in serum/plasma for PK studies and strategies for assessing immunogenicity.  ADCs have complex mol. structures incorporating large- and small-mol. characteristics and require diverse anal. methods, including ligand-binding assays and MS-based methods.  ADCs are typically mixts. with a range of drug-to-antibody ratios.  Biotransformations in vivo can lead to addnl. changes in drug-to-antibody ratios resulting in dynamically changing mixts.  Thus, a std. calibration curve consisting of the ref. std. may not be appropriate for quantification of analytes in vivo and represents a unique challenge.  This paper will share our perspective on why ADC bioanal. is so complex and describe the strategies and rationale that we have used for ADCs, with highlights of original data from a variety of nonclin. and clin. case studies.  Our strategy has involved novel protein structural characterization tools to help understand ADC biotransformations in vivo and use of the analyte knowledge gained to guide the development of quant. bioanal. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDYXrBsuA0UrVg90H21EOLACvtfcHk0liHNL4mu-fujQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtLY%253D&md5=ee3a3fc2802412e0ce257a609dc91d52</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Fbio.12.299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.12.299%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DDere%26aufirst%3DR.%2BC.%26aulast%3DCarrasco-Triguero%26aufirst%3DM.%26atitle%3DBioanalytical%2520Assay%2520Strategies%2520for%2520the%2520Development%2520of%2520Antibody%25E2%2580%2593drug%2520Conjugate%2520Biotherapeutics%26jtitle%3DBioanalysis%26date%3D2013%26volume%3D5%26issue%3D2%26spage%3D201%26epage%3D226%26doi%3D10.4155%2Fbio.12.299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Peyton Shieh, Megan R. Hill, Wenxu Zhang, Samantha L. Kristufek, <span class="NLM_string-name hlFld-ContribAuthor">Jeremiah A. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Clip Chemistry: Diverse (Bio)(macro)molecular and Material Function through Breaking Covalent Bonds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (12)
                                     , 7059-7121. <a href="https://doi.org/10.1021/acs.chemrev.0c01282" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c01282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c01282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c01282%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DClip%252BChemistry%25253A%252BDiverse%252B%252528Bio%252529%252528macro%252529molecular%252Band%252BMaterial%252BFunction%252Bthrough%252BBreaking%252BCovalent%252BBonds%26aulast%3DShieh%26aufirst%3DPeyton%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05122020%26date%3D06042021%26volume%3D121%26issue%3D12%26spage%3D7059%26epage%3D7121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jared T. Miller, Caitlin N. Vitro, Siteng Fang, Samantha R. Benjamin, <span class="NLM_string-name hlFld-ContribAuthor">L. Nathan Tumey</span>. </span><span class="cited-content_cbyCitation_article-title">Enzyme-Agnostic Lysosomal Screen Identifies New Legumain-Cleavable ADC Linkers. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (4)
                                     , 842-858. <a href="https://doi.org/10.1021/acs.bioconjchem.1c00124" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.1c00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.1c00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.1c00124%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DEnzyme-Agnostic%252BLysosomal%252BScreen%252BIdentifies%252BNew%252BLegumain-Cleavable%252BADC%252BLinkers%26aulast%3DMiller%26aufirst%3DJared%2BT.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12032021%26date%3D18032021%26date%3D31032021%26volume%3D32%26issue%3D4%26spage%3D842%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Sunil Bhakta, Nicole Blaquiere, Jinhua Chen, Josefa dela Cruz-Chuh, Karen E. Gascoigne, Steven J. Hartman, Mingtao He, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liang Liu, Liling Liu, Qi Liu, Ying Lu, Fanwei Meng, Melinda M. Mulvihill, Aimee O’Donohue, Rebecca K. Rowntree, Leanna R. Staben, Steven T. Staben, John Wai, Jian Wang, BinQing Wei, Catherine Wilson, Jianfeng Xin, Zijin Xu, Hui Yao, Donglu Zhang, Hongyan Zhang, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2534-2575. <a href="https://doi.org/10.1021/acs.jmedchem.0c01845" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B1%25253A%252BExploration%252Bof%252BAntibody%252BLinker%25252C%252BPayload%252BLoading%25252C%252Band%252BPayload%252BMolecular%252BProperties%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2534%26epage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Jinhua Chen, Nicholas Corr, Josefa dela Cruz-Chuh, Geoffrey Del Rosario, Aaron Fullerton, Steven J. Hartman, Fan Jiang, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liling Liu, Ying Lu, Melinda M. Mulvihill, Jeremy M. Murray, Aimee O’Donohue, Rebecca K. Rowntree, William S. Sawyer, Leanna R. Staben, John Wai, Jian Wang, BinQing Wei, Wentao Wei, Zijin Xu, Hui Yao, Shang-Fan Yu, Donglu Zhang, Hongyan Zhang, Shenhua Zhang, Yongxin Zhao, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2576-2607. <a href="https://doi.org/10.1021/acs.jmedchem.0c01846" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01846%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B2%25253A%252BImprovement%252Bof%252BIn%252BVitro%252BAntiproliferation%252BActivity%252Band%252BIn%252BVivo%252BAntitumor%252BEfficacy%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2576%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alla Pryyma, Shanal Gunasekera, Joshua Lewin, <span class="NLM_string-name hlFld-ContribAuthor">David M. Perrin</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid, High-Yielding Solid-Phase Synthesis of Cathepsin-B Cleavable Linkers for Targeted Cancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (12)
                                     , 2685-2690. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00563" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00563%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DRapid%25252C%252BHigh-Yielding%252BSolid-Phase%252BSynthesis%252Bof%252BCathepsin-B%252BCleavable%252BLinkers%252Bfor%252BTargeted%252BCancer%252BTherapeutics%26aulast%3DPryyma%26aufirst%3DAlla%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12102020%26date%3D30112020%26date%3D04122020%26volume%3D31%26issue%3D12%26spage%3D2685%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vasilii F. Otvagin, Natalia S. Kuzmina, Lubov V. Krylova, Arthur B. Volovetsky, Alexander V. Nyuchev, Andrei E. Gavryushin, Ivan N. Meshkov, Yulia G. Gorbunova, Yuliya V. Romanenko, Oscar I. Koifman, Irina V. Balalaeva, <span class="NLM_string-name hlFld-ContribAuthor">Alexey Yu Fedorov</span>. </span><span class="cited-content_cbyCitation_article-title">Water-Soluble Chlorin/Arylaminoquinazoline Conjugate for Photodynamic and Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11182-11193. <a href="https://doi.org/10.1021/acs.jmedchem.9b01294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWater-Soluble%252BChlorin%25252FArylaminoquinazoline%252BConjugate%252Bfor%252BPhotodynamic%252Band%252BTargeted%252BTherapy%26aulast%3DOtvagin%26aufirst%3DVasilii%2BF.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08082019%26date%3D13122019%26date%3D29112019%26volume%3D62%26issue%3D24%26spage%3D11182%26epage%3D11193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Suzie J. Scales, Siao Ping Tsai, Neelie Zacharias, Josefa dela Cruz-Chuh, Gordy Bullen, Erick Velasquez, Julie Chang, Elise Bruguera, Katherine R. Kozak, <span class="NLM_string-name hlFld-ContribAuthor">Jack Sadowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Cysteine-Conjugatable Disulfide FRET Probe: Influence of Charge on Linker Cleavage and Payload Trafficking for an Anti-HER2 Antibody Conjugate. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (12)
                                     , 3046-3056. <a href="https://doi.org/10.1021/acs.bioconjchem.9b00678" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.9b00678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.9b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.9b00678%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BCysteine-Conjugatable%252BDisulfide%252BFRET%252BProbe%25253A%252BInfluence%252Bof%252BCharge%252Bon%252BLinker%252BCleavage%252Band%252BPayload%252BTrafficking%252Bfor%252Ban%252BAnti-HER2%252BAntibody%252BConjugate%26aulast%3DScales%26aufirst%3DSuzie%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07102019%26date%3D07112019%26date%3D03122019%26date%3D14112019%26volume%3D30%26issue%3D12%26spage%3D3046%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kouichi Tanaka, Takashi Miki, Kunihiko Murata, Ayumi Yamaguchi, Yoshihito Kayaki, Shigeki Kuwata, Takao Ikariya, <span class="NLM_string-name hlFld-ContribAuthor">Masahito Watanabe</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive Amination of Ketonic Compounds Catalyzed by Cp*Ir(III) Complexes Bearing a Picolinamidato Ligand. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (17)
                                     , 10962-10977. <a href="https://doi.org/10.1021/acs.joc.9b01565" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01565%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DReductive%252BAmination%252Bof%252BKetonic%252BCompounds%252BCatalyzed%252Bby%252BCp%252AIr%252528III%252529%252BComplexes%252BBearing%252Ba%252BPicolinamidato%252BLigand%26aulast%3DTanaka%26aufirst%3DKouichi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D09082019%26date%3D30072019%26volume%3D84%26issue%3D17%26spage%3D10962%26epage%3D10977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dian Su, Jinhua Chen, Ely Cosino, Josefa dela Cruz-Chuh, Helen Davis, Geoffrey Del Rosario, Isabel Figueroa, Leanne Goon, Jintang He, Amrita V. Kamath, Surinder Kaur, Katherine R. Kozak, Jeffrey Lau, Donna Lee, M. Violet Lee, Douglas Leipold, Luna Liu, Peter Liu, Guo-Liang Lu, Chris Nelson, Carl Ng, Thomas H. Pillow, Paul Polakis, Andrew G. Polson, Rebecca K. Rowntree, Ola Saad, Brian Safina, Nicola J. Stagg, Moana Tercel, Richard Vandlen, Breanna S. Vollmar, John Wai, Tao Wang, BinQing Wei, Keyang Xu, Juanjuan Xue, Zijin Xu, Gang Yan, Hui Yao, Shang-Fan Yu, Donglu Zhang, Fiona Zhong, <span class="NLM_string-name hlFld-ContribAuthor">Peter S. Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody–Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (5)
                                     , 1356-1370. <a href="https://doi.org/10.1021/acs.bioconjchem.9b00133" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.9b00133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.9b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.9b00133%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DAntibody%2525E2%252580%252593Drug%252BConjugates%252BDerived%252Bfrom%252BCytotoxic%252Bseco-CBI-Dimer%252BPayloads%252BAre%252BHighly%252BEfficacious%252Bin%252BXenograft%252BModels%252Band%252BForm%252BProtein%252BAdducts%252BIn%252BVivo%26aulast%3DSu%26aufirst%3DDian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17022019%26date%3D22042019%26date%3D10042019%26volume%3D30%26issue%3D5%26spage%3D1356%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Peng, Wenkun Luo, Huanfeng Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Biaolin Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem Achmatowicz Rearrangement and Acetalization of 1-[5-(Hydroxyalkyl)-furan-2-yl]-cyclobutanols Leading to Dispiroacetals and Subsequent Ring-Expansion to Form 6,7-Dihydrobenzofuran-4(5H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (20)
                                     , 12869-12879. <a href="https://doi.org/10.1021/acs.joc.8b01765" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01765%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTandem%252BAchmatowicz%252BRearrangement%252Band%252BAcetalization%252Bof%252B1-%25255B5-%252528Hydroxyalkyl%252529-furan-2-yl%25255D-cyclobutanols%252BLeading%252Bto%252BDispiroacetals%252Band%252BSubsequent%252BRing-Expansion%252Bto%252BForm%252B6%25252C7-Dihydrobenzofuran-4%2525285H%252529-ones%26aulast%3DPeng%26aufirst%3DHui%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D01102018%26date%3D21092018%26volume%3D83%26issue%3D20%26spage%3D12869%26epage%3D12879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Candice Maria  Mckertish</span>, <span class="hlFld-ContribAuthor ">Veysel  Kayser</span>. </span><span class="cited-content_cbyCitation_article-title">Advances and Limitations of Antibody Drug Conjugates for Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (8)
                                     , 872. <a href="https://doi.org/10.3390/biomedicines9080872" title="DOI URL">https://doi.org/10.3390/biomedicines9080872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9080872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9080872%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DAdvances%252Band%252BLimitations%252Bof%252BAntibody%252BDrug%252BConjugates%252Bfor%252BCancer%26aulast%3DMckertish%26aufirst%3DCandice%2BMaria%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D8%26spage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang-Ping  Yao</span>, <span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Rachel  Hudson</span>, <span class="hlFld-ContribAuthor ">Xiang-Min  Tong</span>, <span class="hlFld-ContribAuthor ">Ming-Hai  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>18 </em><a href="https://doi.org/10.1016/j.drudis.2021.06.012" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDuocarmycin-based%252Bantibody%2525E2%252580%252593drug%252Bconjugates%252Bas%252Ban%252Bemerging%252Bbiotherapeutic%252Bentity%252Bfor%252Btargeted%252Bcancer%252Btherapy%25253A%252BPharmaceutical%252Bstrategy%252Band%252Bclinical%252Bprogress%26aulast%3DYao%26aufirst%3DHang-Ping%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimberly K.  Kajihara</span>, <span class="hlFld-ContribAuthor ">Homer  Pantua</span>, <span class="hlFld-ContribAuthor ">Hilda  Hernandez-Barry</span>, <span class="hlFld-ContribAuthor ">Meredith  Hazen</span>, <span class="hlFld-ContribAuthor ">Kiran  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Nancy  Chiang</span>, <span class="hlFld-ContribAuthor ">Rachana  Ohri</span>, <span class="hlFld-ContribAuthor ">Erick R.  Castellanos</span>, <span class="hlFld-ContribAuthor ">Lynn  Martin</span>, <span class="hlFld-ContribAuthor ">Marissa L.  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Jian  Payandeh</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Storek</span>, <span class="hlFld-ContribAuthor ">Kellen  Schneider</span>, <span class="hlFld-ContribAuthor ">Peter A.  Smith</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Siao Ping  Tsai</span>, <span class="hlFld-ContribAuthor ">Richard  Vandlen</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Loyet</span>, <span class="hlFld-ContribAuthor ">Gerald  Nakamura</span>, <span class="hlFld-ContribAuthor ">Thomas  Pillow</span>, <span class="hlFld-ContribAuthor ">Dhaya  Seshasayee</span>, <span class="hlFld-ContribAuthor ">Sharookh B.  Kapadia</span>, <span class="hlFld-ContribAuthor ">Wouter L. W.  Hazenbos</span>, . </span><span class="cited-content_cbyCitation_article-title">Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/mBio.00202-21" title="DOI URL">https://doi.org/10.1128/mBio.00202-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.00202-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.00202-21%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DPotent%252BKilling%252Bof%252BPseudomonas%252Baeruginosa%252Bby%252Ban%252BAntibody-Antibiotic%252BConjugate%26aulast%3DKajihara%26aufirst%3DKimberly%2BK.%26date%3D2021%26volume%3D12%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Bargh</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Walsh</span>, <span class="hlFld-ContribAuthor ">Nicola  Ashman</span>, <span class="hlFld-ContribAuthor ">Albert  Isidro-Llobet</span>, <span class="hlFld-ContribAuthor ">Jason S.  Carroll</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">A dual-enzyme cleavable linker for antibody–drug conjugates. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (28)
                                     , 3457-3460. <a href="https://doi.org/10.1039/D1CC00957E" title="DOI URL">https://doi.org/10.1039/D1CC00957E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC00957E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC00957E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bdual-enzyme%252Bcleavable%252Blinker%252Bfor%252Bantibody%2525E2%252580%252593drug%252Bconjugates%26aulast%3DBargh%26aufirst%3DJonathan%2BD.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D28%26spage%3D3457%26epage%3D3460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Su</span>, <span class="hlFld-ContribAuthor ">Dian  Xiao</span>, <span class="hlFld-ContribAuthor ">Fei  Xie</span>, <span class="hlFld-ContribAuthor ">Lianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Yanming  Wang</span>, <span class="hlFld-ContribAuthor ">Shiyong  Fan</span>, <span class="hlFld-ContribAuthor ">Xinbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Song  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody–drug conjugates: Recent advances in linker chemistry. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.042" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.042%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DAntibody%2525E2%252580%252593drug%252Bconjugates%25253A%252BRecent%252Badvances%252Bin%252Blinker%252Bchemistry%26aulast%3DSu%26aufirst%3DZheng%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Scarpino</span>, <span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Tímea  Imre</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi-Balogh</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     , 223-244. <a href="https://doi.org/10.1007/s10822-020-00371-5" title="DOI URL">https://doi.org/10.1007/s10822-020-00371-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-020-00371-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-020-00371-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DWIDOCK%25253A%252Ba%252Breactive%252Bdocking%252Bprotocol%252Bfor%252Bvirtual%252Bscreening%252Bof%252Bcovalent%252Binhibitors%26aulast%3DScarpino%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D2%26spage%3D223%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shasank S.  Swain</span>, <span class="hlFld-ContribAuthor ">Sudhir K.  Paidesetty</span>, <span class="hlFld-ContribAuthor ">Budheswar  Dehury</span>, <span class="hlFld-ContribAuthor ">Madhusmita  Das</span>, <span class="hlFld-ContribAuthor ">Sundeep C.  Vedithi</span>, <span class="hlFld-ContribAuthor ">Rabindra N.  Padhy</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-63913-9" title="DOI URL">https://doi.org/10.1038/s41598-020-63913-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-63913-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-63913-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DComputer-aided%252Bsynthesis%252Bof%252Bdapsone-phytochemical%252Bconjugates%252Bagainst%252Bdapsone-resistant%252BMycobacterium%252Bleprae%26aulast%3DSwain%26aufirst%3DShasank%2BS.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohua  Long</span>, <span class="hlFld-ContribAuthor ">Cheng  Tao</span>, <span class="hlFld-ContribAuthor ">Yinghong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaobin  Zeng</span>, <span class="hlFld-ContribAuthor ">Meiqun  Cao</span>, <span class="hlFld-ContribAuthor ">Zhengzhi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Total synthesis of tubulysin U and N
              14
              -desacetoxytubulysin H. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (28)
                                     , 5349-5353. <a href="https://doi.org/10.1039/D0OB01109F" title="DOI URL">https://doi.org/10.1039/D0OB01109F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01109F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01109F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTotal%252Bsynthesis%252Bof%252Btubulysin%252BU%252Band%252BN%252B14%252B-desacetoxytubulysin%252BH%26aulast%3DLong%26aufirst%3DBohua%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D28%26spage%3D5349%26epage%3D5353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcin  Poreba</span>. </span><span class="cited-content_cbyCitation_article-title">Protease‐activated prodrugs: strategies, challenges, and future directions. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2020,</strong> <em>287 </em>
                                    (10)
                                     , 1936-1969. <a href="https://doi.org/10.1111/febs.15227" title="DOI URL">https://doi.org/10.1111/febs.15227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15227%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DProtease%2525E2%252580%252590activated%252Bprodrugs%25253A%252Bstrategies%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bdirections%26aulast%3DPoreba%26aufirst%3DMarcin%26date%3D2020%26date%3D2020%26volume%3D287%26issue%3D10%26spage%3D1936%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donmienne  Leung</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Wurst</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Ruben  Martinez</span>, <span class="hlFld-ContribAuthor ">Amita  Datta-Mannan</span>, <span class="hlFld-ContribAuthor ">Yiqing  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody Conjugates-Recent Advances and Future Innovations. </span><span class="cited-content_cbyCitation_journal-name">Antibodies</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     , 2. <a href="https://doi.org/10.3390/antib9010002" title="DOI URL">https://doi.org/10.3390/antib9010002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antib9010002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantib9010002%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibodies%26atitle%3DAntibody%252BConjugates-Recent%252BAdvances%252Band%252BFuture%252BInnovations%26aulast%3DLeung%26aufirst%3DDonmienne%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyunbo  Shim</span>. </span><span class="cited-content_cbyCitation_article-title">Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 360. <a href="https://doi.org/10.3390/biom10030360" title="DOI URL">https://doi.org/10.3390/biom10030360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10030360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10030360%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DBispecific%252BAntibodies%252Band%252BAntibody%2525E2%252580%252593Drug%252BConjugates%252Bfor%252BCancer%252BTherapy%25253A%252BTechnological%252BConsiderations%26aulast%3DShim%26aufirst%3DHyunbo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Puregmaa  Khongorzul</span>, <span class="hlFld-ContribAuthor ">Cai Jia  Ling</span>, <span class="hlFld-ContribAuthor ">Farhan Ullah  Khan</span>, <span class="hlFld-ContribAuthor ">Awais Ullah  Ihsan</span>, <span class="hlFld-ContribAuthor ">Juan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody–Drug Conjugates: A Comprehensive Review. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2020,</strong> <em>18 </em>
                                    (1)
                                     , 3-19. <a href="https://doi.org/10.1158/1541-7786.MCR-19-0582" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-19-0582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-19-0582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-19-0582%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DAntibody%2525E2%252580%252593Drug%252BConjugates%25253A%252BA%252BComprehensive%252BReview%26aulast%3DKhongorzul%26aufirst%3DPuregmaa%26date%3D2020%26date%3D2019%26volume%3D18%26issue%3D1%26spage%3D3%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh B.  Sutar</span>, <span class="hlFld-ContribAuthor ">Jaishree K.  Mali</span>, <span class="hlFld-ContribAuthor ">Vikas N.  Telvekar</span>, <span class="hlFld-ContribAuthor ">Raju S.  Rajmani</span>, <span class="hlFld-ContribAuthor ">Amit  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111713. <a href="https://doi.org/10.1016/j.ejmech.2019.111713" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111713%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTransferrin%252Bconjugates%252Bof%252Bantitubercular%252Bdrug%252Bisoniazid%25253A%252BSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Befficacy%26aulast%3DSutar%26aufirst%3DYogesh%2BB.%26date%3D2019%26volume%3D183%26spage%3D111713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Dal Corso</span>, <span class="hlFld-ContribAuthor ">Luca  Pignataro</span>, <span class="hlFld-ContribAuthor ">Laura  Belvisi</span>, <span class="hlFld-ContribAuthor ">Cesare  Gennari</span>. </span><span class="cited-content_cbyCitation_article-title">Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (65)
                                     , 14740-14757. <a href="https://doi.org/10.1002/chem.201903127" title="DOI URL">https://doi.org/10.1002/chem.201903127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903127%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DInnovative%252BLinker%252BStrategies%252Bfor%252BTumor%2525E2%252580%252590Targeted%252BDrug%252BConjugates%26aulast%3DDal%2BCorso%26aufirst%3DAlberto%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D65%26spage%3D14740%26epage%3D14757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Brady G.  Vigliarolo</span>, <span class="hlFld-ContribAuthor ">Morshed A.  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Jennifer N.K.  Nyarko</span>, <span class="hlFld-ContribAuthor ">Darrell D.  Mousseau</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Phenix</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of fluorogenic substrate-based probes for detecting Cathepsin B activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103194. <a href="https://doi.org/10.1016/j.bioorg.2019.103194" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103194%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bfluorogenic%252Bsubstrate-based%252Bprobes%252Bfor%252Bdetecting%252BCathepsin%252BB%252Bactivity%26aulast%3DWang%26aufirst%3DShusheng%26date%3D2019%26volume%3D92%26spage%3D103194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divya  Dheer</span>, <span class="hlFld-ContribAuthor ">Julien  Nicolas</span>, <span class="hlFld-ContribAuthor ">Ravi  Shankar</span>. </span><span class="cited-content_cbyCitation_article-title">Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2019,</strong> <em>151-152 </em>, 130-151. <a href="https://doi.org/10.1016/j.addr.2019.01.010" title="DOI URL">https://doi.org/10.1016/j.addr.2019.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2019.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2019.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DCathepsin-sensitive%252Bnanoscale%252Bdrug%252Bdelivery%252Bsystems%252Bfor%252Bcancer%252Btherapy%252Band%252Bother%252Bdiseases%26aulast%3DDheer%26aufirst%3DDivya%26date%3D2019%26volume%3D151-152%26spage%3D130%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Bargh</span>, <span class="hlFld-ContribAuthor ">Albert  Isidro-Llobet</span>, <span class="hlFld-ContribAuthor ">Jeremy S.  Parker</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Cleavable linkers in antibody–drug conjugates. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2019,</strong> <em>48 </em>
                                    (16)
                                     , 4361-4374. <a href="https://doi.org/10.1039/C8CS00676H" title="DOI URL">https://doi.org/10.1039/C8CS00676H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CS00676H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CS00676H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DCleavable%252Blinkers%252Bin%252Bantibody%2525E2%252580%252593drug%252Bconjugates%26aulast%3DBargh%26aufirst%3DJonathan%2BD.%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D16%26spage%3D4361%26epage%3D4374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janina  Schmitz</span>, <span class="hlFld-ContribAuthor ">Erik  Gilberg</span>, <span class="hlFld-ContribAuthor ">Reik  Löser</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, <span class="hlFld-ContribAuthor ">Ulrike  Bartz</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Cathepsin B: Active site mapping with peptidic substrates and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (1)
                                     , 1-15. <a href="https://doi.org/10.1016/j.bmc.2018.10.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCathepsin%252BB%25253A%252BActive%252Bsite%252Bmapping%252Bwith%252Bpeptidic%252Bsubstrates%252Band%252Binhibitors%26aulast%3DSchmitz%26aufirst%3DJanina%26date%3D2019%26volume%3D27%26issue%3D1%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deboprosad  Mondal</span>, <span class="hlFld-ContribAuthor ">Jacob  Ford</span>, <span class="hlFld-ContribAuthor ">Kevin G.  Pinney</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (40)
                                     , 3594-3599. <a href="https://doi.org/10.1016/j.tetlet.2018.08.021" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.08.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.08.021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DImproved%252BMethodology%252Bfor%252Bthe%252BSynthesis%252Bof%252Ba%252BCathepsin%252BB%252BCleavable%252BDipeptide%252BLinker%25252C%252BWidely%252BUsed%252Bin%252BAntibody-Drug%252BConjugate%252BResearch%26aulast%3DMondal%26aufirst%3DDeboprosad%26date%3D2018%26volume%3D59%26issue%3D40%26spage%3D3594%26epage%3D3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Simplified Molecular Construct for Measuring the Cleavage of ADC Linker Moieties by Protease<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reduction of ADC to the simplified construct is illustrated using the dipeptide linker Val-Cit (compound <b>1</b>).</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based design of cathepsin B-cleavable, nonpeptidic ADC linkers. (A, B) PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a> shows that a network of hydrogen bonds are involved in proper positioning of a substrate for nucleophilic attack by the thiol of Cys29 residue. Modeling based on the structure led to three series of new linkers: the F-olefin, the triazole, and the cBu series. The inhibitor (carbon atoms colored in green) forms a thioimidate adduct with the protein, mimicking the acyl enzyme intermediate of substrate hydrolysis. Orange dotted lines show selected hydrogen bonds mentioned in the text. The moieties corresponding to the P1 and P2 side chains of a peptide substrate are labeled in blue in the chemical sketch. The scissile amide bond is in red. (C, D) Model of the tetrahedral intermediate of hydrolysis for a cBu linker with a <i>p</i>-aminobenzyl alcohol leaving group (<b>15</b>, carbon atoms in cyan). Orange dotted lines show selected hydrogen bonds mentioned in the text. The 1,1-dicarboxamide moiety is predicted to form the same hydrogen bonds with the protein as the PDB compound, while the cyclobutyl group is expected to occupy the S2 site. The norfloxacin moiety is too far from the active site to participate in the amide bond hydrolysis, so it is omitted in the figure for clarity. (E, F) X-ray crystal structure of human cathepsin B in complex with <b>28</b>, a covalent inhibitor analogous to the cBu-Cit linker, refined at 1.6 Å resolution. The Polder omit electron density map contoured at 2.8σ is shown as blue mesh. Orange dotted lines show select hydrogen bonds mentioned in the text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> properties across all series. Data from <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are plotted. Chemical series are color-coded: peptides from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> are in red, fluoroolefins from <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> in magenta, 1,2,3-triazoles from <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> in orange, and cycloalkyl-1,1-dicarboxamides from <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> in green. For reference, compounds Val-Cit (<b>1</b>), Val-Ala (<b>2</b>), Val-Arg (<b>3</b>), cBu-Cit (<b>15</b>), and cBu-Arg (<b>19</b>) are labeled, and three different levels of <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> ratio are shown by black lines. Compounds on the same line share the same <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of ADCs bearing different linkers in their antiproliferation potencies and intracellular concentrations of the released payload in SK-BR-3 cancer cell line. MMAE drug was conjugated to anti-Her2 and anti-CD22 (control) monoclonal antibodies via the Val-Cit and cBu-Cit linker, respectively (mAb-<b>29</b>, mAb-<b>31</b>). (A) Cell viability after 5 days of ADC treatment. Each sample was in quadruplicate. (B) Intracellular concentrations of the released MMAE in SK-BR-3 cells measured at 23 h after the treatment with the ADCs. For comparison, ADCs bearing Val-(<i>R</i>)-Cit or cBu-(<i>R</i>)-Cit linker were also included (mAb-<b>30</b>, mAb-<b>32</b>). Each sample was in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of protease inhibitors on the release of MMAE payload by ADCs bearing different linkers. SK-BR-3 cells were treated overnight with 1 μg/mL of anti-Her2 ADC carrying one of the four linker-MMAEs (<b>29</b>, <b>31</b>, <b>33</b>, or <b>34</b>) and 50 μM protease inhibitor. Cell lysates were then prepared and analyzed by LC–MS/MS. Intracellular MMAE levels were quantified by total ion chromatogram (TIC), and for each linker-MMAE, all inhibitor-treated samples were normalized to the respective DMSO-treated control (100% TIC). Each sample was in triplicate except for the DMSO treated controls (<i>n</i> = 4, in black).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of ADC efficacies in mouse xenograft tumor models. (A, B) In vivo efficacy of the anti-CD22 ADCs carrying MMAE payload was assessed in mice bearing WSU-DLCL2 (A) or Bjab-luc (B) human lymphoma xenografts. (C) In vivo efficacy of the anti-Napi2b ADCs carrying PBD dimer payload was evaluated in mice bearing OVCAR3X2.1 human ovarian xenografts. In each study, animals received on day 0 a single intravenous injection of antibody–drug conjugates through the tail vein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/medium/jm-2017-01430r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the in vivo stability of ADCs in mice bearing Bjab-luc human lymphoma xenograft. Blood samples were taken from the mice in groups 2 and 4 of the efficacy study shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, at 1, 7, and 14 days postdosing. (A) Total antibody concentrations. (B) Conjugated antibody concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01430/20180201/images/large/jm-2017-01430r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01430&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Junutula, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span> </span><span class="NLM_article-title">Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">972</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=972-973&issue=11&author=J.+R.+Junutulaauthor=H.-P.+Gerber&title=Next-Generation+Antibody-Drug+Conjugates+%28ADCs%29+for+Cancer+Therapy&doi=10.1021%2Facsmedchemlett.6b00421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00421%26sid%3Dliteratum%253Aachs%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26aulast%3DGerber%26aufirst%3DH.-P.%26atitle%3DNext-Generation%2520Antibody-Drug%2520Conjugates%2520%2528ADCs%2529%2520for%2520Cancer%2520Therapy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D11%26spage%3D972%26epage%3D973%26doi%3D10.1021%2Facsmedchemlett.6b00421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Saber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, J. K.</span><span> </span><span class="NLM_article-title">An FDA Oncology Analysis of Antibody-Drug Conjugates</span> <span class="citation_source-journal">Regul. Toxicol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1016/j.yrtph.2015.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1016%2Fj.yrtph.2015.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=25661711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2rsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=444-452&issue=3&author=H.+Saberauthor=J.+K.+Leighton&title=An+FDA+Oncology+Analysis+of+Antibody-Drug+Conjugates&doi=10.1016%2Fj.yrtph.2015.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An FDA oncology analysis of antibody-drug conjugates</span></div><div class="casAuthors">Saber, Haleh; Leighton, John K.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) are complex mols. composed of monoclonal antibodies conjugated to potent cytotoxic agents through chem. linkers.  Because of this complexity, sponsors have used different approaches for the design of nonclin. studies to support the safety evaluation of ADCs and first-in-human (FIH) dose selection.  We analyzed this data with the goal of describing the relationship between nonclin. study results and Phase 1 study outcomes.  We summarized the following data from investigational new drug applications (INDs) for ADCs: plasma stability, animal study designs and toxicities, and algorithms used for FIH dose selection.  Our review found that selecting a FIH dose that is 1/6th the highest non-severely toxic dose (HNSTD) in cynomolgus monkeys or 1/10th the STD10 in rodents scaled according to body surface area (BSA) generally resulted in the acceptable balance of safety and efficient dose-escalation in a Phase 1 trial.  Other approaches may also be acceptable, e.g. 1/10th the HNSTD in monkeys using BSA or 1/10th the NOAEL in monkeys or rodents using body wt. for scaling.  While the animal data for the vc-MMAE platform yielded variable range of HNSTDs in cynomolgus monkeys, MTDs were in a narrow range in patients, suggesting that for ADCs sharing the same small mol. drug, linker and drug:antibody ratio, prior clin. data can inform the design of a Phase 1 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNKxNbn4b6rVg90H21EOLACvtfcHk0lgTX_UziubU7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2rsrY%253D&md5=513d5d669e869260ceb67a4419f5b208</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2015.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2015.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DSaber%26aufirst%3DH.%26aulast%3DLeighton%26aufirst%3DJ.%2BK.%26atitle%3DAn%2520FDA%2520Oncology%2520Analysis%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2015%26volume%3D71%26issue%3D3%26spage%3D444%26epage%3D452%26doi%3D10.1016%2Fj.yrtph.2015.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Donaghy, H.</span><span> </span><span class="NLM_article-title">Effects of Antibody, Drug and Linker on the Preclinical and Clinical Toxicities of Antibody-Drug Conjugates</span> <span class="citation_source-journal">MAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1080/19420862.2016.1156829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1080%2F19420862.2016.1156829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=27045800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFant7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=659-671&issue=4&author=H.+Donaghy&title=Effects+of+Antibody%2C+Drug+and+Linker+on+the+Preclinical+and+Clinical+Toxicities+of+Antibody-Drug+Conjugates&doi=10.1080%2F19420862.2016.1156829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates</span></div><div class="casAuthors">Donaghy, Heather</div><div class="citationInfo"><span class="NLM_cas:title">mAbs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">659-671</span>CODEN:
                <span class="NLM_cas:coden">MABSCP</span>;
        ISSN:<span class="NLM_cas:issn">1942-0870</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) represent a new class of cancer therapeutics.  Their design involves a tumor-specific antibody, a linker and a cytotoxic payload.  They were designed to allow specific targeting of highly potent cytotoxic agents to tumor cells while sparing normal cells.  Frequent toxicities that may be driven by any of the components of an ADC have been reported.  There are currently more than 50 ADCs in active clin. development, and a further ∼20 that have been discontinued.  For this review, the reported toxicities of ADCs were analyzed, and the mechanisms for their effects are explored in detail.  Methods to reduce toxicities, including dosing strategies and drug design, are discussed.  The toxicities reported for active and discontinued drugs are important to drive the rational design and improve the therapeutic index of ADCs of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb4UbDQ7svIrVg90H21EOLACvtfcHk0lhnaiqqOu9ErA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFant7k%253D&md5=b2ba3e43e8362d8a3f7c368a5af5f94e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F19420862.2016.1156829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F19420862.2016.1156829%26sid%3Dliteratum%253Aachs%26aulast%3DDonaghy%26aufirst%3DH.%26atitle%3DEffects%2520of%2520Antibody%252C%2520Drug%2520and%2520Linker%2520on%2520the%2520Preclinical%2520and%2520Clinical%2520Toxicities%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DMAbs%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D659%26epage%3D671%26doi%3D10.1080%2F19420862.2016.1156829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Shen, B.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenrick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons-Reponte, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudys, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hass, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solis, W. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawli, L. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandlen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junutula, J. R.</span><span> </span><span class="NLM_article-title">Conjugation Site Modulates the in Vivo Stability and Therapeutic Activity of Antibody-Drug Conjugates</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1038/nbt.2108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.2108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=22267010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=184-189&issue=2&author=B.-Q.+Shenauthor=K.+Xuauthor=L.+Liuauthor=H.+Raabauthor=S.+Bhaktaauthor=M.+Kenrickauthor=K.+L.+Parsons-Reponteauthor=J.+Tienauthor=S.-F.+Yuauthor=E.+Maiauthor=D.+Liauthor=J.+Tibbittsauthor=J.+Baudysauthor=O.+M.+Saadauthor=S.+J.+Scalesauthor=P.+J.+McDonaldauthor=P.+E.+Hassauthor=C.+Eigenbrotauthor=T.+Nguyenauthor=W.+a+Solisauthor=R.+N.+Fujiauthor=K.+M.+Flagellaauthor=D.+Patelauthor=S.+D.+Spencerauthor=L.+a+Khawliauthor=A.+Ebensauthor=W.+L.+Wongauthor=R.+Vandlenauthor=S.+Kaurauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=J.+R.+Junutula&title=Conjugation+Site+Modulates+the+in+Vivo+Stability+and+Therapeutic+Activity+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnbt.2108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span></div><div class="casAuthors">Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saad, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Nguyen, Trung; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawli, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates.  To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge.  The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione.  In contrast, a partially accessible site with a pos. charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction.  The site with partial solvent-accessibility and neutral charge displayed both properties.  In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected pos. by succinimide ring hydrolysis and neg. by maleimide exchange with thiol-reactive constituents in plasma.  Thus, the chem. and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkINkMwQTMFrVg90H21EOLACvtfcHk0lj8XroJRAo6JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D&md5=c647fc5bdfe93dfdabb15ca40934837f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2108%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DB.-Q.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DParsons-Reponte%26aufirst%3DK.%2BL.%26aulast%3DTien%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DMai%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DTibbitts%26aufirst%3DJ.%26aulast%3DBaudys%26aufirst%3DJ.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DMcDonald%26aufirst%3DP.%2BJ.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSolis%26aufirst%3DW.%2Ba%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DK.%2BM.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DKhawli%26aufirst%3DL.%2Ba%26aulast%3DEbens%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26atitle%3DConjugation%2520Site%2520Modulates%2520the%2520in%2520Vivo%2520Stability%2520and%2520Therapeutic%2520Activity%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26issue%3D2%26spage%3D184%26epage%3D189%26doi%3D10.1038%2Fnbt.2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dorywalska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton-Witt, J. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasa-Moreno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farias, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galindo Casas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaria, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foletti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajpal, A.</span><span> </span><span class="NLM_article-title">Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span><span class="refDoi"> DOI: 10.1021/bc5005747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc5005747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=650-659&author=M.+Dorywalskaauthor=P.+Stropauthor=J.+a.+Melton-Wittauthor=A.+Hasa-Morenoauthor=S.+E.+Fariasauthor=M.+Galindo+Casasauthor=K.+Delariaauthor=V.+Luiauthor=K.+Poulsenauthor=C.+Looauthor=S.+Krimmauthor=G.+Boltonauthor=L.+Moineauthor=R.+Dushinauthor=T.-T.+Tranauthor=S.-H.+Liuauthor=M.+Rickertauthor=D.+Folettiauthor=D.+L.+Sheltonauthor=J.+Ponsauthor=A.+Rajpal&title=Effect+of+Attachment+Site+on+Stability+of+Cleavable+Antibody+Drug+Conjugates&doi=10.1021%2Fbc5005747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates</span></div><div class="casAuthors">Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Galindo Casas, Meritxell; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Loo, Carole; Krimm, Stellanie; Bolton, Gary; Moine, Ludivine; Dushin, Russell; Tran, Thomas-Toan; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The systemic stability of the antibody-drug linker is crucial for delivery of an intact antibody-drug conjugate (ADC) to target-expressing tumors.  Linkers stable in circulation but readily processed in the target cell are necessary for both safety and potency of the delivered conjugate.  Here, we report a range of stabilities for an auristatin-based payload site-specifically attached through a cleavable valine-citrulline-p-aminobenzylcarbamate (VC-PABC) linker across various sites on an antibody.  We demonstrate that the conjugation site plays an important role in detg. VC-PABC linker stability in mouse plasma, and that the stability of the linker pos. correlates with ADC cytotoxic potency both in vitro and in vivo.  Furthermore, we show that the VC-PABC cleavage in mouse plasma is not mediated by Cathepsin B, the protease thought to be primarily responsible for linker processing in the lysosomal degrdn. pathway.  Although the VC-PABC cleavage is not detected in primate plasma in vitro, linker stabilization in the mouse is an essential prerequisite for designing successful efficacy and safety studies in rodents during preclin. stages of ADC programs.  The divergence of linker metab. in mouse plasma and its intracellular cleavage offers an opportunity for linker optimization in the circulation without compromising its efficient payload release in the target cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof2xwnbbtSz7Vg90H21EOLACvtfcHk0liZ1QVN7hSfVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsb4%253D&md5=c6ea72edbc33b0ad4aa743bc21707401</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fbc5005747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc5005747%26sid%3Dliteratum%253Aachs%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DMelton-Witt%26aufirst%3DJ.%2Ba.%26aulast%3DHasa-Moreno%26aufirst%3DA.%26aulast%3DFarias%26aufirst%3DS.%2BE.%26aulast%3DGalindo%2BCasas%26aufirst%3DM.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DPoulsen%26aufirst%3DK.%26aulast%3DLoo%26aufirst%3DC.%26aulast%3DKrimm%26aufirst%3DS.%26aulast%3DBolton%26aufirst%3DG.%26aulast%3DMoine%26aufirst%3DL.%26aulast%3DDushin%26aufirst%3DR.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DFoletti%26aufirst%3DD.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DEffect%2520of%2520Attachment%2520Site%2520on%2520Stability%2520of%2520Cleavable%2520Antibody%2520Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D650%26epage%3D659%26doi%3D10.1021%2Fbc5005747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cohen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vugts, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, G. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter-van Walsum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, G. A. M. S.</span><span> </span><span class="NLM_article-title">Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5700</span><span class="NLM_x">–</span> <span class="NLM_lpage">5710</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1158%2F0008-5472.CAN-14-1141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5700-5710&issue=20&author=R.+Cohenauthor=D.+J.+Vugtsauthor=G.+W.+M.+Visserauthor=M.+Stigter-van+Walsumauthor=M.+Bolijnauthor=M.+Spigaauthor=P.+Lazzariauthor=S.+Shankarauthor=M.+Saniauthor=M.+Zandaauthor=G.+A.+M.+S.+van+Dongen&title=Development+of+Novel+ADCs%3A+Conjugation+of+Tubulysin+Analogues+to+Trastuzumab+Monitored+by+Dual+Radiolabeling&doi=10.1158%2F0008-5472.CAN-14-1141"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1141%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DVugts%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DG.%2BW.%2BM.%26aulast%3DStigter-van%2BWalsum%26aufirst%3DM.%26aulast%3DBolijn%26aufirst%3DM.%26aulast%3DSpiga%26aufirst%3DM.%26aulast%3DLazzari%26aufirst%3DP.%26aulast%3DShankar%26aufirst%3DS.%26aulast%3DSani%26aufirst%3DM.%26aulast%3DZanda%26aufirst%3DM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%2BM.%2BS.%26atitle%3DDevelopment%2520of%2520Novel%2520ADCs%253A%2520Conjugation%2520of%2520Tubulysin%2520Analogues%2520to%2520Trastuzumab%2520Monitored%2520by%2520Dual%2520Radiolabeling%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D20%26spage%3D5700%26epage%3D5710%26doi%3D10.1158%2F0008-5472.CAN-14-1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Beck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaia, N.</span><span> </span><span class="NLM_article-title">Strategies and Challenges for the next Generation of Therapeutic Antibodies</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1038/nri2747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnri2747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=20414207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltV2ksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=345-352&issue=5&author=A.+Beckauthor=T.+Wurchauthor=C.+Baillyauthor=N.+Corvaia&title=Strategies+and+Challenges+for+the+next+Generation+of+Therapeutic+Antibodies&doi=10.1038%2Fnri2747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and challenges for the next generation of therapeutic antibodies</span></div><div class="casAuthors">Beck, Alain; Wurch, Thierry; Bailly, Christian; Corvaia, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-352</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies and related products are the fastest growing class of therapeutic agents.  By analyzing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, the authors can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market.  Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic.  Here, the authors discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with addnl. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZTNUjT-_v7Vg90H21EOLACvtfcHk0ljyDbHMBrGH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltV2ksb8%253D&md5=f8b6ffa33310f5ab2a5dfb92872b71a0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri2747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2747%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DWurch%26aufirst%3DT.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DCorvaia%26aufirst%3DN.%26atitle%3DStrategies%2520and%2520Challenges%2520for%2520the%2520next%2520Generation%2520of%2520Therapeutic%2520Antibodies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26issue%3D5%26spage%3D345%26epage%3D352%26doi%3D10.1038%2Fnri2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasch, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific in Vitro Anticancer Activity</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span><span class="refDoi"> DOI: 10.1021/bc025536j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc025536j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=855-869&issue=4&author=G.+M.+Dubowchikauthor=R.+A.+Firestoneauthor=L.+Padillaauthor=D.+Willnerauthor=S.+J.+Hofsteadauthor=K.+Mosureauthor=J.+O.+Knipeauthor=S.+J.+Laschauthor=P.+A.+Trail&title=Cathepsin+B-Labile+Dipeptide+Linkers+for+Lysosomal+Release+of+Doxorubicin+from+Internalizing+Immunoconjugates%3A+Model+Studies+of+Enzymatic+Drug+Release+and+Antigen-Specific+in+Vitro+Anticancer+Activity&doi=10.1021%2Fbc025536j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity</span></div><div class="casAuthors">Dubowchik, Gene M.; Firestone, Raymond A.; Padilla, Linda; Willner, David; Hofstead, Sandra J.; Mosure, Kathleen; Knipe, Jay O.; Lasch, Shirley J.; Trail, Pamela A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-869</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The anticancer drug doxorubicin (DOX) was linked to chimeric BR96, an internalizing monoclonal antibody that binds to a Lewisy-related, tumor-assocd. antigen, through 2 lysosomally cleavable dipeptides, Phe-Lys and Val-Cit, giving immunoconjugates (I and II).  A self-immolative p-aminobenzyloxycarbonyl (PABC) spacer between the dipeptides and the DOX was required for rapid and quant. generation of free drug. DOX release from the model substrate Z-Phe-Lys-PABC-DOX was 30-fold faster than from Z-Val-Cit-PABC-DOX with the cysteine protease cathepsin B alone, but rates were identical in a rat liver lysosomal prepn. suggesting the participation of more than one enzyme.  Conjugates I and II showed rapid and near quant. drug release with cathepsin B and in a lysosomal prepn., while demonstrating excellent stability in human plasma.  Against tumor cell lines with varying levels of BR96 expression, both conjugates showed potent, antigen-specific cytotoxic activity, suggesting that they will be effective in delivering DOX selectively to antigen-expressing carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolCImqg5WKbVg90H21EOLACvtfcHk0ljyDbHMBrGH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFentr8%253D&md5=09fb70d94d8997033b109fa3b5e79621</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbc025536j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc025536j%26sid%3Dliteratum%253Aachs%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26aulast%3DFirestone%26aufirst%3DR.%2BA.%26aulast%3DPadilla%26aufirst%3DL.%26aulast%3DWillner%26aufirst%3DD.%26aulast%3DHofstead%26aufirst%3DS.%2BJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DLasch%26aufirst%3DS.%2BJ.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DCathepsin%2520B-Labile%2520Dipeptide%2520Linkers%2520for%2520Lysosomal%2520Release%2520of%2520Doxorubicin%2520from%2520Internalizing%2520Immunoconjugates%253A%2520Model%2520Studies%2520of%2520Enzymatic%2520Drug%2520Release%2520and%2520Antigen-Specific%2520in%2520Vitro%2520Anticancer%2520Activity%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D4%26spage%3D855%26epage%3D869%26doi%3D10.1021%2Fbc025536j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Senter, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, E. L.</span><span> </span><span class="NLM_article-title">The Discovery and Development of Brentuximab Vedotin for Use in Relapsed Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1038/nbt.2289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.2289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=22781692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=631-637&issue=7&author=P.+D.+Senterauthor=E.+L.+Sievers&title=The+Discovery+and+Development+of+Brentuximab+Vedotin+for+Use+in+Relapsed+Hodgkin+Lymphoma+and+Systemic+Anaplastic+Large+Cell+Lymphoma&doi=10.1038%2Fnbt.2289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma</span></div><div class="casAuthors">Senter, Peter D.; Sievers, Eric L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-637</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Progress was made recently in developing antibody-drug conjugates (ADCs) that can selectively deliver cancer drugs to tumor cells.  In principle, the idea is simple: by attaching drugs to tumor-seeking antibodies, target cells will be killed and nontarget cells will be spared.  In practice, many parameters needed to be addressed to develop safe and effective ADCs, including the expression profiles of tumor vs. normal tissues, the potency of the drug, the linker attaching the drug and placement of the drug on the antibody, and the pharmacokinetic and stability profiles of the resulting ADC.  All these issues had been taken into account in developing brentuximab vedotin (Adcetris), an ADC that recently received accelerated approval by the US Food and Drug Administration for the treatment of relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).  Research is under way to extend the applications of brentuximab vedotin and to advance the field by developing other ADCs with new linker and conjugation strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyPib6JxGsSrVg90H21EOLACvtfcHk0lgfHyCvk8HWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFCqtbw%253D&md5=6940eb8178e8c8c150a7b21361e23234</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2289%26sid%3Dliteratum%253Aachs%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DSievers%26aufirst%3DE.%2BL.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520Brentuximab%2520Vedotin%2520for%2520Use%2520in%2520Relapsed%2520Hodgkin%2520Lymphoma%2520and%2520Systemic%2520Anaplastic%2520Large%2520Cell%2520Lymphoma%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26issue%3D7%26spage%3D631%26epage%3D637%26doi%3D10.1038%2Fnbt.2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span> </span><span class="NLM_article-title">Current ADC Linker Chemistry</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3526</span><span class="NLM_x">–</span> <span class="NLM_lpage">3540</span><span class="refDoi"> DOI: 10.1007/s11095-015-1657-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1007%2Fs11095-015-1657-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=25759187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Omu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=3526-3540&author=N.+Jainauthor=S.+W.+Smithauthor=S.+Ghoneauthor=B.+Tomczuk&title=Current+ADC+Linker+Chemistry&doi=10.1007%2Fs11095-015-1657-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current ADC Linker Chemistry</span></div><div class="casAuthors">Jain, Nareshkumar; Smith, Sean W.; Ghone, Sanjeevani; Tomczuk, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3526-3540</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The list of ADCs in the clinic continues to grow, bolstered by the success of first two marketed ADCs: ADCETRIS and Kadcyla.  Currently, there are 40 ADCs in various phases of clin. development.  However, only 34 of these have published their structures.  Of the 34 disclosed structures, 24 of them use a linkage to the thiol of cysteines on the monoclonal antibody.  The remaining 10 candidates utilize chem. to surface lysines of the antibody.  Due to the inherent heterogeneity of conjugation to the multiple lysines or cysteines found in mAbs, significant research efforts are now being directed toward the prodn. of discrete, homogeneous ADC products, via site-specific conjugation.  These site-specific conjugations may involve genetic engineering of the mAb to introduce discrete, available cysteines or non-natural amino acids with an orthogonally-reactive functional group handle such as an aldehyde, ketone, azido, or alkynyl tag.  These site-specific approaches not only increase the homogeneity of ADCs but also enable novel bio-orthogonal chemistries that utilize reactive moieties other than thiol or amine.  This broadens the diversity of linkers that can be utilized which will lead to better linker design in future generations of ADCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDSDdeJOKlG7Vg90H21EOLACvtfcHk0lgHdng8OrZG7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Omu70%253D&md5=efbfe1c9469f4bf93f6a19ebc966ea1d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11095-015-1657-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-015-1657-7%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DS.%2BW.%26aulast%3DGhone%26aufirst%3DS.%26aulast%3DTomczuk%26aufirst%3DB.%26atitle%3DCurrent%2520ADC%2520Linker%2520Chemistry%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D3526%26epage%3D3540%26doi%3D10.1007%2Fs11095-015-1657-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dal Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzamalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gébleux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattarella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, D.</span><span> </span><span class="NLM_article-title">Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1826</span><span class="NLM_x">–</span> <span class="NLM_lpage">1833</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyhs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1826-1833&issue=7&author=A.+Dal+Corsoauthor=S.+Cazzamalliauthor=R.+G%C3%A9bleuxauthor=M.+Mattarellaauthor=D.+Neri&title=Protease-Cleavable+Linkers+Modulate+the+Anticancer+Activity+of+Noninternalizing+Antibody-Drug+Conjugates&doi=10.1021%2Facs.bioconjchem.7b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates</span></div><div class="casAuthors">Dal Corso, Alberto; Cazzamalli, Samuele; Gebleux, Remy; Mattarella, Martin; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1826-1833</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) represent an attractive class of biopharmaceutical agents, with the potential to selectively deliver potent cytotoxic agents to tumors.  It is generally assumed that ADC products should preferably bind and internalize into cancer cells in order to liberate their toxic payload, but a growing body of evidence indicates that also ADCs based on noninternalizing antibodies may be potently active.  In this Communication, we investigated dipeptide-based linkers (frequently used for internalizing ADC products) in the context of the noninternalizing F16 antibody, specific to a splice isoform of tenascin-C.  Using monomethyl auristatin E (MMAE) as potent cytotoxic drug, we obsd. that a single amino acid substitution of the Val-Cit dipeptide linker can substantially modulate the in vivo stability of the corresponding ADC products, as well as the anticancer activity in mice bearing the human epidermoid A431 carcinoma.  In these settings, the linker based on the Val-Ala dipeptide exhibited better performances, compared to Val-Cit, Val-Lys, and Val-Arg analogs.  Mass spectrometric anal. revealed that the four linkers displayed not only different stability in vivo but also differences in cleavage sites.  Moreover, the absence of anticancer activity for a F16-MMAE conjugate featuring a noncleavable linker indicated that drug release modalities, based on proteolytic degrdn. of the Ig moiety, cannot be exploited with noninternalizing antibodies.  ADC products based on the noninternalizing F16 antibody may be useful for the treatment of several human malignancies, as the cognate antigen is abundantly expressed in the extracellular matrix of several tumors, while being virtually undetectable in most normal adult tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOwK4KEoAgLVg90H21EOLACvtfcHk0ljznUst9EvTwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyhs7fK&md5=7ebb8cd3dc791ce2b5d29a1a2153a72c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00304%26sid%3Dliteratum%253Aachs%26aulast%3DDal%2BCorso%26aufirst%3DA.%26aulast%3DCazzamalli%26aufirst%3DS.%26aulast%3DG%25C3%25A9bleux%26aufirst%3DR.%26aulast%3DMattarella%26aufirst%3DM.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DProtease-Cleavable%2520Linkers%2520Modulate%2520the%2520Anticancer%2520Activity%2520of%2520Noninternalizing%2520Antibody-Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26issue%3D7%26spage%3D1826%26epage%3D1833%26doi%3D10.1021%2Facs.bioconjchem.7b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setiady, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovtun, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishkin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccia, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costoplus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaletskaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdison, W. C.</span><span> </span><span class="NLM_article-title">A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1158%2F1535-7163.MCT-16-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=27197308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVeqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1311-1320&issue=6&author=R.+Singhauthor=Y.+Y.+Setiadyauthor=J.+Ponteauthor=Y.+V.+Kovtunauthor=K.+C.+Laiauthor=E.+E.+Hongauthor=N.+Fishkinauthor=L.+Dongauthor=G.+E.+Jonesauthor=J.+A.+Cocciaauthor=L.+Lanieriauthor=K.+Vealeauthor=J.+A.+Costoplusauthor=A.+Skaletskayaauthor=R.+Gabrielauthor=P.+Salomonauthor=R.+Wuauthor=Q.+Qiuauthor=H.+K.+Ericksonauthor=J.+M.+Lambertauthor=R.+V.+Chariauthor=W.+C.+Widdison&title=A+New+Triglycyl+Peptide+Linker+for+Antibody-Drug+Conjugates+%28ADCs%29+with+Improved+Targeted+Killing+of+Cancer+Cells&doi=10.1158%2F1535-7163.MCT-16-0021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells</span></div><div class="casAuthors">Singh, Rajeeva; Setiady, Yulius Y.; Ponte, Jose; Kovtun, Yelena V.; Lai, Katharine C.; Hong, E. Erica; Fishkin, Nathan; Dong, Ling; Jones, Gregory E.; Coccia, Jennifer A.; Lanieri, Leanne; Veale, Karen; Costoplus, Juliet A.; Skaletskaya, Anna; Gabriel, Rabih; Salomon, Paulin; Wu, Rui; Qiu, Qifeng; Erickson, Hans K.; Lambert, John M.; Chari, Ravi V. J.; Widdison, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A triglycyl peptide linker (CX) was designed for use in antibody-drug conjugates (ADC), aiming to provide efficient release and lysosomal efflux of cytotoxic catabolites within targeted cancer cells.  ADCs comprising anti-epithelial cell adhesion mol. (anti-EpCAM) and anti-EGFR antibodies with maytansinoid payloads were prepd. using CX or a noncleavable SMCC linker (CX and SMCC ADCs).  The in vitro cytotoxic activities of CX and SMCC ADCs were similar for several cancer cell lines; however, the CX ADC was more active (5-100-fold lower IC50) than the SMCC ADC in other cell lines, including a multidrug-resistant line.  Both CX and SMCC ADCs showed comparable MTDs and pharmacokinetics in CD-1 mice.  In Calu-3 tumor xenografts, antitumor efficacy was obsd. with the anti-EpCAM CX ADC at a 5-fold lower dose than the corresponding SMCC ADC in vivo.  Similarly, the anti-EGFR CX ADC showed improved antitumor activity over the resp. SMCC conjugate in HSC-2 and H1975 tumor models; however, both exhibited similar activity against FaDu xenografts.  Mechanistically, in contrast with the charged lysine-linked catabolite of SMCC ADC, a significant fraction of the carboxylic acid catabolite of CX ADC could be uncharged in the acidic lysosomes, and thus diffuse out readily into the cytosol.  Upon release from tumor cells, CX catabolites are charged at extracellular pH and do not penetrate and kill neighboring cells, similar to the SMCC catabolite.  Overall, these data suggest that CX represents a promising linker option for the development of ADCs with improved therapeutic properties.  Mol Cancer Ther; 15(6); 1311-20. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf-TVhCpDSJbVg90H21EOLACvtfcHk0lihq25QhoB5lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVeqs7c%253D&md5=854059079d1e44942fef682889e96220</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0021%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DSetiady%26aufirst%3DY.%2BY.%26aulast%3DPonte%26aufirst%3DJ.%26aulast%3DKovtun%26aufirst%3DY.%2BV.%26aulast%3DLai%26aufirst%3DK.%2BC.%26aulast%3DHong%26aufirst%3DE.%2BE.%26aulast%3DFishkin%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DG.%2BE.%26aulast%3DCoccia%26aufirst%3DJ.%2BA.%26aulast%3DLanieri%26aufirst%3DL.%26aulast%3DVeale%26aufirst%3DK.%26aulast%3DCostoplus%26aufirst%3DJ.%2BA.%26aulast%3DSkaletskaya%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DR.%26aulast%3DSalomon%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DErickson%26aufirst%3DH.%2BK.%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DWiddison%26aufirst%3DW.%2BC.%26atitle%3DA%2520New%2520Triglycyl%2520Peptide%2520Linker%2520for%2520Antibody-Drug%2520Conjugates%2520%2528ADCs%2529%2520with%2520Improved%2520Targeted%2520Killing%2520of%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26issue%3D6%26spage%3D1311%26epage%3D1320%26doi%3D10.1158%2F1535-7163.MCT-16-0021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Puthenveetil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teske, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosselet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumey, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, E. I.</span><span> </span><span class="NLM_article-title">Multivalent Peptidic Linker Enables Identification of Preferred Sites of Conjugation for a Potent Thialanstatin Antibody Drug Conjugate</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0178452</span><span class="refDoi"> DOI: 10.1371/journal.pone.0178452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1371%2Fjournal.pone.0178452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0178452&issue=5&author=S.+Puthenveetilauthor=H.+Heauthor=F.+Loganzoauthor=S.+Mustoauthor=J.+Teskeauthor=M.+Greenauthor=X.+Tanauthor=C.+Hosseletauthor=J.+Lucasauthor=L.+N.+Tumeyauthor=P.+Sapraauthor=C.+Subramanyamauthor=C.+J.+O%E2%80%99Donnellauthor=E.+I.+Graziani&title=Multivalent+Peptidic+Linker+Enables+Identification+of+Preferred+Sites+of+Conjugation+for+a+Potent+Thialanstatin+Antibody+Drug+Conjugate&doi=10.1371%2Fjournal.pone.0178452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0178452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0178452%26sid%3Dliteratum%253Aachs%26aulast%3DPuthenveetil%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLoganzo%26aufirst%3DF.%26aulast%3DMusto%26aufirst%3DS.%26aulast%3DTeske%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DHosselet%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DTumey%26aufirst%3DL.%2BN.%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DGraziani%26aufirst%3DE.%2BI.%26atitle%3DMultivalent%2520Peptidic%2520Linker%2520Enables%2520Identification%2520of%2520Preferred%2520Sites%2520of%2520Conjugation%2520for%2520a%2520Potent%2520Thialanstatin%2520Antibody%2520Drug%2520Conjugate%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3De0178452%26doi%3D10.1371%2Fjournal.pone.0178452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R.</span><span> </span><span class="NLM_article-title">Twenty Years of the MEROPS Database of Proteolytic Enzymes, Their Substrates and Inhibitors</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">D1</span><span class="NLM_x">) </span> <span class="NLM_fpage">D343</span><span class="NLM_x">–</span> <span class="NLM_lpage">D350</span><span class="refDoi"> DOI: 10.1093/nar/gkv1118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1093%2Fnar%2Fgkv1118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=26527717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=D343-D350&issue=D1&author=N.+D.+Rawlingsauthor=A.+J.+Barrettauthor=R.+Finn&title=Twenty+Years+of+the+MEROPS+Database+of+Proteolytic+Enzymes%2C+Their+Substrates+and+Inhibitors&doi=10.1093%2Fnar%2Fgkv1118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors</span></div><div class="casAuthors">Rawlings, Neil D.; Barrett, Alan J.; Finn, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D343-D350</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The MEROPS database (http://merops.sanger.ac.uk) is an integrated source of information about peptidases, their substrates and inhibitors, which are of great relevance to biol., medicine and biotechnol.  The hierarchical classification of the database is as follows: homologous sets of sequences are grouped into a protein species; protein species are grouped into a family; families are grouped into clans.  There is a type example for each protein species (known as a 'holotype'), family and clan, and each protein species, family and clan has its own unique identifier.  Pages to show the involvement of peptidases and peptidase inhibitors in biol. pathways have been created.  Each page shows the peptidases and peptidase inhibitors involved in the pathway, along with the known substrate cleavages and peptidase-inhibitor interactions, and a link to the KEGG database of biol. pathways.  Links have also been established with the IUPHAR Guide to Pharmacol.  A new service has been set up to allow the submission of identified substrate cleavages so that conservation of the cleavage site can be assessed.  This should help establish whether or not a cleavage site is physiol. relevant on the basis that such a cleavage site is likely to be conserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ImObN0bWOrVg90H21EOLACvtfcHk0ljV9wwsFJFGeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gu7rF&md5=9ede9e4742347becdc30067a7ac5a192</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv1118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv1118%26sid%3Dliteratum%253Aachs%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DFinn%26aufirst%3DR.%26atitle%3DTwenty%2520Years%2520of%2520the%2520MEROPS%2520Database%2520of%2520Proteolytic%2520Enzymes%252C%2520Their%2520Substrates%2520and%2520Inhibitors%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26issue%3DD1%26spage%3DD343%26epage%3DD350%26doi%3D10.1093%2Fnar%2Fgkv1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Musil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towatari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">The Refined 2.15 A X-Ray Crystal Structure of Human Liver Cathepsin B: The Structural Basis for Its Specificity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2321-2330&issue=9&author=D.+Musilauthor=D.+Zucicauthor=D.+Turkauthor=R.+a+Enghauthor=I.+Mayrauthor=R.+Huberauthor=T.+Popovicauthor=V.+Turkauthor=T.+Towatariauthor=N.+Katunuma&title=The+Refined+2.15+A+X-Ray+Crystal+Structure+of+Human+Liver+Cathepsin+B%3A+The+Structural+Basis+for+Its+Specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DZucic%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DEngh%26aufirst%3DR.%2Ba%26aulast%3DMayr%26aufirst%3DI.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DPopovic%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTowatari%26aufirst%3DT.%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DThe%2520Refined%25202.15%2520A%2520X-Ray%2520Crystal%2520Structure%2520of%2520Human%2520Liver%2520Cathepsin%2520B%253A%2520The%2520Structural%2520Basis%2520for%2520Its%2520Specificity%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26issue%3D9%26spage%3D2321%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Illy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purisima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mort, J. S.</span><span> </span><span class="NLM_article-title">Role of the Occluding Loop in Cathepsin B Activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span><span class="refDoi"> DOI: 10.1074/jbc.272.2.1197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1074%2Fjbc.272.2.1197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=1197-1202&issue=2&author=C.+Illyauthor=O.+Quraishiauthor=J.+Wangauthor=E.+Purisimaauthor=T.+Vernetauthor=J.+S.+Mort&title=Role+of+the+Occluding+Loop+in+Cathepsin+B+Activity&doi=10.1074%2Fjbc.272.2.1197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.2.1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.2.1197%26sid%3Dliteratum%253Aachs%26aulast%3DIlly%26aufirst%3DC.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPurisima%26aufirst%3DE.%26aulast%3DVernet%26aufirst%3DT.%26aulast%3DMort%26aufirst%3DJ.%2BS.%26atitle%3DRole%2520of%2520the%2520Occluding%2520Loop%2520in%2520Cathepsin%2520B%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D2%26spage%3D1197%26epage%3D1202%26doi%3D10.1074%2Fjbc.272.2.1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mohamed, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, B. F.</span><span> </span><span class="NLM_article-title">Cysteine Cathepsins: Multifunctional Enzymes in Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1038/nrc1949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnrc1949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=16990854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=764-775&issue=10&author=M.+M.+Mohamedauthor=B.+F.+Sloane&title=Cysteine+Cathepsins%3A+Multifunctional+Enzymes+in+Cancer&doi=10.1038%2Fnrc1949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: multifunctional enzymes in cancer</span></div><div class="casAuthors">Mohamed, Mona Mostafa; Sloane, Bonnie F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">764-775</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cysteine cathepsins are highly upregulated in a wide variety of cancers by mechanisms ranging from gene amplification to post-transcriptional modification.  Their localization within intracellular lysosomes often changes during neoplastic progression, resulting in secretion of both inactive and active forms and assocn. with binding partners on the tumor cell surface.  Secreted, cell-surface and intracellular cysteine cathepsins function in proteolytic pathways that increase neoplastic progression.  Direct proof for causal roles in tumor growth, migration, invasion, angiogenesis and metastasis has been shown by downregulating or ablating the expression of individual cysteine cathepsins in tumor cells and in transgenic mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDlqycZnS3qbVg90H21EOLACvtfcHk0ljpXakxRpUzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7Y%253D&md5=360e206cd24a46a71c0d223c6bbd5875</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc1949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1949%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DM.%2BM.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26atitle%3DCysteine%2520Cathepsins%253A%2520Multifunctional%2520Enzymes%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D10%26spage%3D764%26epage%3D775%26doi%3D10.1038%2Fnrc1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gondi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, J. S.</span><span> </span><span class="NLM_article-title">Cathepsin B as a Cancer Target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1517/14728222.2013.740461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1517%2F14728222.2013.740461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=23293836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislOnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=281-291&issue=3&author=C.+S.+Gondiauthor=J.+S.+Rao&title=Cathepsin+B+as+a+Cancer+Target&doi=10.1517%2F14728222.2013.740461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B as a cancer target</span></div><div class="casAuthors">Gondi, Christopher S.; Rao, Jasti S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Cathepsin B is of significant importance to cancer therapy as it is involved in various pathologies and oncogenic processes in humans.  Numerous studies have shown that abnormal regulation of cathepsin B overexpression is correlated with invasive and metastatic phenotypes in cancers.  Cathepsin B is normally assocd. with the lysosomes involved in autophagy and immune response, but its aberrant expression has been shown to lead to cancers.Areas covered: This review highlights the oncogenic role of cathepsin B, discusses the regulation of cathepsin B in light of oncogenesis, discusses the role of cathepsin B as a signaling mol., and highlights the therapeutic potential of targeting cathepsin B.Expert opinion: Targeting cathepsin B alone does not appear to abolish tumor growth, and this is probably because cathepsin B appears to have diverse functions and influence numerous pathways.  It is not clear whether global suppression of cathepsin B activity or expression would produce unintended effects or cause the activation or suppression of unwanted pathways.  A localized approach for targeting the expression of cathepsin B would be more relevant.  Moreover, a combination of targeting cathepsin B with other relevant oncogenic mols. has significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtcRD5I_kMbVg90H21EOLACvtfcHk0lgg7w6rrXGZog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislOnur8%253D&md5=502239d3736e79eecd38c6e08b72127e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.740461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.740461%26sid%3Dliteratum%253Aachs%26aulast%3DGondi%26aufirst%3DC.%2BS.%26aulast%3DRao%26aufirst%3DJ.%2BS.%26atitle%3DCathepsin%2520B%2520as%2520a%2520Cancer%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D281%26epage%3D291%26doi%3D10.1517%2F14728222.2013.740461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Roshy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moin, K.</span><span> </span><span class="NLM_article-title">Pericellular Cathepsin B and Malignant Progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1023/A:1023007717757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1023%2FA%3A1023007717757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=12785001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=271-286&author=S.+Roshyauthor=B.+F.+Sloaneauthor=K.+Moin&title=Pericellular+Cathepsin+B+and+Malignant+Progression&doi=10.1023%2FA%3A1023007717757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pericellular cathepsin B and malignant progression</span></div><div class="casAuthors">Roshy, Stefanie; Sloane, Bonnie F.; Moin, Kamiar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">271-286</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Cathepsin B is a lysosomal cysteine protease in normal cells and tissues.  In malignant tumors and premalignant lesions, the expression of cathepsin B is highly upregulated and the enzyme is secreted and becomes assocd. with the cell surface.  Increases in expression are mediated at many levels ranging from gene amplification to increased stability of mRNA and protein.  Cathepsin B is synthesized as a pre-proenzyme and the primary pathways for its normal trafficking to the lysosome utilize mannose 6-phosphate receptors (MPRs).  Inactive procathepsin B is processed to active single and double chain forms of cathepsin B in the late endosomes and lysosomes, resp.  Tumor cells secrete procathepsin B and both active forms of cathepsin B. Secretion of procathepsin B occurs principally as a result of increased expression, whereas secretion of active cathepsin B seems to involve active processes that can be induced by a variety of mechanisms.  Once secreted procathepsin B binds to the tumor cell surface via p11, the light chain of the annexin II hetero-tetramer.  This binding seems to facilitate conversion of procathepsin B to its active forms.  Cathepsin B and the annexin II hetero-tetramer colocalize in caveolae (lipid raft) fractions isolated from tumor cells.  Serine proteases and matrix metalloproteinases also have been found to assoc. with caveolae and some with the annexin II hetero-tetramer.  Our working hypothesis is that pericellular cathepsin B through its proximity to other proteases in caveolae participates in, perhaps even initiates, a proteolytic cascade on the tumor cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMshEulUWsx7Vg90H21EOLACvtfcHk0lhjT8Vp4R1WAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CjtLs%253D&md5=90c4716a4c1f7fa190ebaf6a0704abf0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023007717757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023007717757%26sid%3Dliteratum%253Aachs%26aulast%3DRoshy%26aufirst%3DS.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26aulast%3DMoin%26aufirst%3DK.%26atitle%3DPericellular%2520Cathepsin%2520B%2520and%2520Malignant%2520Progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D271%26epage%3D286%26doi%3D10.1023%2FA%3A1023007717757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mitrović, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirković, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosič, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span> </span><span class="NLM_article-title">Inhibition of Endopeptidase and Exopeptidase Activity of Cathepsin B Impairs Extracellular Matrix Degradation and Tumour Invasion</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1515/hsz-2015-0236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2Fhsz-2015-0236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=164-174&issue=2&author=A.+Mitrovi%C4%87author=B.+Mirkovi%C4%87author=I.+Sosi%C4%8Dauthor=S.+Gobecauthor=J.+Kos&title=Inhibition+of+Endopeptidase+and+Exopeptidase+Activity+of+Cathepsin+B+Impairs+Extracellular+Matrix+Degradation+and+Tumour+Invasion&doi=10.1515%2Fhsz-2015-0236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0236%26sid%3Dliteratum%253Aachs%26aulast%3DMitrovi%25C4%2587%26aufirst%3DA.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Endopeptidase%2520and%2520Exopeptidase%2520Activity%2520of%2520Cathepsin%2520B%2520Impairs%2520Extracellular%2520Matrix%2520Degradation%2520and%2520Tumour%2520Invasion%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26issue%3D2%26spage%3D164%26epage%3D174%26doi%3D10.1515%2Fhsz-2015-0236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cezari, M. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Cathepsin B Carboxydipeptidase Specificity Analysis Using Internally Quenched Fluorescent Peptides</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.1042/bj20020840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1042%2Fbj20020840" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2002&pages=365-369&issue=1&author=M.+H.+S.+Cezariauthor=L.+Puzerauthor=M.+A.+Julianoauthor=A.+K.+Carmonaauthor=L.+Juliano&title=Cathepsin+B+Carboxydipeptidase+Specificity+Analysis+Using+Internally+Quenched+Fluorescent+Peptides&doi=10.1042%2Fbj20020840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1042%2Fbj20020840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020840%26sid%3Dliteratum%253Aachs%26aulast%3DCezari%26aufirst%3DM.%2BH.%2BS.%26aulast%3DPuzer%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DCarmona%26aufirst%3DA.%2BK.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DCathepsin%2520B%2520Carboxydipeptidase%2520Specificity%2520Analysis%2520Using%2520Internally%2520Quenched%2520Fluorescent%2520Peptides%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D368%26issue%3D1%26spage%3D365%26epage%3D369%26doi%3D10.1042%2Fbj20020840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Choe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbaum, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span> </span><span class="NLM_article-title">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">12824</span><span class="NLM_x">–</span> <span class="NLM_lpage">12832</span><span class="refDoi"> DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&issue=18&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+Profiling+of+Cysteine+Proteases+Using+a+Combinatorial+Peptide+Library+Identifies+Functionally+Unique+Specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0ljghs0htv6b1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520Profiling%2520of%2520Cysteine%2520Proteases%2520Using%2520a%2520Combinatorial%2520Peptide%2520Library%2520Identifies%2520Functionally%2520Unique%2520Specificities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D18%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuire, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duzer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppa, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigg, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughty, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knap, A. K.</span><span> </span><span class="NLM_article-title">Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4524</span><span class="NLM_x">–</span> <span class="NLM_lpage">4534</span><span class="refDoi"> DOI: 10.1021/jm010206q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010206q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1eltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4524-4534&issue=26&author=P.+D.+Greenspanauthor=K.+L.+Clarkauthor=R.+A.+Tommasiauthor=S.+D.+Cowenauthor=L.+W.+McQuireauthor=D.+L.+Farleyauthor=J.+H.+Van+Duzerauthor=R.+L.+Goldbergauthor=H.+Zhouauthor=Z.+Duauthor=J.+J.+Fittauthor=D.+E.+Coppaauthor=Z.+Fangauthor=W.+Macchiaauthor=L.+Zhuauthor=M.+P.+Capparelliauthor=R.+Goldsteinauthor=A.+M.+Wiggauthor=J.+R.+Doughtyauthor=R.+S.+Bohacekauthor=A.+K.+Knap&title=Identification+of+Dipeptidyl+Nitriles+as+Potent+and+Selective+Inhibitors+of+Cathepsin+B+through+Structure-Based+Drug+Design&doi=10.1021%2Fjm010206q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design</span></div><div class="casAuthors">Greenspan, Paul D.; Clark, Kirk L.; Tommasi, Ruben A.; Cowen, Scott D.; McQuire, Leslie W.; Farley, David L.; van Duzer, John H.; Goldberg, Ronald L.; Zhou, Huanghai; Du, Zhengming; Fitt, John J.; Coppa, David E.; Fang, Zheng; Macchia, William; Zhu, Lijuan; Capparelli, Michael P.; Goldstein, Robert; Wigg, Andrew M.; Doughty, John R.; Bohacek, Regine S.; Knap, Ania K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4524-4534</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin B is a member of the papain superfamily of cysteine proteases and has been implicated in the pathol. of numerous diseases, including arthritis and cancer.  As part of an effort to identify potent, reversible inhibitors of this protease, we examd. a series of dipeptidyl nitriles, starting with the previously reported Cbz-Phe-NH-CH2CN (19, IC50 = 62 μM).  High-resoln. x-ray crystallog. data and mol. modeling were used to optimize the P1, P2, and P3 substituents of this template.  Cathepsin B is unique in its class in that it contains a carboxylate recognition site in the S2' pocket of the active site.  Inhibitor potency and selectivity were enhanced by tethering a carboxylate functionality from the carbon α to the nitrile to interact with this region of the enzyme.  This resulted in the identification of a compd., a 7 nM inhibitor of cathepsin B, with excellent selectivity over other cysteine cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUT8o-gafaJbVg90H21EOLACvtfcHk0lia83lGhkMJOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1eltrs%253D&md5=14a409ddc82d1ee0d43609d85c5fc647</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm010206q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010206q%26sid%3Dliteratum%253Aachs%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DClark%26aufirst%3DK.%2BL.%26aulast%3DTommasi%26aufirst%3DR.%2BA.%26aulast%3DCowen%26aufirst%3DS.%2BD.%26aulast%3DMcQuire%26aufirst%3DL.%2BW.%26aulast%3DFarley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DGoldberg%26aufirst%3DR.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DFitt%26aufirst%3DJ.%2BJ.%26aulast%3DCoppa%26aufirst%3DD.%2BE.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DMacchia%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCapparelli%26aufirst%3DM.%2BP.%26aulast%3DGoldstein%26aufirst%3DR.%26aulast%3DWigg%26aufirst%3DA.%2BM.%26aulast%3DDoughty%26aufirst%3DJ.%2BR.%26aulast%3DBohacek%26aufirst%3DR.%2BS.%26aulast%3DKnap%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520Dipeptidyl%2520Nitriles%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Cathepsin%2520B%2520through%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D26%26spage%3D4524%26epage%3D4534%26doi%3D10.1021%2Fjm010206q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Junutula, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, D. D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duenas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDorman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venook, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Wong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandlen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, W.</span><span> </span><span class="NLM_article-title">Site-Specific Conjugation of a Cytotoxic Drug to an Antibody Improves the Therapeutic Index</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1038/nbt.1480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt.1480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=18641636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Wmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=925-932&issue=8&author=J.+R.+Junutulaauthor=H.+Raabauthor=S.+Clarkauthor=S.+Bhaktaauthor=D.+D.+D.+Leipoldauthor=S.+Weirauthor=Y.+Chenauthor=M.+Simpsonauthor=S.+P.+Tsaiauthor=M.+S.+Dennisauthor=Y.+Luauthor=Y.+G.+Mengauthor=C.+Ngauthor=J.+Yangauthor=C.+C.+Leeauthor=E.+Duenasauthor=J.+Gorrellauthor=V.+Kattaauthor=A.+Kimauthor=K.+McDormanauthor=K.+Flagellaauthor=R.+Venookauthor=S.+Rossauthor=S.+D.+Spencerauthor=W.+Lee+Wongauthor=H.+B.+Lowmanauthor=R.+Vandlenauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=W.+Mallet&title=Site-Specific+Conjugation+of+a+Cytotoxic+Drug+to+an+Antibody+Improves+the+Therapeutic+Index&doi=10.1038%2Fnbt.1480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index</span></div><div class="casAuthors">Junutula, Jagath R.; Raab, Helga; Clark, Suzanna; Bhakta, Sunil; Leipold, Douglas D.; Weir, Sylvia; Chen, Yvonne; Simpson, Michelle; Tsai, Siao Ping; Dennis, Mark S.; Lu, Yanmei; Meng, Y. Gloria; Ng, Carl; Yang, Jihong; Lee, Chien C.; Duenas, Eileen; Gorrell, Jeffrey; Katta, Viswanatham; Kim, Amy; McDorman, Kevin; Flagella, Kelly; Venook, Rayna; Ross, Sarajane; Spencer, Susan D.; Wong, Wai Lee; Lowman, Henry B.; Vandlen, Richard; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Mallet, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">925-932</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antibody-drug conjugates enhance the antitumor effects of antibodies and reduce adverse systemic effects of potent cytotoxic drugs.  However, conventional drug conjugation strategies yield heterogeneous conjugates with relatively narrow therapeutic index (max. tolerated dose/curative dose).  Using leads from the authors' previously described phage display-based method to predict suitable conjugation sites, the authors engineered cysteine substitutions at positions on light and heavy chains that provide reactive thiol groups and do not perturb Ig folding and assembly, or alter antigen binding.  When conjugated to monomethyl auristatin E, an antibody against the ovarian cancer antigen MUC16 is as efficacious as a conventional conjugate in mouse xenograft models.  Moreover, it is tolerated at higher doses in rats and cynomolgus monkeys than the same conjugate prepd. by conventional approaches.  The favorable in vivo properties of the near-homogeneous compn. of this conjugate suggest that this strategy offers a general approach to retaining the antitumor efficacy of antibody-drug conjugates, while minimizing their systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4HIiPBABzRLVg90H21EOLACvtfcHk0lhjEZx0ORtS3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Wmu7s%253D&md5=d55f59594fb6349d0337dfed2783e83c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1480%26sid%3Dliteratum%253Aachs%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DLeipold%26aufirst%3DD.%2BD.%2BD.%26aulast%3DWeir%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DS.%2BP.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DY.%2BG.%26aulast%3DNg%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DDuenas%26aufirst%3DE.%26aulast%3DGorrell%26aufirst%3DJ.%26aulast%3DKatta%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DMcDorman%26aufirst%3DK.%26aulast%3DFlagella%26aufirst%3DK.%26aulast%3DVenook%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DLee%2BWong%26aufirst%3DW.%26aulast%3DLowman%26aufirst%3DH.%2BB.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DMallet%26aufirst%3DW.%26atitle%3DSite-Specific%2520Conjugation%2520of%2520a%2520Cytotoxic%2520Drug%2520to%2520an%2520Antibody%2520Improves%2520the%2520Therapeutic%2520Index%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26issue%3D8%26spage%3D925%26epage%3D932%26doi%3D10.1038%2Fnbt.1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vollmar, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourie-O’Donohue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, H. K.</span><span> </span><span class="NLM_article-title">Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2548</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGks7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=2538-2548&issue=10&author=B.+S.+Vollmarauthor=B.+Weiauthor=R.+Ohriauthor=J.+Zhouauthor=J.+Heauthor=S.-F.+Yuauthor=D.+Leipoldauthor=E.+Cosinoauthor=S.+Yeeauthor=A.+Fourie-O%E2%80%99Donohueauthor=G.+Liauthor=G.+L.+Phillipsauthor=K.+R.+Kozakauthor=A.+Kamathauthor=K.+Xuauthor=G.+Leeauthor=G.+A.+Lazarauthor=H.+K.+Erickson&title=Attachment+Site+Cysteine+Thiol+pKa+Is+a+Key+Driver+for+Site-Dependent+Stability+of+THIOMAB+Antibody-Drug+Conjugates&doi=10.1021%2Facs.bioconjchem.7b00365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates</span></div><div class="casAuthors">Vollmar, Breanna S.; Wei, Binqing; Ohri, Rachana; Zhou, Jianhui; He, Jintang; Yu, Shang-Fan; Leipold, Douglas; Cosino, Ely; Yee, Sharon; Fourie-O'Donohue, Aimee; Li, Guangmin; Phillips, Gail L.; Kozak, Katherine R.; Kamath, Amrita; Xu, Keyang; Lee, Genee; Lazar, Greg A.; Erickson, Hans K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2548</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incorporation of cysteines into antibodies by mutagenesis allows for the direct conjugation of small mols. to specific sites on the antibody via disulfide bonds.  The stability of the disulfide bond linkage between the small mol. and the antibody is highly dependent on the location of the engineered cysteine in either the heavy chain (HC) or the light chain (LC) of the antibody.  Here, we explore the basis for this site-dependent stability.  We evaluated the in vivo efficacy and pharmacokinetics of five different cysteine mutants of trastuzumab conjugated to a pyrrolobenzodiazepine (PBD) via disulfide bonds.  A significant correlation was obsd. between disulfide stability and efficacy for the conjugates.  We hypothesized that the obsd. site-dependent stability of the disulfide-linked conjugates could be due to differences in the attachment site cysteine thiol pKa.  We measured the cysteine thiol pKa using isothermal titrn. calorimetry (ITC) and found that the variants with the highest thiol pKa (LC K149C and HC A140C) were found to yield the conjugates with the greatest in vivo stability.  Guided by homol. modeling, we identified several mutations adjacent to LC K149C that reduced the cysteine thiol pKa and, thus, decreased the in vivo stability of the disulfide-linked PBD conjugated to LC K149C.  We also present results suggesting that the high thiol pKa of LC K149C is responsible for the sustained circulation stability of LC K149C TDCs utilizing a maleimide-based linker.  Taken together, our results provide evidence that the site-dependent stability of cys-engineered antibody-drug conjugates may be explained by interactions between the engineered cysteine and the local protein environment that serves to modulate the side-chain thiol pKa.  The influence of cysteine thiol pKa on stability and efficacy offers a new parameter for the optimization of ADCs that utilize cysteine engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfrN62jixCbVg90H21EOLACvtfcHk0lggOZCdQoLb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGks7vL&md5=ba1805c493f468d4ffbb198dbf8b3d02</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00365%26sid%3Dliteratum%253Aachs%26aulast%3DVollmar%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DOhri%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DLeipold%26aufirst%3DD.%26aulast%3DCosino%26aufirst%3DE.%26aulast%3DYee%26aufirst%3DS.%26aulast%3DFourie-O%25E2%2580%2599Donohue%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DG.%2BL.%26aulast%3DKozak%26aufirst%3DK.%2BR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLazar%26aufirst%3DG.%2BA.%26aulast%3DErickson%26aufirst%3DH.%2BK.%26atitle%3DAttachment%2520Site%2520Cysteine%2520Thiol%2520pKa%2520Is%2520a%2520Key%2520Driver%2520for%2520Site-Dependent%2520Stability%2520of%2520THIOMAB%2520Antibody-Drug%2520Conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26issue%3D10%26spage%3D2538%26epage%3D2548%26doi%3D10.1021%2Facs.bioconjchem.7b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Doronina, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toki, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgov, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, B. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerveny, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chace, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBlanc, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearing, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegall, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Development of Potent Monoclonal Antibody Auristatin Conjugates for Cancer Therapy</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span><span class="refDoi"> DOI: 10.1038/nbt832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1038%2Fnbt832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=12778055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=778-784&issue=7&author=S.+O.+Doroninaauthor=B.+E.+Tokiauthor=M.+Y.+Torgovauthor=B.+a+Mendelsohnauthor=C.+G.+Cervenyauthor=D.+F.+Chaceauthor=R.+L.+DeBlancauthor=R.+P.+Gearingauthor=T.+D.+Boveeauthor=C.+B.+Siegallauthor=J.+a+Franciscoauthor=A.+F.+Wahlauthor=D.+L.+Meyerauthor=P.+D.+Senter&title=Development+of+Potent+Monoclonal+Antibody+Auristatin+Conjugates+for+Cancer+Therapy&doi=10.1038%2Fnbt832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span></div><div class="casAuthors">Doronina, Svetlana O.; Toki, Brian E.; Torgov, Michael Y.; Mendelsohn, Brian A.; Cerveny, Charles G.; Chace, Dana F.; DeBlanc, Ron L.; Gearing, R. Patrick; Bovee, Tim D.; Siegall, Clay B.; Francisco, Joseph A.; Wahl, Alan F.; Meyer, Damon L.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">778-784</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs auristatin E (AE) and monomethylauristatin E (MMAE), linked to the chimeric mAbs cBR96 (specific to Lewis Y on carcinomas) and cAC10 (specific to CD30 on hematol. malignancies).  The linkers used for conjugate formation included an acid-labile hydrazone and protease-sensitive dipeptides, leading to uniformly substituted conjugates that efficiently released active drug in the lysosomes of antigen-pos. (Ag+) tumor cells.  The peptide-linked mAb-valine-citrulline-MMAE and mAb-phenylalanine-lysine-MMAE conjugates were much more stable in buffers and plasma than the conjugates of mAb and the hydrazone of 5-benzoylvaleric acid-AE ester (AEVB).  As a result, the mAb-Val-Cit-MMAE conjugates exhibited greater in vitro specificity and lower in vivo toxicity than corresponding hydrazone conjugates.  In vivo studies demonstrated that the peptide-linked conjugates induced regressions and cures of established tumor xenografts with therapeutic indexes as high as 60-fold.  These conjugates illustrate the importance of linker technol., drug potency and conjugation methodol. in developing safe and efficacious mAb-drug conjugates for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro97SFKtdQ7rVg90H21EOLACvtfcHk0lggOZCdQoLb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D&md5=d77716ec93de5ac7473c18a597339086</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnbt832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt832%26sid%3Dliteratum%253Aachs%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DToki%26aufirst%3DB.%2BE.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DMendelsohn%26aufirst%3DB.%2Ba%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DDeBlanc%26aufirst%3DR.%2BL.%26aulast%3DGearing%26aufirst%3DR.%2BP.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DSiegall%26aufirst%3DC.%2BB.%26aulast%3DFrancisco%26aufirst%3DJ.%2Ba%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDevelopment%2520of%2520Potent%2520Monoclonal%2520Antibody%2520Auristatin%2520Conjugates%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D7%26spage%3D778%26epage%3D784%26doi%3D10.1038%2Fnbt832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Montaser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalmanach, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, L.</span><span> </span><span class="NLM_article-title">CA-074, but Not Its Methyl Ester CA-074Me, Is a Selective Inhibitor of Cathepsin B within Living Cells</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x"> (</span><span class="NLM_issue">7–8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span><span class="refDoi"> DOI: 10.1515/BC.2002.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2FBC.2002.147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=1305-1308&issue=7%E2%80%938&author=M.+Montaserauthor=G.+Lalmanachauthor=L.+Mach&title=CA-074%2C+but+Not+Its+Methyl+Ester+CA-074Me%2C+Is+a+Selective+Inhibitor+of+Cathepsin+B+within+Living+Cells&doi=10.1515%2FBC.2002.147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1515%2FBC.2002.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2002.147%26sid%3Dliteratum%253Aachs%26aulast%3DMontaser%26aufirst%3DM.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DMach%26aufirst%3DL.%26atitle%3DCA-074%252C%2520but%2520Not%2520Its%2520Methyl%2520Ester%2520CA-074Me%252C%2520Is%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520B%2520within%2520Living%2520Cells%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26issue%3D7%25E2%2580%25938%26spage%3D1305%26epage%3D1308%26doi%3D10.1515%2FBC.2002.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minematsu-Ikeguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kominami, E.</span><span> </span><span class="NLM_article-title">Characterization of CAA0225, a Novel Inhibitor Specific for Cathepsin L, as a Probe for Autophagic Proteolysis</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1248/bpb.32.475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1248%2Fbpb.32.475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=19252298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-479&issue=3&author=K.+Takahashiauthor=T.+Uenoauthor=I.+Tanidaauthor=N.+Minematsu-Ikeguchiauthor=M.+Murataauthor=E.+Kominami&title=Characterization+of+CAA0225%2C+a+Novel+Inhibitor+Specific+for+Cathepsin+L%2C+as+a+Probe+for+Autophagic+Proteolysis&doi=10.1248%2Fbpb.32.475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis</span></div><div class="casAuthors">Takahashi, Katsuyuki; Ueno, Takashi; Tanida, Isei; Minematsu-Ikeguchi, Naoko; Murata, Mitsuo; Kominami, Eiki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-479</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">We screened a series of new epoxysuccinyl peptides for the development of a lysosomal cathepsin L-specific inhibitor.  Among the compds. tested, (2S,3S)-oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide} (compd. CAA0225) was the most potent inhibitor of cathepsin L.  CAA0225 inhibited rat liver cathepsin L with IC50 values of 1.9 nm, but not rat liver cathepsin B (IC50, >1000 - 5000 nm).  To assess the contribution of cathepsin L to lysosomal proteolysis, we evaluated autophagy, which is the process of lysosomal self-degrdn. of cell constituents.  In HeLa and Huh-7 cells cultured under nutrient-deprived conditions CAA0225 significantly inhibited degrdn. of long-lived proteins; however, the magnitude of inhibition was comparable to that in the presence of CA-074-OMe, which is a cathepsin B-specific inhibitor.  Thus the contributions of cathepsin L and cathepsin B to autophagic protein degrdn. of cytoplasmic proteins are nearly equal.  During autophagy, microtubule-assocd. protein IA/IB light chain 3-II (LC3-II) and γ-aminobutyric acid (A) receptor-assocd. protein (GABARAP)-II, which are specific markers of autophagosomal membranes that engulf cytoplasmic components, also undergo degrdn. upon fusion of autophagosomes with lysosomes.  CAA0225 effectively inhibited degrdn. of LC3-II and GABARAP, whereas CA-074-OMe had only a marginal effect on their levels.  Therefore we conclude that cathepsin L does not play a general role in the degrdn. of proteins in the lumen of autophagosomes, but rather is involved specifically in the degrdn. of autophagosomal membrane markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4bMti3zSNRrVg90H21EOLACvtfcHk0lj6oYXQmEDeFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVarurg%253D&md5=3ca4f7ed503320e9a8c160d626cb7aa7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1248%2Fbpb.32.475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.32.475%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DTanida%26aufirst%3DI.%26aulast%3DMinematsu-Ikeguchi%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DKominami%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520CAA0225%252C%2520a%2520Novel%2520Inhibitor%2520Specific%2520for%2520Cathepsin%2520L%252C%2520as%2520a%2520Probe%2520for%2520Autophagic%2520Proteolysis%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D32%26issue%3D3%26spage%3D475%26epage%3D479%26doi%3D10.1248%2Fbpb.32.475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Pharmacological Inhibitors to Identify Roles of Cathepsin K in Cell-Based Studies: A Comparison of Available Tools</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span><span class="refDoi"> DOI: 10.1515/BC.2009.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1515%2FBC.2009.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2009&pages=941-948&issue=9&author=S.+Desmaraisauthor=F.+Mass%C3%A9author=M.+D.+Percival&title=Pharmacological+Inhibitors+to+Identify+Roles+of+Cathepsin+K+in+Cell-Based+Studies%3A+A+Comparison+of+Available+Tools&doi=10.1515%2FBC.2009.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1515%2FBC.2009.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2009.092%26sid%3Dliteratum%253Aachs%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DPharmacological%2520Inhibitors%2520to%2520Identify%2520Roles%2520of%2520Cathepsin%2520K%2520in%2520Cell-Based%2520Studies%253A%2520A%2520Comparison%2520of%2520Available%2520Tools%26jtitle%3DBiol.%2520Chem.%26date%3D2009%26volume%3D390%26issue%3D9%26spage%3D941%26epage%3D948%26doi%3D10.1515%2FBC.2009.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Marciniszyn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartsuck, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Mode of Inhibition of Acid Proteases by Pepstatin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7088</span><span class="NLM_x">–</span> <span class="NLM_lpage">7094</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1976&pages=7088-7094&issue=22&author=J.+Marciniszynauthor=J.+A.+Hartsuckauthor=J.+Tang&title=Mode+of+Inhibition+of+Acid+Proteases+by+Pepstatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarciniszyn%26aufirst%3DJ.%26aulast%3DHartsuck%26aufirst%3DJ.%2BA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DMode%2520of%2520Inhibition%2520of%2520Acid%2520Proteases%2520by%2520Pepstatin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1976%26volume%3D251%26issue%3D22%26spage%3D7088%26epage%3D7094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Libby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, a L.</span><span> </span><span class="NLM_article-title">Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased Muscles</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x"> (</span><span class="NLM_issue">4328</span><span class="NLM_x">) </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1126/science.622552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.1126%2Fscience.622552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=622552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADyaE1cXpvFOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=1978&pages=534-536&issue=4328&author=P.+Libbyauthor=a+L.+Goldberg&title=Leupeptin%2C+a+Protease+Inhibitor%2C+Decreases+Protein+Degradation+in+Normal+and+Diseased+Muscles&doi=10.1126%2Fscience.622552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles</span></div><div class="casAuthors">Libby, Peter; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">4328</span>),
    <span class="NLM_cas:pages">534-6</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The protease inhibitor leupeptin decreased protein degrdn. in rat skeletal and cardiac muscle incubated in vitro, whereas protein synthesis remained unaltered.  Leupeptin also lowered protein breakdown in denervated rat muscles and affected muscles from mice with hereditary muscular dystrophy.  Leupeptin may thus be useful in retarding tissue atrophy.  Since homogenates of leupeptin-treated muscles had decreased cathepsin B  [9047-22-7] activity, this lysosomal protease may play a role in protein turnover in normal and diseased muscles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu3olGcFFW_LVg90H21EOLACvtfcHk0ljglqRDJkjV8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXpvFOhsw%253D%253D&md5=83994895cf8685a1844e8efc6e17f640</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.622552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.622552%26sid%3Dliteratum%253Aachs%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGoldberg%26aufirst%3Da%2BL.%26atitle%3DLeupeptin%252C%2520a%2520Protease%2520Inhibitor%252C%2520Decreases%2520Protein%2520Degradation%2520in%2520Normal%2520and%2520Diseased%2520Muscles%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1978%26volume%3D199%26issue%3D4328%26spage%3D534%26epage%3D536%26doi%3D10.1126%2Fscience.622552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gregson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, D. E.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of a Novel Pyrrolobenzodiazepine DNA-Interactive Agent with Highly Efficient Cross-Linking Ability and Potent Cytotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1021/jm001064n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001064n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=737-748&issue=5&author=S.+J.+Gregsonauthor=P.+W.+Howardauthor=J.+A.+Hartleyauthor=N.+A.+Brooksauthor=L.+J.+Adamsauthor=T.+C.+Jenkinsauthor=L.+R.+Kellandauthor=D.+E.+Thurston&title=Design%2C+Synthesis%2C+and+Evaluation+of+a+Novel+Pyrrolobenzodiazepine+DNA-Interactive+Agent+with+Highly+Efficient+Cross-Linking+Ability+and+Potent+Cytotoxicity&doi=10.1021%2Fjm001064n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm001064n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001064n%26sid%3Dliteratum%253Aachs%26aulast%3DGregson%26aufirst%3DS.%2BJ.%26aulast%3DHoward%26aufirst%3DP.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DAdams%26aufirst%3DL.%2BJ.%26aulast%3DJenkins%26aufirst%3DT.%2BC.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DThurston%26aufirst%3DD.%2BE.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520a%2520Novel%2520Pyrrolobenzodiazepine%2520DNA-Interactive%2520Agent%2520with%2520Highly%2520Efficient%2520Cross-Linking%2520Ability%2520and%2520Potent%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D5%26spage%3D737%26epage%3D748%26doi%3D10.1021%2Fjm001064n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dere, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco-Triguero, M.</span><span> </span><span class="NLM_article-title">Bioanalytical Assay Strategies for the Development of Antibody–drug Conjugate Biotherapeutics</span> <span class="citation_source-journal">Bioanalysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.4155/bio.12.299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=10.4155%2Fbio.12.299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=23330562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=201-226&issue=2&author=S.+Kaurauthor=K.+Xuauthor=O.+M.+Saadauthor=R.+C.+Dereauthor=M.+Carrasco-Triguero&title=Bioanalytical+Assay+Strategies+for+the+Development+of+Antibody%E2%80%93drug+Conjugate+Biotherapeutics&doi=10.4155%2Fbio.12.299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics</span></div><div class="casAuthors">Kaur, Surinder; Xu, Keyang; Saad, Ola M.; Dere, Randall C.; Carrasco-Triguero, Montserrat</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-226</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) are monoclonal antibodies with covalently bound cytotoxic drugs.  They are designed to target tumor antigens selectively and offer the hope of cancer treatment without the debilitating side-effects of conventional therapies.  The concept of ADCs is not new; however, development of these therapeutics is challenging and only recently are promising clin. data emerging.  These challenges include ADC bioanal., such as quantifying in serum/plasma for PK studies and strategies for assessing immunogenicity.  ADCs have complex mol. structures incorporating large- and small-mol. characteristics and require diverse anal. methods, including ligand-binding assays and MS-based methods.  ADCs are typically mixts. with a range of drug-to-antibody ratios.  Biotransformations in vivo can lead to addnl. changes in drug-to-antibody ratios resulting in dynamically changing mixts.  Thus, a std. calibration curve consisting of the ref. std. may not be appropriate for quantification of analytes in vivo and represents a unique challenge.  This paper will share our perspective on why ADC bioanal. is so complex and describe the strategies and rationale that we have used for ADCs, with highlights of original data from a variety of nonclin. and clin. case studies.  Our strategy has involved novel protein structural characterization tools to help understand ADC biotransformations in vivo and use of the analyte knowledge gained to guide the development of quant. bioanal. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDYXrBsuA0UrVg90H21EOLACvtfcHk0ljqDiLqqCZiBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtLY%253D&md5=ee3a3fc2802412e0ce257a609dc91d52</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Fbio.12.299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.12.299%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DDere%26aufirst%3DR.%2BC.%26aulast%3DCarrasco-Triguero%26aufirst%3DM.%26atitle%3DBioanalytical%2520Assay%2520Strategies%2520for%2520the%2520Development%2520of%2520Antibody%25E2%2580%2593drug%2520Conjugate%2520Biotherapeutics%26jtitle%3DBioanalysis%26date%3D2013%26volume%3D5%26issue%3D2%26spage%3D201%26epage%3D226%26doi%3D10.4155%2Fbio.12.299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY','PDB','1GMY'); return false;">PDB: 1GMY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AY2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AY2','PDB','6AY2'); return false;">PDB: 6AY2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01430">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37288"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01430">10.1021/acs.jmedchem.7b01430</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figure S1 showing models of the tetrahedral intermediate of hydrolysis for <b>7</b> and <b>9</b>; Figure S2 showing the body weight data for the efficacy study in the CD22-expressing lymphoma model WSU-DLCL2; Table S1 listing the crystallographic data statistics; synthesis and characterization of compounds <b>1</b>–<b>36</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>7</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>9</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Three-dimensional coordinates of the model of the tetrahedral intermediate of hydrolysis for compound chain A of PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GMY">1GMY</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_005.pdb">PDB</a>)</p></li><li><p class="inline">SMILES strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_006.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_001.pdf">jm7b01430_si_001.pdf (1.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_002.pdb">jm7b01430_si_002.pdb (7.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_003.pdb">jm7b01430_si_003.pdb (8.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_004.pdb">jm7b01430_si_004.pdb (6.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_005.pdb">jm7b01430_si_005.pdb (179.04 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01430/suppl_file/jm7b01430_si_006.csv">jm7b01430_si_006.csv (4.85 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray crystallographic structure of <b>28</b> bound to human cathepsin B was deposited in the PDB under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AY2">6AY2</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01430&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01430%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01430" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679902bd4dee3d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
